id	sid	tid	token	lemma	pos
iajs-3630	1	1	302	302	NUM
iajs-3630	1	2	©	©	PROPN
iajs-3630	1	3	2025	2025	NUM
iajs-3630	1	4	the	the	DET
iajs-3630	1	5	author(s	author(s	NOUN
iajs-3630	1	6	)	)	PUNCT
iajs-3630	1	7	.	.	PUNCT
iajs-3630	2	1	published	publish	VERB
iajs-3630	2	2	by	by	ADP
iajs-3630	2	3	college	college	NOUN
iajs-3630	2	4	of	of	ADP
iajs-3630	2	5	education	education	NOUN
iajs-3630	2	6	for	for	ADP
iajs-3630	2	7	pure	pure	ADJ
iajs-3630	2	8	science	science	NOUN
iajs-3630	2	9	(	(	PUNCT
iajs-3630	2	10	ibn	ibn	PROPN
iajs-3630	2	11	al	al	PROPN
iajs-3630	2	12	-	-	PUNCT
iajs-3630	2	13	haitham	haitham	PROPN
iajs-3630	2	14	)	)	PUNCT
iajs-3630	2	15	,	,	PUNCT
iajs-3630	2	16	university	university	NOUN
iajs-3630	2	17	of	of	ADP
iajs-3630	2	18	baghdad	baghdad	PROPN
iajs-3630	2	19	.	.	PUNCT
iajs-3630	3	1	this	this	PRON
iajs-3630	3	2	is	be	AUX
iajs-3630	3	3	an	an	DET
iajs-3630	3	4	open	open	ADJ
iajs-3630	3	5	-	-	PUNCT
iajs-3630	3	6	access	access	NOUN
iajs-3630	3	7	article	article	NOUN
iajs-3630	3	8	distributed	distribute	VERB
iajs-3630	3	9	under	under	ADP
iajs-3630	3	10	the	the	DET
iajs-3630	3	11	terms	term	NOUN
iajs-3630	3	12	of	of	ADP
iajs-3630	3	13	the	the	DET
iajs-3630	3	14	creative	creative	ADJ
iajs-3630	3	15	commons	common	NOUN
iajs-3630	3	16	attribution	attribution	NOUN
iajs-3630	3	17	4.0	4.0	NUM
iajs-3630	3	18	international	international	ADJ
iajs-3630	3	19	license	license	NOUN
iajs-3630	3	20	evaluation	evaluation	NOUN
iajs-3630	3	21	of	of	ADP
iajs-3630	3	22	irisin	irisin	ADJ
iajs-3630	3	23	level	level	NOUN
iajs-3630	3	24	in	in	ADP
iajs-3630	3	25	iraqi	iraqi	ADJ
iajs-3630	3	26	patients	patient	NOUN
iajs-3630	3	27	with	with	ADP
iajs-3630	3	28	type	type	NOUN
iajs-3630	3	29	2	2	NUM
iajs-3630	3	30	diabetes	diabetes	NOUN
iajs-3630	3	31	and	and	CCONJ
iajs-3630	3	32	pre	pre	ADJ
iajs-3630	3	33	-	-	ADJ
iajs-3630	3	34	diabetes	diabetes	ADJ
iajs-3630	3	35	status	status	NOUN
iajs-3630	3	36	as	as	ADP
iajs-3630	3	37	a	a	DET
iajs-3630	3	38	predictive	predictive	ADJ
iajs-3630	3	39	factor	factor	NOUN
iajs-3630	3	40	hiba	hiba	PROPN
iajs-3630	3	41	mohammed	mohammed	PROPN
iajs-3630	4	1	hatem1	hatem1	PROPN
iajs-3630	4	2	*	*	PUNCT
iajs-3630	4	3	and	and	CCONJ
iajs-3630	4	4	kadhim	kadhim	ADJ
iajs-3630	4	5	khudhair	khudhair	NOUN
iajs-3630	4	6	ghudhaib2	ghudhaib2	NOUN
iajs-3630	5	1	1,2department	1,2department	NUM
iajs-3630	5	2	of	of	ADP
iajs-3630	5	3	chemistry	chemistry	NOUN
iajs-3630	5	4	,	,	PUNCT
iajs-3630	5	5	college	college	NOUN
iajs-3630	5	6	of	of	ADP
iajs-3630	5	7	science	science	NOUN
iajs-3630	5	8	for	for	ADP
iajs-3630	5	9	women	woman	NOUN
iajs-3630	5	10	,	,	PUNCT
iajs-3630	5	11	university	university	NOUN
iajs-3630	5	12	of	of	ADP
iajs-3630	5	13	baghdad	baghdad	PROPN
iajs-3630	5	14	,	,	PUNCT
iajs-3630	5	15	baghdad	baghdad	PROPN
iajs-3630	5	16	,	,	PUNCT
iajs-3630	5	17	iraq	iraq	PROPN
iajs-3630	5	18	.	.	PUNCT
iajs-3630	6	1	*	*	PUNCT
iajs-3630	6	2	corresponding	correspond	VERB
iajs-3630	6	3	author	author	NOUN
iajs-3630	6	4	.	.	PUNCT
iajs-3630	7	1	received	receive	VERB
iajs-3630	7	2	:	:	PUNCT
iajs-3630	7	3	27	27	NUM
iajs-3630	7	4	june	june	PROPN
iajs-3630	7	5	2023	2023	NUM
iajs-3630	7	6	accepted	accept	VERB
iajs-3630	7	7	:	:	PUNCT
iajs-3630	7	8	14	14	NUM
iajs-3630	7	9	august	august	PROPN
iajs-3630	7	10	2023	2023	NUM
iajs-3630	7	11	published	publish	VERB
iajs-3630	7	12	:	:	PUNCT
iajs-3630	7	13	20	20	NUM
iajs-3630	7	14	january	january	NOUN
iajs-3630	7	15	2025	2025	NUM
iajs-3630	7	16	doi.org/10.30526/38.1.3630	doi.org/10.30526/38.1.3630	PROPN
iajs-3630	7	17	abstract	abstract	NOUN
iajs-3630	7	18	the	the	DET
iajs-3630	7	19	prevalence	prevalence	NOUN
iajs-3630	7	20	of	of	ADP
iajs-3630	7	21	diabetes	diabetes	NOUN
iajs-3630	7	22	is	be	AUX
iajs-3630	7	23	increasing	increase	VERB
iajs-3630	7	24	rapidly	rapidly	ADV
iajs-3630	7	25	and	and	CCONJ
iajs-3630	7	26	is	be	AUX
iajs-3630	7	27	now	now	ADV
iajs-3630	7	28	recognized	recognize	VERB
iajs-3630	7	29	as	as	ADP
iajs-3630	7	30	a	a	DET
iajs-3630	7	31	significant	significant	ADJ
iajs-3630	7	32	global	global	ADJ
iajs-3630	7	33	health	health	NOUN
iajs-3630	7	34	problem	problem	NOUN
iajs-3630	7	35	.	.	PUNCT
iajs-3630	8	1	diabetes	diabetes	NOUN
iajs-3630	8	2	occurs	occur	VERB
iajs-3630	8	3	when	when	SCONJ
iajs-3630	8	4	a	a	DET
iajs-3630	8	5	person	person	NOUN
iajs-3630	8	6	does	do	AUX
iajs-3630	8	7	not	not	PART
iajs-3630	8	8	produce	produce	VERB
iajs-3630	8	9	enough	enough	ADJ
iajs-3630	8	10	insulin	insulin	NOUN
iajs-3630	8	11	due	due	ADP
iajs-3630	8	12	to	to	ADP
iajs-3630	8	13	an	an	DET
iajs-3630	8	14	imbalance	imbalance	NOUN
iajs-3630	8	15	in	in	ADP
iajs-3630	8	16	insulin	insulin	NOUN
iajs-3630	8	17	production	production	NOUN
iajs-3630	8	18	.	.	PUNCT
iajs-3630	9	1	this	this	PRON
iajs-3630	9	2	can	can	AUX
iajs-3630	9	3	lead	lead	VERB
iajs-3630	9	4	to	to	ADP
iajs-3630	9	5	the	the	DET
iajs-3630	9	6	failure	failure	NOUN
iajs-3630	9	7	of	of	ADP
iajs-3630	9	8	organs	organ	NOUN
iajs-3630	9	9	and	and	CCONJ
iajs-3630	9	10	tissues	tissue	NOUN
iajs-3630	9	11	such	such	ADJ
iajs-3630	9	12	as	as	ADP
iajs-3630	9	13	the	the	DET
iajs-3630	9	14	kidneys	kidney	NOUN
iajs-3630	9	15	,	,	PUNCT
iajs-3630	9	16	heart	heart	NOUN
iajs-3630	9	17	,	,	PUNCT
iajs-3630	9	18	blood	blood	NOUN
iajs-3630	9	19	vessels	vessel	NOUN
iajs-3630	9	20	,	,	PUNCT
iajs-3630	9	21	eyes	eye	NOUN
iajs-3630	9	22	,	,	PUNCT
iajs-3630	9	23	nerves	nerve	NOUN
iajs-3630	9	24	,	,	PUNCT
iajs-3630	9	25	and	and	CCONJ
iajs-3630	9	26	kidneys	kidney	NOUN
iajs-3630	9	27	.	.	PUNCT
iajs-3630	10	1	as	as	ADP
iajs-3630	10	2	a	a	DET
iajs-3630	10	3	result	result	NOUN
iajs-3630	10	4	,	,	PUNCT
iajs-3630	10	5	early	early	ADJ
iajs-3630	10	6	diagnosis	diagnosis	NOUN
iajs-3630	10	7	and	and	CCONJ
iajs-3630	10	8	classification	classification	NOUN
iajs-3630	10	9	of	of	ADP
iajs-3630	10	10	type	type	NOUN
iajs-3630	10	11	2	2	NUM
iajs-3630	10	12	diabetes	diabetes	NOUN
iajs-3630	10	13	mellitus	mellitus	NOUN
iajs-3630	10	14	(	(	PUNCT
iajs-3630	10	15	t2	t2	NOUN
iajs-3630	10	16	dm	dm	NOUN
iajs-3630	10	17	)	)	PUNCT
iajs-3630	10	18	are	be	AUX
iajs-3630	10	19	critical	critical	ADJ
iajs-3630	10	20	to	to	ADP
iajs-3630	10	21	aiding	aid	VERB
iajs-3630	10	22	physician	physician	NOUN
iajs-3630	10	23	assessments	assessment	NOUN
iajs-3630	10	24	.	.	PUNCT
iajs-3630	11	1	subsequently	subsequently	ADV
iajs-3630	11	2	,	,	PUNCT
iajs-3630	11	3	the	the	DET
iajs-3630	11	4	current	current	ADJ
iajs-3630	11	5	study	study	NOUN
iajs-3630	11	6	aims	aim	VERB
iajs-3630	11	7	to	to	PART
iajs-3630	11	8	determine	determine	VERB
iajs-3630	11	9	irisin	irisin	ADJ
iajs-3630	11	10	levels	level	NOUN
iajs-3630	11	11	in	in	ADP
iajs-3630	11	12	patients	patient	NOUN
iajs-3630	11	13	with	with	ADP
iajs-3630	11	14	t2	t2	PROPN
iajs-3630	11	15	dm	dm	PROPN
iajs-3630	11	16	and	and	CCONJ
iajs-3630	11	17	predm	predm	ADV
iajs-3630	11	18	as	as	ADP
iajs-3630	11	19	early	early	ADJ
iajs-3630	11	20	predictors	predictor	NOUN
iajs-3630	11	21	for	for	ADP
iajs-3630	11	22	disease	disease	NOUN
iajs-3630	11	23	cases	case	NOUN
iajs-3630	11	24	.	.	PUNCT
iajs-3630	12	1	the	the	DET
iajs-3630	12	2	current	current	ADJ
iajs-3630	12	3	study	study	NOUN
iajs-3630	12	4	included	include	VERB
iajs-3630	12	5	138	138	NUM
iajs-3630	12	6	subjects	subject	NOUN
iajs-3630	12	7	divided	divide	VERB
iajs-3630	12	8	into	into	ADP
iajs-3630	12	9	three	three	NUM
iajs-3630	12	10	groups	group	NOUN
iajs-3630	12	11	based	base	VERB
iajs-3630	12	12	on	on	ADP
iajs-3630	12	13	fasting	fast	VERB
iajs-3630	12	14	blood	blood	NOUN
iajs-3630	12	15	glucose	glucose	NOUN
iajs-3630	12	16	(	(	PUNCT
iajs-3630	12	17	fbg	fbg	PROPN
iajs-3630	12	18	)	)	PUNCT
iajs-3630	12	19	and	and	CCONJ
iajs-3630	12	20	glycosylated	glycosylated	ADJ
iajs-3630	12	21	hemoglobin	hemoglobin	NOUN
iajs-3630	12	22	criteria	criterion	NOUN
iajs-3630	12	23	,	,	PUNCT
iajs-3630	12	24	including	include	VERB
iajs-3630	12	25	t2	t2	NOUN
iajs-3630	12	26	dm	dm	PROPN
iajs-3630	12	27	,	,	PUNCT
iajs-3630	12	28	46	46	NUM
iajs-3630	12	29	patients	patient	NOUN
iajs-3630	12	30	,	,	PUNCT
iajs-3630	12	31	pre	pre	ADJ
iajs-3630	12	32	-	-	NOUN
iajs-3630	12	33	diabetes	diabetes	ADJ
iajs-3630	12	34	,	,	PUNCT
iajs-3630	12	35	46	46	NUM
iajs-3630	12	36	participants	participant	NOUN
iajs-3630	12	37	,	,	PUNCT
iajs-3630	12	38	and	and	CCONJ
iajs-3630	12	39	healthy	healthy	ADJ
iajs-3630	12	40	subject	subject	ADJ
iajs-3630	12	41	groups	group	NOUN
iajs-3630	12	42	,	,	PUNCT
iajs-3630	12	43	46	46	NUM
iajs-3630	12	44	persons	person	NOUN
iajs-3630	12	45	)	)	PUNCT
iajs-3630	12	46	when	when	SCONJ
iajs-3630	12	47	they	they	PRON
iajs-3630	12	48	enrolled	enrol	VERB
iajs-3630	12	49	in	in	ADP
iajs-3630	12	50	the	the	DET
iajs-3630	12	51	national	national	ADJ
iajs-3630	12	52	diabetes	diabetes	NOUN
iajs-3630	12	53	center/	center/	VERB
iajs-3630	12	54	al	al	PROPN
iajs-3630	12	55	-	-	PUNCT
iajs-3630	12	56	mustansiriya	mustansiriya	PROPN
iajs-3630	12	57	university	university	NOUN
iajs-3630	12	58	.	.	PUNCT
iajs-3630	13	1	enzyme	enzyme	NOUN
iajs-3630	13	2	-	-	PUNCT
iajs-3630	13	3	linked	link	VERB
iajs-3630	13	4	immunosorbent	immunosorbent	ADJ
iajs-3630	13	5	assays	assay	NOUN
iajs-3630	13	6	were	be	AUX
iajs-3630	13	7	used	use	VERB
iajs-3630	13	8	to	to	PART
iajs-3630	13	9	detect	detect	VERB
iajs-3630	13	10	the	the	DET
iajs-3630	13	11	levels	level	NOUN
iajs-3630	13	12	of	of	ADP
iajs-3630	13	13	irisin	irisin	NOUN
iajs-3630	13	14	and	and	CCONJ
iajs-3630	13	15	insulin	insulin	NOUN
iajs-3630	13	16	,	,	PUNCT
iajs-3630	13	17	and	and	CCONJ
iajs-3630	13	18	spectrophotometric	spectrophotometric	ADJ
iajs-3630	13	19	techniques	technique	NOUN
iajs-3630	13	20	were	be	AUX
iajs-3630	13	21	used	use	VERB
iajs-3630	13	22	to	to	PART
iajs-3630	13	23	determine	determine	VERB
iajs-3630	13	24	the	the	DET
iajs-3630	13	25	levels	level	NOUN
iajs-3630	13	26	of	of	ADP
iajs-3630	13	27	fbg	fbg	PROPN
iajs-3630	13	28	and	and	CCONJ
iajs-3630	13	29	lipid	lipid	NOUN
iajs-3630	13	30	profile	profile	NOUN
iajs-3630	13	31	.	.	PUNCT
iajs-3630	14	1	the	the	DET
iajs-3630	14	2	results	result	NOUN
iajs-3630	14	3	of	of	ADP
iajs-3630	14	4	irisin	irisin	NOUN
iajs-3630	14	5	revealed	reveal	VERB
iajs-3630	14	6	significant	significant	ADJ
iajs-3630	14	7	differences	difference	NOUN
iajs-3630	14	8	among	among	ADP
iajs-3630	14	9	the	the	DET
iajs-3630	14	10	studied	study	VERB
iajs-3630	14	11	groups	group	NOUN
iajs-3630	14	12	.	.	PUNCT
iajs-3630	15	1	also	also	ADV
iajs-3630	15	2	,	,	PUNCT
iajs-3630	15	3	the	the	DET
iajs-3630	15	4	insulin	insulin	NOUN
iajs-3630	15	5	results	result	NOUN
iajs-3630	15	6	showed	show	VERB
iajs-3630	15	7	substantial	substantial	ADJ
iajs-3630	15	8	differences	difference	NOUN
iajs-3630	15	9	between	between	ADP
iajs-3630	15	10	the	the	DET
iajs-3630	15	11	diabetic	diabetic	ADJ
iajs-3630	15	12	and	and	CCONJ
iajs-3630	15	13	control	control	NOUN
iajs-3630	15	14	groups	group	NOUN
iajs-3630	15	15	.	.	PUNCT
iajs-3630	16	1	moreover	moreover	ADV
iajs-3630	16	2	,	,	PUNCT
iajs-3630	16	3	the	the	DET
iajs-3630	16	4	results	result	NOUN
iajs-3630	16	5	of	of	ADP
iajs-3630	16	6	hom	hom	NOUN
iajs-3630	16	7	-	-	PUNCT
iajs-3630	16	8	ir	ir	PROPN
iajs-3630	16	9	and	and	CCONJ
iajs-3630	16	10	homa	homa	NOUN
iajs-3630	16	11	-	-	PUNCT
iajs-3630	16	12	is	be	AUX
iajs-3630	16	13	and	and	CCONJ
iajs-3630	16	14	lipid	lipid	NOUN
iajs-3630	16	15	profiles	profile	NOUN
iajs-3630	16	16	showed	show	VERB
iajs-3630	16	17	significant	significant	ADJ
iajs-3630	16	18	differences	difference	NOUN
iajs-3630	16	19	between	between	ADP
iajs-3630	16	20	the	the	DET
iajs-3630	16	21	studied	study	VERB
iajs-3630	16	22	groups	group	NOUN
iajs-3630	16	23	.	.	PUNCT
iajs-3630	17	1	the	the	DET
iajs-3630	17	2	results	result	NOUN
iajs-3630	17	3	showed	show	VERB
iajs-3630	17	4	that	that	SCONJ
iajs-3630	17	5	irisin	irisin	NOUN
iajs-3630	17	6	can	can	AUX
iajs-3630	17	7	serve	serve	VERB
iajs-3630	17	8	as	as	ADP
iajs-3630	17	9	an	an	DET
iajs-3630	17	10	early	early	ADJ
iajs-3630	17	11	indicator	indicator	NOUN
iajs-3630	17	12	of	of	ADP
iajs-3630	17	13	prediabetes	prediabete	NOUN
iajs-3630	17	14	.	.	PUNCT
iajs-3630	18	1	these	these	DET
iajs-3630	18	2	results	result	NOUN
iajs-3630	18	3	were	be	AUX
iajs-3630	18	4	reinforced	reinforce	VERB
iajs-3630	18	5	by	by	ADP
iajs-3630	18	6	the	the	DET
iajs-3630	18	7	results	result	NOUN
iajs-3630	18	8	of	of	ADP
iajs-3630	18	9	the	the	DET
iajs-3630	18	10	roc	roc	PROPN
iajs-3630	18	11	analysis	analysis	NOUN
iajs-3630	18	12	,	,	PUNCT
iajs-3630	18	13	which	which	PRON
iajs-3630	18	14	indicated	indicate	VERB
iajs-3630	18	15	that	that	SCONJ
iajs-3630	18	16	irisin	irisin	NOUN
iajs-3630	18	17	is	be	AUX
iajs-3630	18	18	an	an	DET
iajs-3630	18	19	excellent	excellent	ADJ
iajs-3630	18	20	indicator	indicator	NOUN
iajs-3630	18	21	for	for	ADP
iajs-3630	18	22	diagnosing	diagnose	VERB
iajs-3630	18	23	the	the	DET
iajs-3630	18	24	studied	studied	ADJ
iajs-3630	18	25	condition	condition	NOUN
iajs-3630	18	26	.	.	PUNCT
iajs-3630	19	1	keywords	keyword	NOUN
iajs-3630	19	2	:	:	PUNCT
iajs-3630	19	3	homa	homa	NOUN
iajs-3630	19	4	-	-	PUNCT
iajs-3630	19	5	ir	ir	PROPN
iajs-3630	19	6	,	,	PUNCT
iajs-3630	19	7	homa	homa	NOUN
iajs-3630	19	8	-	-	PUNCT
iajs-3630	19	9	is	be	AUX
iajs-3630	19	10	,	,	PUNCT
iajs-3630	19	11	insulin	insulin	NOUN
iajs-3630	19	12	,	,	PUNCT
iajs-3630	19	13	irisin	irisin	NOUN
iajs-3630	19	14	,	,	PUNCT
iajs-3630	19	15	pre	pre	ADJ
iajs-3630	19	16	-	-	NOUN
iajs-3630	19	17	diabetes	diabetes	ADJ
iajs-3630	19	18	,	,	PUNCT
iajs-3630	19	19	type	type	NOUN
iajs-3630	19	20	2	2	NUM
iajs-3630	19	21	diabetes	diabetes	NOUN
iajs-3630	19	22	mellitus	mellitus	NOUN
iajs-3630	19	23	.	.	PUNCT
iajs-3630	20	1	1	1	X
iajs-3630	20	2	.	.	X
iajs-3630	20	3	introduction	introduction	NOUN
iajs-3630	20	4	the	the	DET
iajs-3630	20	5	prevalence	prevalence	NOUN
iajs-3630	20	6	of	of	ADP
iajs-3630	20	7	diabetes	diabetes	NOUN
iajs-3630	20	8	is	be	AUX
iajs-3630	20	9	rapidly	rapidly	ADV
iajs-3630	20	10	increasing	increase	VERB
iajs-3630	20	11	and	and	CCONJ
iajs-3630	20	12	is	be	AUX
iajs-3630	20	13	now	now	ADV
iajs-3630	20	14	recognized	recognize	VERB
iajs-3630	20	15	as	as	ADP
iajs-3630	20	16	a	a	DET
iajs-3630	20	17	significant	significant	ADJ
iajs-3630	20	18	worldwide	worldwide	ADJ
iajs-3630	20	19	health	health	NOUN
iajs-3630	20	20	problem	problem	NOUN
iajs-3630	20	21	(	(	PUNCT
iajs-3630	20	22	1	1	NUM
iajs-3630	20	23	)	)	PUNCT
iajs-3630	20	24	.	.	PUNCT
iajs-3630	21	1	diabetes	diabetes	NOUN
iajs-3630	21	2	mellitus	mellitus	NOUN
iajs-3630	21	3	(	(	PUNCT
iajs-3630	21	4	dm	dm	PROPN
iajs-3630	21	5	)	)	PUNCT
iajs-3630	21	6	is	be	AUX
iajs-3630	21	7	a	a	DET
iajs-3630	21	8	type	type	NOUN
iajs-3630	21	9	of	of	ADP
iajs-3630	21	10	metabolic	metabolic	NOUN
iajs-3630	21	11	disorder	disorder	NOUN
iajs-3630	21	12	in	in	ADP
iajs-3630	21	13	which	which	PRON
iajs-3630	21	14	patients	patient	NOUN
iajs-3630	21	15	experience	experience	VERB
iajs-3630	21	16	high	high	ADJ
iajs-3630	21	17	blood	blood	NOUN
iajs-3630	21	18	sugar	sugar	NOUN
iajs-3630	21	19	levels	level	NOUN
iajs-3630	21	20	as	as	ADP
iajs-3630	21	21	a	a	DET
iajs-3630	21	22	result	result	NOUN
iajs-3630	21	23	of	of	ADP
iajs-3630	21	24	their	their	PRON
iajs-3630	21	25	bodies	body	NOUN
iajs-3630	21	26	'	'	PART
iajs-3630	21	27	inability	inability	NOUN
iajs-3630	21	28	to	to	PART
iajs-3630	21	29	react	react	VERB
iajs-3630	21	30	to	to	ADP
iajs-3630	21	31	or	or	CCONJ
iajs-3630	21	32	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3630	21	33	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3630	21	34	https://doi.org/10.30526/38.1.3501	https://doi.org/10.30526/38.1.3501	PROPN
iajs-3630	21	35	https://orcid.org/0009-0004-8122-8142	https://orcid.org/0009-0004-8122-8142	VERB
iajs-3630	21	36	mailto:heba.mohammed1205a@csw.uobaghdad.edu.iq	mailto:heba.mohammed1205a@csw.uobaghdad.edu.iq	PROPN
iajs-3630	21	37	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	PROPN
iajs-3630	21	38	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3630	21	39	ihjpas	ihjpa	NOUN
iajs-3630	21	40	.	.	PUNCT
iajs-3630	22	1	2025	2025	NUM
iajs-3630	22	2	,	,	PUNCT
iajs-3630	22	3	38	38	NUM
iajs-3630	22	4	(	(	PUNCT
iajs-3630	22	5	1	1	NUM
iajs-3630	22	6	)	)	PUNCT
iajs-3630	22	7	303	303	NUM
iajs-3630	22	8	produce	produce	VERB
iajs-3630	22	9	enough	enough	ADJ
iajs-3630	22	10	insulin	insulin	NOUN
iajs-3630	22	11	;	;	PUNCT
iajs-3630	22	12	this	this	DET
iajs-3630	22	13	hormone	hormone	NOUN
iajs-3630	22	14	helps	help	VERB
iajs-3630	22	15	to	to	PART
iajs-3630	22	16	stabilize	stabilize	VERB
iajs-3630	22	17	the	the	DET
iajs-3630	22	18	blood	blood	NOUN
iajs-3630	22	19	glucose	glucose	NOUN
iajs-3630	22	20	level	level	NOUN
iajs-3630	22	21	by	by	ADP
iajs-3630	22	22	instructing	instruct	VERB
iajs-3630	22	23	cells	cell	NOUN
iajs-3630	22	24	to	to	PART
iajs-3630	22	25	take	take	VERB
iajs-3630	22	26	up	up	ADP
iajs-3630	22	27	glucose	glucose	NOUN
iajs-3630	22	28	and	and	CCONJ
iajs-3630	22	29	prevent	prevent	VERB
iajs-3630	22	30	the	the	DET
iajs-3630	22	31	production	production	NOUN
iajs-3630	22	32	of	of	ADP
iajs-3630	22	33	hepatic	hepatic	ADJ
iajs-3630	22	34	glucose	glucose	NOUN
iajs-3630	22	35	(	(	PUNCT
iajs-3630	22	36	2,3	2,3	NUM
iajs-3630	22	37	)	)	PUNCT
iajs-3630	22	38	.	.	PUNCT
iajs-3630	23	1	the	the	DET
iajs-3630	23	2	primary	primary	ADJ
iajs-3630	23	3	sign	sign	NOUN
iajs-3630	23	4	of	of	ADP
iajs-3630	23	5	diabetes	diabetes	NOUN
iajs-3630	23	6	is	be	AUX
iajs-3630	23	7	hyperglycemia	hyperglycemia	NOUN
iajs-3630	23	8	.	.	PUNCT
iajs-3630	24	1	long	long	ADJ
iajs-3630	24	2	-	-	PUNCT
iajs-3630	24	3	term	term	NOUN
iajs-3630	24	4	exposure	exposure	NOUN
iajs-3630	24	5	to	to	ADP
iajs-3630	24	6	hyperglycemia	hyperglycemia	NOUN
iajs-3630	24	7	will	will	AUX
iajs-3630	24	8	have	have	VERB
iajs-3630	24	9	physiological	physiological	ADJ
iajs-3630	24	10	effects	effect	NOUN
iajs-3630	24	11	on	on	ADP
iajs-3630	24	12	the	the	DET
iajs-3630	24	13	organs	organ	NOUN
iajs-3630	24	14	,	,	PUNCT
iajs-3630	24	15	including	include	VERB
iajs-3630	24	16	chronic	chronic	ADJ
iajs-3630	24	17	progressive	progressive	ADJ
iajs-3630	24	18	lesions	lesion	NOUN
iajs-3630	24	19	and	and	CCONJ
iajs-3630	24	20	organ	organ	NOUN
iajs-3630	24	21	and	and	CCONJ
iajs-3630	24	22	tissue	tissue	NOUN
iajs-3630	24	23	failure	failure	NOUN
iajs-3630	24	24	in	in	ADP
iajs-3630	24	25	the	the	DET
iajs-3630	24	26	kidneys	kidney	NOUN
iajs-3630	24	27	,	,	PUNCT
iajs-3630	24	28	heart	heart	NOUN
iajs-3630	24	29	,	,	PUNCT
iajs-3630	24	30	blood	blood	NOUN
iajs-3630	24	31	vessels	vessel	NOUN
iajs-3630	24	32	,	,	PUNCT
iajs-3630	24	33	eyes	eye	NOUN
iajs-3630	24	34	,	,	PUNCT
iajs-3630	24	35	nerves	nerve	NOUN
iajs-3630	24	36	,	,	PUNCT
iajs-3630	24	37	and	and	CCONJ
iajs-3630	24	38	kidneys	kidney	NOUN
iajs-3630	24	39	(	(	PUNCT
iajs-3630	24	40	4,5	4,5	NUM
iajs-3630	24	41	)	)	PUNCT
iajs-3630	24	42	.	.	PUNCT
iajs-3630	25	1	diabetic	diabetic	ADJ
iajs-3630	25	2	complications	complication	NOUN
iajs-3630	25	3	were	be	AUX
iajs-3630	25	4	investigated	investigate	VERB
iajs-3630	25	5	in	in	ADP
iajs-3630	25	6	numerous	numerous	ADJ
iajs-3630	25	7	previous	previous	ADJ
iajs-3630	25	8	studies	study	NOUN
iajs-3630	25	9	that	that	PRON
iajs-3630	25	10	include	include	VERB
iajs-3630	25	11	diabetic	diabetic	ADJ
iajs-3630	25	12	nephropathy	nephropathy	NOUN
iajs-3630	25	13	(	(	PUNCT
iajs-3630	25	14	6	6	NUM
iajs-3630	25	15	)	)	PUNCT
iajs-3630	25	16	,	,	PUNCT
iajs-3630	25	17	diabetic	diabetic	ADJ
iajs-3630	25	18	with	with	ADP
iajs-3630	25	19	osteoporosis	osteoporosis	NOUN
iajs-3630	25	20	(	(	PUNCT
iajs-3630	25	21	7	7	NUM
iajs-3630	25	22	)	)	PUNCT
iajs-3630	25	23	,	,	PUNCT
iajs-3630	25	24	and	and	CCONJ
iajs-3630	25	25	diabetic	diabetic	ADJ
iajs-3630	25	26	with	with	ADP
iajs-3630	25	27	periodontitis	periodontitis	NOUN
iajs-3630	25	28	(	(	PUNCT
iajs-3630	25	29	8)	8)	NUM
iajs-3630	25	30	.	.	PUNCT
iajs-3630	25	31	obesity	obesity	NOUN
iajs-3630	25	32	represents	represent	VERB
iajs-3630	25	33	an	an	DET
iajs-3630	25	34	unhealthy	unhealthy	ADJ
iajs-3630	25	35	excess	excess	NOUN
iajs-3630	25	36	in	in	ADP
iajs-3630	25	37	body	body	NOUN
iajs-3630	25	38	fat	fat	ADJ
iajs-3630	25	39	mass	mass	NOUN
iajs-3630	25	40	characterized	characterize	VERB
iajs-3630	25	41	by	by	ADP
iajs-3630	25	42	developing	develop	VERB
iajs-3630	25	43	a	a	DET
iajs-3630	25	44	chronic	chronic	NOUN
iajs-3630	25	45	,	,	PUNCT
iajs-3630	25	46	widespread	widespread	ADJ
iajs-3630	25	47	,	,	PUNCT
iajs-3630	25	48	low	low	ADJ
iajs-3630	25	49	-	-	PUNCT
iajs-3630	25	50	grade	grade	NOUN
iajs-3630	25	51	inflammatory	inflammatory	ADJ
iajs-3630	25	52	state	state	NOUN
iajs-3630	25	53	.	.	PUNCT
iajs-3630	26	1	obesityrelated	obesityrelate	VERB
iajs-3630	26	2	inflammation	inflammation	NOUN
iajs-3630	26	3	can	can	AUX
iajs-3630	26	4	affect	affect	VERB
iajs-3630	26	5	insulin	insulin	NOUN
iajs-3630	26	6	signaling	signal	VERB
iajs-3630	26	7	in	in	ADP
iajs-3630	26	8	tissues	tissue	NOUN
iajs-3630	26	9	sensitive	sensitive	ADJ
iajs-3630	26	10	to	to	ADP
iajs-3630	26	11	insulin	insulin	NOUN
iajs-3630	26	12	(	(	PUNCT
iajs-3630	26	13	including	include	VERB
iajs-3630	26	14	skeletal	skeletal	ADJ
iajs-3630	26	15	muscle	muscle	NOUN
iajs-3630	26	16	and	and	CCONJ
iajs-3630	26	17	adipose	adipose	ADJ
iajs-3630	26	18	tissue	tissue	NOUN
iajs-3630	26	19	)	)	PUNCT
iajs-3630	26	20	,	,	PUNCT
iajs-3630	26	21	leading	lead	VERB
iajs-3630	26	22	to	to	ADP
iajs-3630	26	23	insulin	insulin	NOUN
iajs-3630	26	24	resistance	resistance	NOUN
iajs-3630	26	25	(	(	PUNCT
iajs-3630	26	26	ir	ir	NOUN
iajs-3630	26	27	)	)	PUNCT
iajs-3630	26	28	(	(	PUNCT
iajs-3630	26	29	9	9	NUM
iajs-3630	26	30	)	)	PUNCT
iajs-3630	26	31	.	.	PUNCT
iajs-3630	27	1	as	as	ADP
iajs-3630	27	2	a	a	DET
iajs-3630	27	3	result	result	NOUN
iajs-3630	27	4	,	,	PUNCT
iajs-3630	27	5	the	the	DET
iajs-3630	27	6	global	global	ADJ
iajs-3630	27	7	obesity	obesity	NOUN
iajs-3630	27	8	pandemic	pandemic	NOUN
iajs-3630	27	9	is	be	AUX
iajs-3630	27	10	causing	cause	VERB
iajs-3630	27	11	an	an	DET
iajs-3630	27	12	essential	essential	ADJ
iajs-3630	27	13	rise	rise	NOUN
iajs-3630	27	14	in	in	ADP
iajs-3630	27	15	the	the	DET
iajs-3630	27	16	incidence	incidence	NOUN
iajs-3630	27	17	of	of	ADP
iajs-3630	27	18	cardiometabolic	cardiometabolic	NOUN
iajs-3630	27	19	diseases	disease	NOUN
iajs-3630	27	20	,	,	PUNCT
iajs-3630	27	21	such	such	ADJ
iajs-3630	27	22	as	as	ADP
iajs-3630	27	23	type	type	NOUN
iajs-3630	27	24	2	2	NUM
iajs-3630	27	25	dm	dm	PROPN
iajs-3630	27	26	(	(	PUNCT
iajs-3630	27	27	t2	t2	PROPN
iajs-3630	27	28	dm	dm	PROPN
iajs-3630	27	29	)	)	PUNCT
iajs-3630	27	30	,	,	PUNCT
iajs-3630	27	31	at	at	ADP
iajs-3630	27	32	the	the	DET
iajs-3630	27	33	same	same	ADJ
iajs-3630	27	34	time	time	NOUN
iajs-3630	27	35	.	.	PUNCT
iajs-3630	28	1	obesity	obesity	NOUN
iajs-3630	28	2	,	,	PUNCT
iajs-3630	28	3	pre	pre	NOUN
iajs-3630	28	4	-	-	NOUN
iajs-3630	28	5	diabetes	diabetes	ADJ
iajs-3630	28	6	(	(	PUNCT
iajs-3630	28	7	pre	pre	ADJ
iajs-3630	28	8	-	-	ADJ
iajs-3630	28	9	dm	dm	NOUN
iajs-3630	28	10	)	)	PUNCT
iajs-3630	28	11	,	,	PUNCT
iajs-3630	28	12	and	and	CCONJ
iajs-3630	28	13	ir	ir	PROPN
iajs-3630	28	14	are	be	AUX
iajs-3630	28	15	all	all	ADV
iajs-3630	28	16	intimately	intimately	ADV
iajs-3630	28	17	related	relate	VERB
iajs-3630	28	18	,	,	PUNCT
iajs-3630	28	19	as	as	SCONJ
iajs-3630	28	20	is	be	AUX
iajs-3630	28	21	widely	widely	ADV
iajs-3630	28	22	known	know	VERB
iajs-3630	28	23	(	(	PUNCT
iajs-3630	28	24	10	10	NUM
iajs-3630	28	25	)	)	PUNCT
iajs-3630	28	26	.	.	PUNCT
iajs-3630	29	1	pre	pre	VERB
iajs-3630	29	2	-	-	ADJ
iajs-3630	29	3	dm	dm	PROPN
iajs-3630	29	4	is	be	AUX
iajs-3630	29	5	quite	quite	ADV
iajs-3630	29	6	common	common	ADJ
iajs-3630	29	7	,	,	PUNCT
iajs-3630	29	8	particularly	particularly	ADV
iajs-3630	29	9	in	in	ADP
iajs-3630	29	10	elderly	elderly	ADJ
iajs-3630	29	11	person	person	NOUN
iajs-3630	29	12	groups	group	NOUN
iajs-3630	29	13	and	and	CCONJ
iajs-3630	29	14	obese	obese	ADJ
iajs-3630	29	15	people	people	NOUN
iajs-3630	29	16	.	.	PUNCT
iajs-3630	30	1	it	it	PRON
iajs-3630	30	2	represents	represent	VERB
iajs-3630	30	3	a	a	DET
iajs-3630	30	4	transition	transition	NOUN
iajs-3630	30	5	stage	stage	NOUN
iajs-3630	30	6	between	between	ADP
iajs-3630	30	7	normal	normal	ADJ
iajs-3630	30	8	glycemia	glycemia	NOUN
iajs-3630	30	9	and	and	CCONJ
iajs-3630	30	10	diabetes	diabetes	NOUN
iajs-3630	30	11	.	.	PUNCT
iajs-3630	31	1	pre	pre	VERB
iajs-3630	31	2	-	-	ADJ
iajs-3630	31	3	dm	dm	PROPN
iajs-3630	31	4	is	be	AUX
iajs-3630	31	5	diagnosed	diagnose	VERB
iajs-3630	31	6	through	through	ADP
iajs-3630	31	7	laboratory	laboratory	NOUN
iajs-3630	31	8	measurements	measurement	NOUN
iajs-3630	31	9	of	of	ADP
iajs-3630	31	10	fasting	fast	VERB
iajs-3630	31	11	blood	blood	NOUN
iajs-3630	31	12	glucose	glucose	NOUN
iajs-3630	31	13	(	(	PUNCT
iajs-3630	31	14	fbg	fbg	PROPN
iajs-3630	31	15	)	)	PUNCT
iajs-3630	31	16	and	and	CCONJ
iajs-3630	31	17	glycosylated	glycosylated	ADJ
iajs-3630	31	18	hemoglobin	hemoglobin	NOUN
iajs-3630	31	19	(	(	PUNCT
iajs-3630	31	20	hba1c	hba1c	PROPN
iajs-3630	31	21	)	)	PUNCT
iajs-3630	31	22	.	.	PUNCT
iajs-3630	32	1	the	the	DET
iajs-3630	32	2	expression	expression	NOUN
iajs-3630	32	3	pre	pre	VERB
iajs-3630	32	4	-	-	VERB
iajs-3630	32	5	dm	dm	PROPN
iajs-3630	32	6	is	be	AUX
iajs-3630	32	7	used	use	VERB
iajs-3630	32	8	to	to	PART
iajs-3630	32	9	identify	identify	VERB
iajs-3630	32	10	those	those	PRON
iajs-3630	32	11	who	who	PRON
iajs-3630	32	12	are	be	AUX
iajs-3630	32	13	at	at	ADP
iajs-3630	32	14	risk	risk	NOUN
iajs-3630	32	15	of	of	ADP
iajs-3630	32	16	developing	develop	VERB
iajs-3630	32	17	diabetes	diabetes	NOUN
iajs-3630	32	18	in	in	ADP
iajs-3630	32	19	the	the	DET
iajs-3630	32	20	future	future	NOUN
iajs-3630	32	21	(	(	PUNCT
iajs-3630	32	22	11	11	NUM
iajs-3630	32	23	)	)	PUNCT
iajs-3630	32	24	.	.	PUNCT
iajs-3630	33	1	the	the	DET
iajs-3630	33	2	most	most	ADV
iajs-3630	33	3	significant	significant	ADJ
iajs-3630	33	4	hazard	hazard	NOUN
iajs-3630	33	5	reasons	reason	NOUN
iajs-3630	33	6	for	for	ADP
iajs-3630	33	7	t2	t2	NOUN
iajs-3630	33	8	dm	dm	PROPN
iajs-3630	33	9	and	and	CCONJ
iajs-3630	33	10	pre	pre	ADJ
iajs-3630	33	11	-	-	ADJ
iajs-3630	33	12	dm	dm	NOUN
iajs-3630	33	13	in	in	ADP
iajs-3630	33	14	adults	adult	NOUN
iajs-3630	33	15	are	be	AUX
iajs-3630	33	16	being	be	AUX
iajs-3630	33	17	overweight	overweight	ADJ
iajs-3630	33	18	and	and	CCONJ
iajs-3630	33	19	obese	obese	ADJ
iajs-3630	33	20	(	(	PUNCT
iajs-3630	33	21	12	12	NUM
iajs-3630	33	22	)	)	PUNCT
iajs-3630	33	23	.	.	PUNCT
iajs-3630	34	1	irisin	irisin	PROPN
iajs-3630	34	2	is	be	AUX
iajs-3630	34	3	a	a	DET
iajs-3630	34	4	novel	novel	ADJ
iajs-3630	34	5	myokine	myokine	NOUN
iajs-3630	34	6	that	that	PRON
iajs-3630	34	7	was	be	AUX
iajs-3630	34	8	found	find	VERB
iajs-3630	34	9	to	to	PART
iajs-3630	34	10	be	be	AUX
iajs-3630	34	11	produced	produce	VERB
iajs-3630	34	12	by	by	ADP
iajs-3630	34	13	skeletal	skeletal	ADJ
iajs-3630	34	14	muscle	muscle	NOUN
iajs-3630	34	15	and	and	CCONJ
iajs-3630	34	16	enters	enter	VERB
iajs-3630	34	17	the	the	DET
iajs-3630	34	18	bloodstream	bloodstream	NOUN
iajs-3630	34	19	during	during	ADP
iajs-3630	34	20	exercise	exercise	NOUN
iajs-3630	34	21	.	.	PUNCT
iajs-3630	35	1	irisin	irisin	NOUN
iajs-3630	35	2	increases	increase	VERB
iajs-3630	35	3	the	the	DET
iajs-3630	35	4	browning	browning	NOUN
iajs-3630	35	5	of	of	ADP
iajs-3630	35	6	white	white	ADJ
iajs-3630	35	7	adipose	adipose	ADJ
iajs-3630	35	8	tissue	tissue	NOUN
iajs-3630	35	9	,	,	PUNCT
iajs-3630	35	10	which	which	PRON
iajs-3630	35	11	improves	improve	VERB
iajs-3630	35	12	glucose	glucose	NOUN
iajs-3630	35	13	metabolism	metabolism	NOUN
iajs-3630	35	14	and	and	CCONJ
iajs-3630	35	15	thus	thus	ADV
iajs-3630	35	16	increases	increase	VERB
iajs-3630	35	17	energy	energy	NOUN
iajs-3630	35	18	expenditure	expenditure	NOUN
iajs-3630	35	19	(	(	PUNCT
iajs-3630	35	20	13	13	NUM
iajs-3630	35	21	)	)	PUNCT
iajs-3630	35	22	.	.	PUNCT
iajs-3630	36	1	irisin	irisin	PROPN
iajs-3630	36	2	improves	improve	VERB
iajs-3630	36	3	insulin	insulin	NOUN
iajs-3630	36	4	resistance	resistance	NOUN
iajs-3630	36	5	and	and	CCONJ
iajs-3630	36	6	t2	t2	NOUN
iajs-3630	36	7	dm	dm	X
iajs-3630	36	8	by	by	ADP
iajs-3630	36	9	growing	grow	VERB
iajs-3630	36	10	sensitization	sensitization	NOUN
iajs-3630	36	11	for	for	ADP
iajs-3630	36	12	the	the	DET
iajs-3630	36	13	insulin	insulin	NOUN
iajs-3630	36	14	receptor	receptor	NOUN
iajs-3630	36	15	in	in	ADP
iajs-3630	36	16	skeletal	skeletal	ADJ
iajs-3630	36	17	muscle	muscle	NOUN
iajs-3630	36	18	and	and	CCONJ
iajs-3630	36	19	heart	heart	NOUN
iajs-3630	36	20	by	by	ADP
iajs-3630	36	21	improving	improve	VERB
iajs-3630	36	22	hepatic	hepatic	ADJ
iajs-3630	36	23	glucose	glucose	NOUN
iajs-3630	36	24	and	and	CCONJ
iajs-3630	36	25	lipid	lipid	NOUN
iajs-3630	36	26	metabolism	metabolism	NOUN
iajs-3630	36	27	,	,	PUNCT
iajs-3630	36	28	promoting	promote	VERB
iajs-3630	36	29	pancreatic	pancreatic	ADJ
iajs-3630	36	30	β	β	NOUN
iajs-3630	36	31	cell	cell	NOUN
iajs-3630	36	32	functions	function	NOUN
iajs-3630	36	33	(	(	PUNCT
iajs-3630	36	34	14	14	NUM
iajs-3630	36	35	)	)	PUNCT
iajs-3630	36	36	.	.	PUNCT
iajs-3630	37	1	this	this	DET
iajs-3630	37	2	study	study	NOUN
iajs-3630	37	3	aims	aim	VERB
iajs-3630	37	4	to	to	PART
iajs-3630	37	5	estimate	estimate	VERB
iajs-3630	37	6	irisin	irisin	ADJ
iajs-3630	37	7	levels	level	NOUN
iajs-3630	37	8	in	in	ADP
iajs-3630	37	9	diabetic	diabetic	ADJ
iajs-3630	37	10	patients	patient	NOUN
iajs-3630	37	11	and	and	CCONJ
iajs-3630	37	12	subjects	subject	NOUN
iajs-3630	37	13	with	with	ADP
iajs-3630	37	14	pre	pre	ADJ
iajs-3630	37	15	-	-	ADJ
iajs-3630	37	16	dm	dm	X
iajs-3630	37	17	compared	compare	VERB
iajs-3630	37	18	to	to	ADP
iajs-3630	37	19	healthy	healthy	ADJ
iajs-3630	37	20	persons	person	NOUN
iajs-3630	37	21	to	to	PART
iajs-3630	37	22	know	know	VERB
iajs-3630	37	23	whether	whether	SCONJ
iajs-3630	37	24	it	it	PRON
iajs-3630	37	25	can	can	AUX
iajs-3630	37	26	be	be	AUX
iajs-3630	37	27	applied	apply	VERB
iajs-3630	37	28	as	as	ADP
iajs-3630	37	29	an	an	DET
iajs-3630	37	30	early	early	ADJ
iajs-3630	37	31	predictor	predictor	NOUN
iajs-3630	37	32	for	for	ADP
iajs-3630	37	33	the	the	DET
iajs-3630	37	34	studied	study	VERB
iajs-3630	37	35	cases	case	NOUN
iajs-3630	37	36	.	.	PUNCT
iajs-3630	38	1	2	2	X
iajs-3630	38	2	.	.	X
iajs-3630	38	3	materials	material	NOUN
iajs-3630	38	4	and	and	CCONJ
iajs-3630	38	5	methods	method	NOUN
iajs-3630	38	6	2.1	2.1	NUM
iajs-3630	38	7	.	.	PUNCT
iajs-3630	39	1	study	study	NOUN
iajs-3630	39	2	subjects	subject	NOUN
iajs-3630	39	3	in	in	ADP
iajs-3630	39	4	the	the	DET
iajs-3630	39	5	current	current	ADJ
iajs-3630	39	6	study	study	NOUN
iajs-3630	39	7	,	,	PUNCT
iajs-3630	39	8	levels	level	NOUN
iajs-3630	39	9	of	of	ADP
iajs-3630	39	10	irisin	irisin	NOUN
iajs-3630	39	11	and	and	CCONJ
iajs-3630	39	12	some	some	DET
iajs-3630	39	13	relevant	relevant	ADJ
iajs-3630	39	14	biochemical	biochemical	ADJ
iajs-3630	39	15	parameters	parameter	NOUN
iajs-3630	39	16	were	be	AUX
iajs-3630	39	17	measured	measure	VERB
iajs-3630	39	18	.	.	PUNCT
iajs-3630	40	1	all	all	DET
iajs-3630	40	2	the	the	DET
iajs-3630	40	3	studied	study	VERB
iajs-3630	40	4	samples	sample	NOUN
iajs-3630	40	5	were	be	AUX
iajs-3630	40	6	collected	collect	VERB
iajs-3630	40	7	from	from	ADP
iajs-3630	40	8	patients	patient	NOUN
iajs-3630	40	9	in	in	ADP
iajs-3630	40	10	the	the	DET
iajs-3630	40	11	national	national	ADJ
iajs-3630	40	12	diabetes	diabetes	NOUN
iajs-3630	40	13	center/	center/	NUM
iajs-3630	40	14	mustansiriyah	mustansiriyah	NOUN
iajs-3630	40	15	university	university	NOUN
iajs-3630	40	16	,	,	PUNCT
iajs-3630	40	17	baghdad	baghdad	PROPN
iajs-3630	40	18	,	,	PUNCT
iajs-3630	40	19	iraq	iraq	PROPN
iajs-3630	40	20	.	.	PUNCT
iajs-3630	41	1	a	a	DET
iajs-3630	41	2	total	total	NOUN
iajs-3630	41	3	of	of	ADP
iajs-3630	41	4	138	138	NUM
iajs-3630	41	5	participants	participant	NOUN
iajs-3630	41	6	,	,	PUNCT
iajs-3630	41	7	46	46	NUM
iajs-3630	41	8	healthy	healthy	ADJ
iajs-3630	41	9	individuals	individual	NOUN
iajs-3630	41	10	,	,	PUNCT
iajs-3630	41	11	46	46	NUM
iajs-3630	41	12	people	people	NOUN
iajs-3630	41	13	with	with	ADP
iajs-3630	41	14	t2	t2	NOUN
iajs-3630	41	15	dm	dm	PROPN
iajs-3630	41	16	,	,	PUNCT
iajs-3630	41	17	and	and	CCONJ
iajs-3630	41	18	46	46	NUM
iajs-3630	41	19	people	people	NOUN
iajs-3630	41	20	with	with	ADP
iajs-3630	41	21	pre	pre	ADJ
iajs-3630	41	22	-	-	ADJ
iajs-3630	41	23	dm	dm	ADJ
iajs-3630	41	24	in	in	ADP
iajs-3630	41	25	the	the	DET
iajs-3630	41	26	age	age	NOUN
iajs-3630	41	27	range	range	NOUN
iajs-3630	41	28	of	of	ADP
iajs-3630	41	29	(	(	PUNCT
iajs-3630	41	30	30	30	NUM
iajs-3630	41	31	-	-	SYM
iajs-3630	41	32	65	65	NUM
iajs-3630	41	33	)	)	PUNCT
iajs-3630	41	34	years	year	NOUN
iajs-3630	41	35	,	,	PUNCT
iajs-3630	41	36	were	be	AUX
iajs-3630	41	37	included	include	VERB
iajs-3630	41	38	in	in	ADP
iajs-3630	41	39	this	this	DET
iajs-3630	41	40	study	study	NOUN
iajs-3630	41	41	.	.	PUNCT
iajs-3630	42	1	a	a	DET
iajs-3630	42	2	questionnaire	questionnaire	NOUN
iajs-3630	42	3	presents	present	VERB
iajs-3630	42	4	the	the	DET
iajs-3630	42	5	anthropometric	anthropometric	ADJ
iajs-3630	42	6	and	and	CCONJ
iajs-3630	42	7	biochemical	biochemical	ADJ
iajs-3630	42	8	features	feature	NOUN
iajs-3630	42	9	of	of	ADP
iajs-3630	42	10	each	each	DET
iajs-3630	42	11	group	group	NOUN
iajs-3630	42	12	.	.	PUNCT
iajs-3630	43	1	patients	patient	NOUN
iajs-3630	43	2	were	be	AUX
iajs-3630	43	3	divided	divide	VERB
iajs-3630	43	4	into	into	ADP
iajs-3630	43	5	two	two	NUM
iajs-3630	43	6	groups	group	NOUN
iajs-3630	43	7	based	base	VERB
iajs-3630	43	8	on	on	ADP
iajs-3630	43	9	their	their	PRON
iajs-3630	43	10	fbg	fbg	NOUN
iajs-3630	43	11	and	and	CCONJ
iajs-3630	43	12	hba1c	hba1c	PROPN
iajs-3630	43	13	levels	level	NOUN
iajs-3630	43	14	.	.	PUNCT
iajs-3630	44	1	group	group	NOUN
iajs-3630	44	2	1	1	NUM
iajs-3630	44	3	included	include	VERB
iajs-3630	44	4	46	46	NUM
iajs-3630	44	5	t2	t2	NOUN
iajs-3630	44	6	dm	dm	NOUN
iajs-3630	44	7	patients	patient	NOUN
iajs-3630	44	8	with	with	ADP
iajs-3630	44	9	fbg	fbg	NOUN
iajs-3630	44	10	of	of	ADP
iajs-3630	44	11	more	more	ADJ
iajs-3630	44	12	than	than	ADP
iajs-3630	44	13	126	126	NUM
iajs-3630	44	14	mg	mg	PROPN
iajs-3630	44	15	/	/	SYM
iajs-3630	44	16	dl	dl	PROPN
iajs-3630	44	17	and	and	CCONJ
iajs-3630	44	18	hba1c	hba1c	PROPN
iajs-3630	44	19	of	of	ADP
iajs-3630	44	20	more	more	ADJ
iajs-3630	44	21	than	than	ADP
iajs-3630	44	22	(	(	PUNCT
iajs-3630	44	23	6.4	6.4	NUM
iajs-3630	44	24	%	%	NOUN
iajs-3630	44	25	)	)	PUNCT
iajs-3630	44	26	.	.	PUNCT
iajs-3630	45	1	group	group	NOUN
iajs-3630	45	2	2	2	NUM
iajs-3630	45	3	included	include	VERB
iajs-3630	45	4	46	46	NUM
iajs-3630	45	5	pre	pre	ADJ
iajs-3630	45	6	-	-	ADJ
iajs-3630	45	7	diabetic	diabetic	ADJ
iajs-3630	45	8	patients	patient	NOUN
iajs-3630	45	9	with	with	ADP
iajs-3630	45	10	fbg	fbg	PROPN
iajs-3630	45	11	between	between	ADP
iajs-3630	45	12	(	(	PUNCT
iajs-3630	45	13	100	100	NUM
iajs-3630	45	14	-125	-125	NUM
iajs-3630	45	15	)	)	PUNCT
iajs-3630	45	16	mg	mg	PROPN
iajs-3630	45	17	/	/	SYM
iajs-3630	45	18	dl	dl	PROPN
iajs-3630	45	19	and	and	CCONJ
iajs-3630	45	20	hba1c	hba1c	PROPN
iajs-3630	45	21	between	between	ADP
iajs-3630	45	22	(	(	PUNCT
iajs-3630	45	23	5.7	5.7	NUM
iajs-3630	45	24	-	-	SYM
iajs-3630	45	25	6.4	6.4	NUM
iajs-3630	45	26	)	)	PUNCT
iajs-3630	45	27	percent	percent	NOUN
iajs-3630	45	28	.	.	PUNCT
iajs-3630	46	1	the	the	DET
iajs-3630	46	2	insulin	insulin	NOUN
iajs-3630	46	3	and	and	CCONJ
iajs-3630	46	4	retinol	retinol	NOUN
iajs-3630	46	5	-	-	PUNCT
iajs-3630	46	6	binding	bind	VERB
iajs-3630	46	7	protein	protein	NOUN
iajs-3630	46	8	4	4	NUM
iajs-3630	46	9	concentrations	concentration	NOUN
iajs-3630	46	10	were	be	AUX
iajs-3630	46	11	evaluated	evaluate	VERB
iajs-3630	46	12	using	use	VERB
iajs-3630	46	13	a	a	DET
iajs-3630	46	14	my	my	PRON
iajs-3630	46	15	biosource	biosource	NOUN
iajs-3630	46	16	manufactured	manufacture	VERB
iajs-3630	46	17	enzyme	enzyme	NOUN
iajs-3630	46	18	-	-	PUNCT
iajs-3630	46	19	linked	link	VERB
iajs-3630	46	20	immunosorbent	immunosorbent	NOUN
iajs-3630	46	21	test	test	NOUN
iajs-3630	46	22	elisa	elisa	PROPN
iajs-3630	46	23	kit	kit	PROPN
iajs-3630	46	24	,	,	PUNCT
iajs-3630	46	25	usa	usa	PROPN
iajs-3630	46	26	.	.	PUNCT
iajs-3630	47	1	the	the	DET
iajs-3630	47	2	levels	level	NOUN
iajs-3630	47	3	of	of	ADP
iajs-3630	47	4	total	total	ADJ
iajs-3630	47	5	cholesterol	cholesterol	NOUN
iajs-3630	47	6	,	,	PUNCT
iajs-3630	47	7	triglycerides	triglyceride	NOUN
iajs-3630	47	8	,	,	PUNCT
iajs-3630	47	9	high	high	ADJ
iajs-3630	47	10	-	-	PUNCT
iajs-3630	47	11	density	density	NOUN
iajs-3630	47	12	lipoprotein	lipoprotein	ADJ
iajs-3630	47	13	(	(	PUNCT
iajs-3630	47	14	hdl	hdl	NOUN
iajs-3630	47	15	)	)	PUNCT
iajs-3630	47	16	,	,	PUNCT
iajs-3630	47	17	low	low	ADJ
iajs-3630	47	18	-	-	PUNCT
iajs-3630	47	19	density	density	NOUN
iajs-3630	47	20	lipoprotein	lipoprotein	ADJ
iajs-3630	47	21	(	(	PUNCT
iajs-3630	47	22	ldl	ldl	NOUN
iajs-3630	47	23	)	)	PUNCT
iajs-3630	47	24	,	,	PUNCT
iajs-3630	47	25	and	and	CCONJ
iajs-3630	47	26	very	very	ADV
iajs-3630	47	27	low	low	ADJ
iajs-3630	47	28	-	-	PUNCT
iajs-3630	47	29	density	density	NOUN
iajs-3630	47	30	lipoprotein	lipoprotein	ADJ
iajs-3630	47	31	(	(	PUNCT
iajs-3630	47	32	vldl	vldl	NOUN
iajs-3630	47	33	)	)	PUNCT
iajs-3630	47	34	were	be	AUX
iajs-3630	47	35	measured	measure	VERB
iajs-3630	47	36	using	use	VERB
iajs-3630	47	37	a	a	DET
iajs-3630	47	38	linear	linear	ADJ
iajs-3630	47	39	chemicals	chemical	NOUN
iajs-3630	47	40	s.l	s.l	PROPN
iajs-3630	47	41	kit	kit	PROPN
iajs-3630	47	42	.	.	PUNCT
iajs-3630	48	1	ihjpas	ihjpas	PROPN
iajs-3630	48	2	.	.	PUNCT
iajs-3630	49	1	2025	2025	NUM
iajs-3630	49	2	,	,	PUNCT
iajs-3630	49	3	38	38	NUM
iajs-3630	49	4	(	(	PUNCT
iajs-3630	49	5	1	1	NUM
iajs-3630	49	6	)	)	PUNCT
iajs-3630	49	7	304	304	NUM
iajs-3630	49	8	2.2	2.2	NUM
iajs-3630	49	9	.	.	PUNCT
iajs-3630	50	1	exclusion	exclusion	NOUN
iajs-3630	50	2	criteria	criterion	NOUN
iajs-3630	50	3	patients	patient	NOUN
iajs-3630	50	4	with	with	ADP
iajs-3630	50	5	diabetic	diabetic	ADJ
iajs-3630	50	6	neuropathy	neuropathy	ADJ
iajs-3630	50	7	,	,	PUNCT
iajs-3630	50	8	diabetic	diabetic	ADJ
iajs-3630	50	9	nephropathy	nephropathy	NOUN
iajs-3630	50	10	,	,	PUNCT
iajs-3630	50	11	and	and	CCONJ
iajs-3630	50	12	diabetic	diabetic	ADJ
iajs-3630	50	13	retinopathy	retinopathy	NOUN
iajs-3630	50	14	were	be	AUX
iajs-3630	50	15	excluded	exclude	VERB
iajs-3630	50	16	,	,	PUNCT
iajs-3630	50	17	as	as	ADV
iajs-3630	50	18	well	well	ADV
iajs-3630	50	19	as	as	ADP
iajs-3630	50	20	patients	patient	NOUN
iajs-3630	50	21	over	over	ADP
iajs-3630	50	22	65	65	NUM
iajs-3630	50	23	years	year	NOUN
iajs-3630	50	24	of	of	ADP
iajs-3630	50	25	age	age	NOUN
iajs-3630	50	26	.	.	PUNCT
iajs-3630	51	1	also	also	ADV
iajs-3630	51	2	,	,	PUNCT
iajs-3630	51	3	patients	patient	NOUN
iajs-3630	51	4	treated	treat	VERB
iajs-3630	51	5	with	with	ADP
iajs-3630	51	6	insulin	insulin	NOUN
iajs-3630	51	7	,	,	PUNCT
iajs-3630	51	8	non	non	ADJ
iajs-3630	51	9	-	-	ADJ
iajs-3630	51	10	fasting	fasting	ADJ
iajs-3630	51	11	diabetic	diabetic	ADJ
iajs-3630	51	12	patients	patient	NOUN
iajs-3630	51	13	,	,	PUNCT
iajs-3630	51	14	and	and	CCONJ
iajs-3630	51	15	chronic	chronic	ADJ
iajs-3630	51	16	thyroid	thyroid	NOUN
iajs-3630	51	17	patients	patient	NOUN
iajs-3630	51	18	.	.	PUNCT
iajs-3630	52	1	2.3	2.3	NUM
iajs-3630	52	2	.	.	PUNCT
iajs-3630	53	1	inclusion	inclusion	NOUN
iajs-3630	53	2	criteria	criterion	NOUN
iajs-3630	53	3	clinical	clinical	ADJ
iajs-3630	53	4	screening	screening	NOUN
iajs-3630	53	5	signals	signal	NOUN
iajs-3630	53	6	were	be	AUX
iajs-3630	53	7	used	use	VERB
iajs-3630	53	8	to	to	PART
iajs-3630	53	9	determine	determine	VERB
iajs-3630	53	10	the	the	DET
iajs-3630	53	11	presence	presence	NOUN
iajs-3630	53	12	of	of	ADP
iajs-3630	53	13	metabolic	metabolic	NOUN
iajs-3630	53	14	syndrome	syndrome	NOUN
iajs-3630	53	15	(	(	PUNCT
iajs-3630	53	16	mets	met	NOUN
iajs-3630	53	17	)	)	PUNCT
iajs-3630	53	18	in	in	ADP
iajs-3630	53	19	patients	patient	NOUN
iajs-3630	53	20	.	.	PUNCT
iajs-3630	54	1	patients	patient	NOUN
iajs-3630	54	2	with	with	ADP
iajs-3630	54	3	t2	t2	PROPN
iajs-3630	54	4	dm	dm	PROPN
iajs-3630	54	5	,	,	PUNCT
iajs-3630	54	6	aged	aged	ADJ
iajs-3630	54	7	30	30	NUM
iajs-3630	54	8	to	to	PART
iajs-3630	54	9	65	65	NUM
iajs-3630	54	10	,	,	PUNCT
iajs-3630	54	11	who	who	PRON
iajs-3630	54	12	are	be	AUX
iajs-3630	54	13	also	also	ADV
iajs-3630	54	14	diabetic	diabetic	ADJ
iajs-3630	54	15	and	and	CCONJ
iajs-3630	54	16	who	who	PRON
iajs-3630	54	17	should	should	AUX
iajs-3630	54	18	be	be	AUX
iajs-3630	54	19	fasting	fast	VERB
iajs-3630	54	20	according	accord	VERB
iajs-3630	54	21	to	to	ADP
iajs-3630	54	22	their	their	PRON
iajs-3630	54	23	medical	medical	ADJ
iajs-3630	54	24	history	history	NOUN
iajs-3630	54	25	and	and	CCONJ
iajs-3630	54	26	physical	physical	ADJ
iajs-3630	54	27	examination	examination	NOUN
iajs-3630	54	28	.	.	PUNCT
iajs-3630	55	1	2.4	2.4	NUM
iajs-3630	55	2	.	.	PUNCT
iajs-3630	56	1	blood	blood	NOUN
iajs-3630	56	2	samples	sample	NOUN
iajs-3630	56	3	collection	collection	NOUN
iajs-3630	56	4	five	five	NUM
iajs-3630	56	5	milliliters	milliliter	NOUN
iajs-3630	56	6	(	(	PUNCT
iajs-3630	56	7	mls	mls	PROPN
iajs-3630	56	8	)	)	PUNCT
iajs-3630	56	9	of	of	ADP
iajs-3630	56	10	venous	venous	ADJ
iajs-3630	56	11	blood	blood	NOUN
iajs-3630	56	12	were	be	AUX
iajs-3630	56	13	collected	collect	VERB
iajs-3630	56	14	from	from	ADP
iajs-3630	56	15	each	each	DET
iajs-3630	56	16	patient	patient	NOUN
iajs-3630	56	17	and	and	CCONJ
iajs-3630	56	18	controlled	control	VERB
iajs-3630	56	19	in	in	ADP
iajs-3630	56	20	serumseparating	serumseparate	VERB
iajs-3630	56	21	tubes	tube	NOUN
iajs-3630	56	22	.	.	PUNCT
iajs-3630	57	1	sera	sera	PROPN
iajs-3630	57	2	were	be	AUX
iajs-3630	57	3	obtained	obtain	VERB
iajs-3630	57	4	by	by	ADP
iajs-3630	57	5	centrifuging	centrifuge	VERB
iajs-3630	57	6	4	4	NUM
iajs-3630	57	7	mls	mls	NOUN
iajs-3630	57	8	of	of	ADP
iajs-3630	57	9	blood	blood	NOUN
iajs-3630	57	10	at	at	ADP
iajs-3630	57	11	3000	3000	NUM
iajs-3630	57	12	rpm	rpm	NOUN
iajs-3630	57	13	for	for	ADP
iajs-3630	57	14	10	10	NUM
iajs-3630	57	15	minutes	minute	NOUN
iajs-3630	57	16	.	.	PUNCT
iajs-3630	58	1	after	after	SCONJ
iajs-3630	58	2	it	it	PRON
iajs-3630	58	3	had	have	AUX
iajs-3630	58	4	been	be	AUX
iajs-3630	58	5	allowed	allow	VERB
iajs-3630	58	6	to	to	PART
iajs-3630	58	7	clot	clot	VERB
iajs-3630	58	8	for	for	ADP
iajs-3630	58	9	approximately	approximately	ADV
iajs-3630	58	10	30	30	NUM
iajs-3630	58	11	minutes	minute	NOUN
iajs-3630	58	12	at	at	ADP
iajs-3630	58	13	room	room	NOUN
iajs-3630	58	14	temperature	temperature	NOUN
iajs-3630	58	15	,	,	PUNCT
iajs-3630	58	16	the	the	DET
iajs-3630	58	17	obtained	obtain	VERB
iajs-3630	58	18	serum	serum	NOUN
iajs-3630	58	19	was	be	AUX
iajs-3630	58	20	divided	divide	VERB
iajs-3630	58	21	between	between	ADP
iajs-3630	58	22	two	two	NUM
iajs-3630	58	23	eppendorf	eppendorf	NOUN
iajs-3630	58	24	tubes	tube	NOUN
iajs-3630	58	25	.	.	PUNCT
iajs-3630	59	1	it	it	PRON
iajs-3630	59	2	was	be	AUX
iajs-3630	59	3	stored	store	VERB
iajs-3630	59	4	at	at	ADP
iajs-3630	59	5	-20	-20	PROPN
iajs-3630	59	6	ºc	ºc	PROPN
iajs-3630	59	7	until	until	ADP
iajs-3630	59	8	being	be	AUX
iajs-3630	59	9	used	use	VERB
iajs-3630	59	10	for	for	ADP
iajs-3630	59	11	subsequent	subsequent	ADJ
iajs-3630	59	12	analysis	analysis	NOUN
iajs-3630	59	13	.	.	PUNCT
iajs-3630	60	1	the	the	DET
iajs-3630	60	2	first	first	ADJ
iajs-3630	60	3	section	section	NOUN
iajs-3630	60	4	has	have	AUX
iajs-3630	60	5	been	be	AUX
iajs-3630	60	6	utilized	utilize	VERB
iajs-3630	60	7	to	to	PART
iajs-3630	60	8	determine	determine	VERB
iajs-3630	60	9	fbg	fbg	NOUN
iajs-3630	60	10	,	,	PUNCT
iajs-3630	60	11	chol	chol	NOUN
iajs-3630	60	12	,	,	PUNCT
iajs-3630	60	13	tg	tg	PROPN
iajs-3630	60	14	,	,	PUNCT
iajs-3630	60	15	hdl	hdl	PROPN
iajs-3630	60	16	,	,	PUNCT
iajs-3630	60	17	irisin	irisin	NOUN
iajs-3630	60	18	,	,	PUNCT
iajs-3630	60	19	and	and	CCONJ
iajs-3630	60	20	insulin	insulin	NOUN
iajs-3630	60	21	levels	level	NOUN
iajs-3630	60	22	in	in	ADP
iajs-3630	60	23	the	the	DET
iajs-3630	60	24	second	second	ADJ
iajs-3630	60	25	component	component	NOUN
iajs-3630	60	26	,	,	PUNCT
iajs-3630	60	27	which	which	PRON
iajs-3630	60	28	was	be	AUX
iajs-3630	60	29	kept	keep	VERB
iajs-3630	60	30	at	at	ADP
iajs-3630	60	31	a	a	DET
iajs-3630	60	32	temperature	temperature	NOUN
iajs-3630	60	33	of	of	ADP
iajs-3630	60	34	minus	minus	ADV
iajs-3630	60	35	20	20	NUM
iajs-3630	60	36	°	°	NOUN
iajs-3630	60	37	c	c	NOUN
iajs-3630	60	38	and	and	CCONJ
iajs-3630	60	39	was	be	AUX
iajs-3630	60	40	evaluated	evaluate	VERB
iajs-3630	60	41	by	by	ADP
iajs-3630	60	42	an	an	DET
iajs-3630	60	43	enzyme	enzyme	NOUN
iajs-3630	60	44	-	-	PUNCT
iajs-3630	60	45	linked	link	VERB
iajs-3630	60	46	immunosorbent	immunosorbent	NOUN
iajs-3630	60	47	assay	assay	NOUN
iajs-3630	60	48	kit	kit	NOUN
iajs-3630	60	49	(	(	PUNCT
iajs-3630	60	50	elisa	elisa	NOUN
iajs-3630	60	51	)	)	PUNCT
iajs-3630	60	52	.	.	PUNCT
iajs-3630	61	1	additionally	additionally	ADV
iajs-3630	61	2	,	,	PUNCT
iajs-3630	61	3	1	1	NUM
iajs-3630	61	4	ml	ml	NOUN
iajs-3630	61	5	of	of	ADP
iajs-3630	61	6	whole	whole	ADJ
iajs-3630	61	7	blood	blood	NOUN
iajs-3630	61	8	in	in	ADP
iajs-3630	61	9	edta	edta	NOUN
iajs-3630	61	10	tubes	tube	NOUN
iajs-3630	61	11	was	be	AUX
iajs-3630	61	12	analyzed	analyze	VERB
iajs-3630	61	13	for	for	ADP
iajs-3630	61	14	hba1c	hba1c	PROPN
iajs-3630	61	15	assay	assay	NOUN
iajs-3630	61	16	.	.	PUNCT
iajs-3630	62	1	2.5	2.5	NUM
iajs-3630	62	2	.	.	PUNCT
iajs-3630	63	1	statistical	statistical	ADJ
iajs-3630	63	2	analyses	analysis	NOUN
iajs-3630	63	3	the	the	DET
iajs-3630	63	4	statistical	statistical	ADJ
iajs-3630	63	5	analysis	analysis	NOUN
iajs-3630	63	6	systemsas	systemsa	NOUN
iajs-3630	63	7	(	(	PUNCT
iajs-3630	63	8	2018	2018	NUM
iajs-3630	63	9	)	)	PUNCT
iajs-3630	63	10	program	program	NOUN
iajs-3630	63	11	was	be	AUX
iajs-3630	63	12	applied	apply	VERB
iajs-3630	63	13	to	to	PART
iajs-3630	63	14	categorize	categorize	VERB
iajs-3630	63	15	the	the	DET
iajs-3630	63	16	influence	influence	NOUN
iajs-3630	63	17	of	of	ADP
iajs-3630	63	18	numerous	numerous	ADJ
iajs-3630	63	19	factors	factor	NOUN
iajs-3630	63	20	on	on	ADP
iajs-3630	63	21	research	research	NOUN
iajs-3630	63	22	parameters	parameter	NOUN
iajs-3630	63	23	.	.	PUNCT
iajs-3630	64	1	thus	thus	ADV
iajs-3630	64	2	,	,	PUNCT
iajs-3630	64	3	for	for	ADP
iajs-3630	64	4	statistical	statistical	ADJ
iajs-3630	64	5	comparison	comparison	NOUN
iajs-3630	64	6	between	between	ADP
iajs-3630	64	7	means	mean	NOUN
iajs-3630	64	8	,	,	PUNCT
iajs-3630	64	9	a	a	DET
iajs-3630	64	10	least	least	ADV
iajs-3630	64	11	significant	significant	ADJ
iajs-3630	64	12	difference	difference	NOUN
iajs-3630	64	13	(	(	PUNCT
iajs-3630	64	14	lsd	lsd	NOUN
iajs-3630	64	15	)	)	PUNCT
iajs-3630	64	16	test	test	NOUN
iajs-3630	64	17	(	(	PUNCT
iajs-3630	64	18	analysis	analysis	NOUN
iajs-3630	64	19	of	of	ADP
iajs-3630	64	20	variation	variation	NOUN
iajs-3630	64	21	anova	anova	PROPN
iajs-3630	64	22	)	)	PUNCT
iajs-3630	64	23	was	be	AUX
iajs-3630	64	24	employed	employ	VERB
iajs-3630	64	25	.	.	PUNCT
iajs-3630	65	1	the	the	DET
iajs-3630	65	2	roc	roc	PROPN
iajs-3630	65	3	curve	curve	NOUN
iajs-3630	65	4	was	be	AUX
iajs-3630	65	5	used	use	VERB
iajs-3630	65	6	to	to	PART
iajs-3630	65	7	assess	assess	VERB
iajs-3630	65	8	the	the	DET
iajs-3630	65	9	accuracy	accuracy	NOUN
iajs-3630	65	10	of	of	ADP
iajs-3630	65	11	markers	marker	NOUN
iajs-3630	65	12	as	as	ADP
iajs-3630	65	13	indicators	indicator	NOUN
iajs-3630	65	14	of	of	ADP
iajs-3630	65	15	diabetes	diabetes	NOUN
iajs-3630	65	16	.	.	PUNCT
iajs-3630	66	1	3	3	X
iajs-3630	66	2	.	.	NOUN
iajs-3630	66	3	results	result	NOUN
iajs-3630	66	4	table	table	NOUN
iajs-3630	66	5	1	1	NUM
iajs-3630	66	6	shows	show	VERB
iajs-3630	66	7	the	the	DET
iajs-3630	66	8	values	value	NOUN
iajs-3630	66	9	of	of	ADP
iajs-3630	66	10	age	age	NOUN
iajs-3630	66	11	,	,	PUNCT
iajs-3630	66	12	bmi	bmi	NOUN
iajs-3630	66	13	,	,	PUNCT
iajs-3630	66	14	and	and	CCONJ
iajs-3630	66	15	waist	waist	NOUN
iajs-3630	66	16	-	-	PUNCT
iajs-3630	66	17	to	to	ADP
iajs-3630	66	18	-	-	PUNCT
iajs-3630	66	19	hip	hip	NOUN
iajs-3630	66	20	ratio	ratio	NOUN
iajs-3630	66	21	(	(	PUNCT
iajs-3630	66	22	whr	whr	PROPN
iajs-3630	66	23	)	)	PUNCT
iajs-3630	66	24	for	for	ADP
iajs-3630	66	25	all	all	DET
iajs-3630	66	26	the	the	DET
iajs-3630	66	27	studied	studied	ADJ
iajs-3630	66	28	groups	group	NOUN
iajs-3630	66	29	.	.	PUNCT
iajs-3630	67	1	age	age	NOUN
iajs-3630	67	2	results	result	VERB
iajs-3630	67	3	in	in	ADP
iajs-3630	67	4	mean	mean	PROPN
iajs-3630	67	5	±	±	NUM
iajs-3630	67	6	sd	sd	NOUN
iajs-3630	67	7	for	for	ADP
iajs-3630	67	8	t2	t2	NOUN
iajs-3630	67	9	dm	dm	PROPN
iajs-3630	67	10	,	,	PUNCT
iajs-3630	67	11	pre	pre	ADJ
iajs-3630	67	12	-	-	ADJ
iajs-3630	67	13	dm	dm	ADJ
iajs-3630	67	14	,	,	PUNCT
iajs-3630	67	15	and	and	CCONJ
iajs-3630	67	16	control	control	NOUN
iajs-3630	67	17	groups	group	NOUN
iajs-3630	67	18	[	[	X
iajs-3630	67	19	(	(	PUNCT
iajs-3630	67	20	53.21	53.21	NUM
iajs-3630	67	21	±	±	NUM
iajs-3630	67	22	1.20	1.20	NUM
iajs-3630	67	23	)	)	PUNCT
iajs-3630	67	24	,	,	PUNCT
iajs-3630	67	25	(	(	PUNCT
iajs-3630	67	26	51.00	51.00	NUM
iajs-3630	67	27	±	±	NUM
iajs-3630	67	28	1.35	1.35	NUM
iajs-3630	67	29	)	)	PUNCT
iajs-3630	67	30	and	and	CCONJ
iajs-3630	67	31	(	(	PUNCT
iajs-3630	67	32	42.30	42.30	NUM
iajs-3630	67	33	±1.12	±1.12	NOUN
iajs-3630	67	34	)	)	PUNCT
iajs-3630	67	35	]	]	PUNCT
iajs-3630	67	36	respectively	respectively	ADV
iajs-3630	67	37	,	,	PUNCT
iajs-3630	67	38	the	the	DET
iajs-3630	67	39	results	result	NOUN
iajs-3630	67	40	revealed	reveal	VERB
iajs-3630	67	41	considerable	considerable	ADJ
iajs-3630	67	42	differences	difference	NOUN
iajs-3630	67	43	(	(	PUNCT
iajs-3630	67	44	p=0.0001	p=0.0001	NOUN
iajs-3630	67	45	)	)	PUNCT
iajs-3630	67	46	between	between	ADP
iajs-3630	67	47	the	the	DET
iajs-3630	67	48	t2	t2	PROPN
iajs-3630	67	49	dm	dm	PROPN
iajs-3630	67	50	group	group	NOUN
iajs-3630	67	51	and	and	CCONJ
iajs-3630	67	52	control	control	NOUN
iajs-3630	67	53	group	group	NOUN
iajs-3630	67	54	as	as	ADV
iajs-3630	67	55	well	well	ADV
iajs-3630	67	56	as	as	ADP
iajs-3630	67	57	the	the	DET
iajs-3630	67	58	pre	pre	NOUN
iajs-3630	67	59	-	-	ADJ
iajs-3630	67	60	dm	dm	ADJ
iajs-3630	67	61	and	and	CCONJ
iajs-3630	67	62	control	control	NOUN
iajs-3630	67	63	groups	group	NOUN
iajs-3630	67	64	.	.	PUNCT
iajs-3630	68	1	still	still	ADV
iajs-3630	68	2	,	,	PUNCT
iajs-3630	68	3	there	there	PRON
iajs-3630	68	4	is	be	VERB
iajs-3630	68	5	no	no	DET
iajs-3630	68	6	significant	significant	ADJ
iajs-3630	68	7	variance	variance	NOUN
iajs-3630	68	8	between	between	ADP
iajs-3630	68	9	the	the	DET
iajs-3630	68	10	t2	t2	NOUN
iajs-3630	68	11	dm	dm	PROPN
iajs-3630	68	12	and	and	CCONJ
iajs-3630	68	13	pre	pre	ADJ
iajs-3630	68	14	-	-	ADJ
iajs-3630	68	15	dm	dm	ADJ
iajs-3630	68	16	groups	group	NOUN
iajs-3630	68	17	.	.	PUNCT
iajs-3630	69	1	the	the	DET
iajs-3630	69	2	results	result	NOUN
iajs-3630	69	3	of	of	ADP
iajs-3630	69	4	bmi	bmi	NOUN
iajs-3630	69	5	in	in	ADP
iajs-3630	69	6	patients	patient	NOUN
iajs-3630	69	7	with	with	ADP
iajs-3630	69	8	t2	t2	PROPN
iajs-3630	69	9	dm	dm	PROPN
iajs-3630	69	10	,	,	PUNCT
iajs-3630	69	11	subjects	subject	NOUN
iajs-3630	69	12	with	with	ADP
iajs-3630	69	13	pre	pre	NOUN
iajs-3630	69	14	-	-	NOUN
iajs-3630	69	15	diabetes	diabetes	ADJ
iajs-3630	69	16	,	,	PUNCT
iajs-3630	69	17	and	and	CCONJ
iajs-3630	69	18	healthy	healthy	ADJ
iajs-3630	69	19	persons	person	NOUN
iajs-3630	69	20	in	in	ADP
iajs-3630	69	21	terms	term	NOUN
iajs-3630	69	22	of	of	ADP
iajs-3630	69	23	mean	mean	ADJ
iajs-3630	69	24	±	±	NUM
iajs-3630	69	25	sd	sd	NOUN
iajs-3630	69	26	were	be	AUX
iajs-3630	69	27	found	find	VERB
iajs-3630	69	28	to	to	PART
iajs-3630	69	29	be	be	AUX
iajs-3630	69	30	[	[	X
iajs-3630	69	31	(	(	PUNCT
iajs-3630	69	32	28.61	28.61	NUM
iajs-3630	69	33	±	±	NUM
iajs-3630	69	34	0.94	0.94	NUM
iajs-3630	69	35	)	)	PUNCT
iajs-3630	69	36	,	,	PUNCT
iajs-3630	69	37	(	(	PUNCT
iajs-3630	69	38	27.41	27.41	NUM
iajs-3630	69	39	±	±	NUM
iajs-3630	69	40	0.64	0.64	NUM
iajs-3630	69	41	)	)	PUNCT
iajs-3630	69	42	and	and	CCONJ
iajs-3630	69	43	(	(	PUNCT
iajs-3630	69	44	24.78	24.78	NUM
iajs-3630	69	45	±	±	NUM
iajs-3630	69	46	0.19	0.19	NUM
iajs-3630	69	47	)	)	PUNCT
iajs-3630	69	48	]	]	PUNCT
iajs-3630	69	49	respectively	respectively	ADV
iajs-3630	69	50	.	.	PUNCT
iajs-3630	70	1	the	the	DET
iajs-3630	70	2	results	result	NOUN
iajs-3630	70	3	revealed	reveal	VERB
iajs-3630	70	4	highly	highly	ADV
iajs-3630	70	5	significant	significant	ADJ
iajs-3630	70	6	differences	difference	NOUN
iajs-3630	70	7	(	(	PUNCT
iajs-3630	70	8	p	p	NOUN
iajs-3630	70	9	=	=	NOUN
iajs-3630	70	10	0.0003	0.0003	NUM
iajs-3630	70	11	)	)	PUNCT
iajs-3630	70	12	between	between	ADP
iajs-3630	70	13	the	the	DET
iajs-3630	70	14	t2	t2	PROPN
iajs-3630	70	15	dm	dm	NOUN
iajs-3630	70	16	,	,	PUNCT
iajs-3630	70	17	pre	pre	ADJ
iajs-3630	70	18	-	-	ADJ
iajs-3630	70	19	diabetes	diabetes	ADJ
iajs-3630	70	20	groups	group	NOUN
iajs-3630	70	21	,	,	PUNCT
iajs-3630	70	22	and	and	CCONJ
iajs-3630	70	23	the	the	DET
iajs-3630	70	24	control	control	NOUN
iajs-3630	70	25	group	group	NOUN
iajs-3630	70	26	,	,	PUNCT
iajs-3630	70	27	while	while	SCONJ
iajs-3630	70	28	there	there	PRON
iajs-3630	70	29	was	be	VERB
iajs-3630	70	30	no	no	DET
iajs-3630	70	31	significant	significant	ADJ
iajs-3630	70	32	difference	difference	NOUN
iajs-3630	70	33	between	between	ADP
iajs-3630	70	34	t2	t2	PROPN
iajs-3630	70	35	dm	dm	PROPN
iajs-3630	70	36	and	and	CCONJ
iajs-3630	70	37	pre	pre	ADJ
iajs-3630	70	38	-	-	ADJ
iajs-3630	70	39	dm	dm	ADJ
iajs-3630	70	40	.	.	PUNCT
iajs-3630	71	1	also	also	ADV
iajs-3630	71	2	,	,	PUNCT
iajs-3630	71	3	table	table	NOUN
iajs-3630	71	4	1	1	NUM
iajs-3630	71	5	records	record	NOUN
iajs-3630	71	6	the	the	DET
iajs-3630	71	7	whr	whr	PROPN
iajs-3630	71	8	for	for	ADP
iajs-3630	71	9	the	the	DET
iajs-3630	71	10	t2	t2	PROPN
iajs-3630	71	11	dm	dm	NOUN
iajs-3630	71	12	,	,	PUNCT
iajs-3630	71	13	pre	pre	ADJ
iajs-3630	71	14	-	-	ADJ
iajs-3630	71	15	dm	dm	ADJ
iajs-3630	71	16	,	,	PUNCT
iajs-3630	71	17	and	and	CCONJ
iajs-3630	71	18	control	control	NOUN
iajs-3630	71	19	groups	group	NOUN
iajs-3630	71	20	and	and	CCONJ
iajs-3630	71	21	finds	find	VERB
iajs-3630	71	22	them	they	PRON
iajs-3630	71	23	to	to	PART
iajs-3630	71	24	be	be	AUX
iajs-3630	71	25	[	[	X
iajs-3630	71	26	(	(	PUNCT
iajs-3630	71	27	0.958	0.958	NUM
iajs-3630	71	28	±	±	NOUN
iajs-3630	71	29	0.01	0.01	NUM
iajs-3630	71	30	)	)	PUNCT
iajs-3630	71	31	,	,	PUNCT
iajs-3630	71	32	(	(	PUNCT
iajs-3630	71	33	0.915	0.915	NUM
iajs-3630	71	34	±	±	NUM
iajs-3630	71	35	0.009	0.009	NUM
iajs-3630	71	36	)	)	PUNCT
iajs-3630	71	37	,	,	PUNCT
iajs-3630	71	38	and	and	CCONJ
iajs-3630	71	39	(	(	PUNCT
iajs-3630	71	40	0.917	0.917	NUM
iajs-3630	71	41	±0.004	±0.004	NOUN
iajs-3630	71	42	)	)	PUNCT
iajs-3630	71	43	]	]	PUNCT
iajs-3630	71	44	,	,	PUNCT
iajs-3630	71	45	respectively	respectively	ADV
iajs-3630	71	46	.	.	PUNCT
iajs-3630	72	1	the	the	DET
iajs-3630	72	2	results	result	NOUN
iajs-3630	72	3	revealed	reveal	VERB
iajs-3630	72	4	a	a	DET
iajs-3630	72	5	significant	significant	ADJ
iajs-3630	72	6	difference	difference	NOUN
iajs-3630	72	7	between	between	ADP
iajs-3630	72	8	the	the	DET
iajs-3630	72	9	t2	t2	PROPN
iajs-3630	72	10	dm	dm	NOUN
iajs-3630	72	11	,	,	PUNCT
iajs-3630	72	12	pre	pre	ADJ
iajs-3630	72	13	-	-	ADJ
iajs-3630	72	14	dm	dm	ADJ
iajs-3630	72	15	,	,	PUNCT
iajs-3630	72	16	and	and	CCONJ
iajs-3630	72	17	control	control	NOUN
iajs-3630	72	18	groups	group	NOUN
iajs-3630	72	19	.	.	PUNCT
iajs-3630	73	1	in	in	ADP
iajs-3630	73	2	contrast	contrast	NOUN
iajs-3630	73	3	,	,	PUNCT
iajs-3630	73	4	there	there	PRON
iajs-3630	73	5	was	be	VERB
iajs-3630	73	6	no	no	DET
iajs-3630	73	7	difference	difference	NOUN
iajs-3630	73	8	between	between	ADP
iajs-3630	73	9	the	the	DET
iajs-3630	73	10	pre	pre	NOUN
iajs-3630	73	11	-	-	ADJ
iajs-3630	73	12	dm	dm	ADJ
iajs-3630	73	13	and	and	CCONJ
iajs-3630	73	14	control	control	NOUN
iajs-3630	73	15	groups	group	NOUN
iajs-3630	73	16	.	.	PUNCT
iajs-3630	74	1	ihjpas	ihjpas	PROPN
iajs-3630	74	2	.	.	PUNCT
iajs-3630	75	1	2025	2025	NUM
iajs-3630	75	2	,	,	PUNCT
iajs-3630	75	3	38	38	NUM
iajs-3630	75	4	(	(	PUNCT
iajs-3630	75	5	1	1	NUM
iajs-3630	75	6	)	)	SYM
iajs-3630	75	7	305	305	NUM
iajs-3630	75	8	table	table	NOUN
iajs-3630	75	9	1	1	NUM
iajs-3630	75	10	.	.	PUNCT
iajs-3630	75	11	age	age	NOUN
iajs-3630	75	12	,	,	PUNCT
iajs-3630	75	13	bmi	bmi	PROPN
iajs-3630	75	14	and	and	CCONJ
iajs-3630	75	15	whr	whr	PROPN
iajs-3630	75	16	for	for	ADP
iajs-3630	75	17	the	the	DET
iajs-3630	75	18	study	study	NOUN
iajs-3630	75	19	groups	group	NOUN
iajs-3630	75	20	.	.	PUNCT
iajs-3630	76	1	groups	group	NOUN
iajs-3630	76	2	mean	mean	VERB
iajs-3630	76	3	±sd	±sd	DET
iajs-3630	76	4	age	age	NOUN
iajs-3630	76	5	(	(	PUNCT
iajs-3630	76	6	years	year	NOUN
iajs-3630	76	7	)	)	PUNCT
iajs-3630	76	8	)	)	PUNCT
iajs-3630	77	1	2bmi	2bmi	NUM
iajs-3630	77	2	(	(	PUNCT
iajs-3630	77	3	kg	kg	NOUN
iajs-3630	77	4	/	/	SYM
iajs-3630	77	5	m	m	VERB
iajs-3630	77	6	whr	whr	NOUN
iajs-3630	77	7	duration	duration	NOUN
iajs-3630	77	8	of	of	ADP
iajs-3630	77	9	dm	dm	PROPN
iajs-3630	77	10	(	(	PUNCT
iajs-3630	77	11	years	year	NOUN
iajs-3630	77	12	)	)	PUNCT
iajs-3630	77	13	t2	t2	NOUN
iajs-3630	77	14	dm	dm	X
iajs-3630	77	15	(	(	PUNCT
iajs-3630	77	16	n	n	NOUN
iajs-3630	77	17	=	=	NOUN
iajs-3630	77	18	46	46	NUM
iajs-3630	77	19	)	)	PUNCT
iajs-3630	77	20	53.21	53.21	NUM
iajs-3630	77	21	±	±	NUM
iajs-3630	77	22	1.20	1.20	NUM
iajs-3630	77	23	a	a	DET
iajs-3630	77	24	28.61	28.61	NUM
iajs-3630	77	25	±	±	NUM
iajs-3630	77	26	0.94	0.94	NUM
iajs-3630	77	27	a	a	DET
iajs-3630	77	28	0.958	0.958	NUM
iajs-3630	77	29	±	±	NOUN
iajs-3630	77	30	0.01	0.01	NUM
iajs-3630	77	31	a	a	DET
iajs-3630	77	32	6.73	6.73	NUM
iajs-3630	77	33	±	±	NUM
iajs-3630	77	34	0.69	0.69	NUM
iajs-3630	77	35	pre	pre	NOUN
iajs-3630	77	36	-	-	ADJ
iajs-3630	77	37	dm	dm	INTJ
iajs-3630	77	38	(	(	PUNCT
iajs-3630	77	39	n	n	NOUN
iajs-3630	77	40	=	=	NOUN
iajs-3630	77	41	46	46	NUM
iajs-3630	77	42	)	)	PUNCT
iajs-3630	77	43	51.00	51.00	NUM
iajs-3630	77	44	±	±	NUM
iajs-3630	77	45	1.35	1.35	NUM
iajs-3630	77	46	a	a	DET
iajs-3630	77	47	27.41	27.41	NUM
iajs-3630	77	48	±	±	NUM
iajs-3630	77	49	0.64	0.64	NUM
iajs-3630	77	50	a	a	DET
iajs-3630	77	51	0.915	0.915	NUM
iajs-3630	77	52	±	±	NUM
iajs-3630	77	53	0.009	0.009	NUM
iajs-3630	77	54	b	b	PROPN
iajs-3630	77	55	0.726	0.726	NUM
iajs-3630	77	56	±	±	NUM
iajs-3630	77	57	0.06	0.06	NUM
iajs-3630	77	58	control	control	NOUN
iajs-3630	77	59	(	(	PUNCT
iajs-3630	77	60	n	n	NOUN
iajs-3630	77	61	=	=	NOUN
iajs-3630	77	62	46	46	NUM
iajs-3630	77	63	)	)	PUNCT
iajs-3630	77	64	42.30	42.30	NUM
iajs-3630	77	65	±	±	NUM
iajs-3630	77	66	1.12	1.12	NUM
iajs-3630	77	67	b	b	PROPN
iajs-3630	77	68	24.78	24.78	NUM
iajs-3630	77	69	±	±	NOUN
iajs-3630	77	70	0.19	0.19	NUM
iajs-3630	77	71	b	b	NOUN
iajs-3630	77	72	0.917	0.917	NUM
iajs-3630	77	73	±	±	NUM
iajs-3630	77	74	0.004	0.004	NUM
iajs-3630	77	75	b	b	NOUN
iajs-3630	77	76	lsd	lsd	NOUN
iajs-3630	77	77	3.44	3.44	NUM
iajs-3630	77	78	*	*	PUNCT
iajs-3630	77	79	*	*	PUNCT
iajs-3630	77	80	1.870	1.870	NUM
iajs-3630	77	81	*	*	PUNCT
iajs-3630	77	82	*	*	PUNCT
iajs-3630	78	1	0.0262	0.0262	NUM
iajs-3630	78	2	*	*	PUNCT
iajs-3630	78	3	*	*	PUNCT
iajs-3630	78	4	1.393	1.393	NUM
iajs-3630	78	5	*	*	PUNCT
iajs-3630	78	6	*	*	PUNCT
iajs-3630	78	7	p	p	NUM
iajs-3630	78	8	-	-	PUNCT
iajs-3630	78	9	value	value	NOUN
iajs-3630	78	10	0.0001	0.0001	NUM
iajs-3630	78	11	0.0003	0.0003	NUM
iajs-3630	78	12	0.0016	0.0016	NUM
iajs-3630	78	13	0.0001	0.0001	NUM
iajs-3630	78	14	the	the	DET
iajs-3630	78	15	different	different	ADJ
iajs-3630	78	16	letters	letter	NOUN
iajs-3630	78	17	in	in	ADP
iajs-3630	78	18	the	the	DET
iajs-3630	78	19	same	same	ADJ
iajs-3630	78	20	column	column	NOUN
iajs-3630	78	21	mean	mean	VERB
iajs-3630	78	22	that	that	SCONJ
iajs-3630	78	23	they	they	PRON
iajs-3630	78	24	are	be	AUX
iajs-3630	78	25	differed	differ	VERB
iajs-3630	78	26	significantly	significantly	ADV
iajs-3630	78	27	,	,	PUNCT
iajs-3630	78	28	*	*	PUNCT
iajs-3630	78	29	*	*	PUNCT
iajs-3630	78	30	(	(	PUNCT
iajs-3630	78	31	p	p	NOUN
iajs-3630	78	32	≤	≤	NOUN
iajs-3630	78	33	0.01	0.01	NUM
iajs-3630	78	34	)	)	PUNCT
iajs-3630	78	35	,	,	PUNCT
iajs-3630	78	36	t2	t2	NOUN
iajs-3630	78	37	dm	dm	NOUN
iajs-3630	78	38	:	:	PUNCT
iajs-3630	78	39	type	type	NOUN
iajs-3630	78	40	2	2	NUM
iajs-3630	78	41	diabetes	diabetes	NOUN
iajs-3630	78	42	mellitus	mellitus	NOUN
iajs-3630	78	43	,	,	PUNCT
iajs-3630	78	44	pre	pre	ADJ
iajs-3630	78	45	-	-	ADJ
iajs-3630	78	46	dm	dm	ADJ
iajs-3630	78	47	:	:	PUNCT
iajs-3630	78	48	pre	pre	ADJ
iajs-3630	78	49	-	-	ADJ
iajs-3630	78	50	diabetes	diabetes	ADJ
iajs-3630	78	51	mellitus	mellitus	NOUN
iajs-3630	78	52	.	.	PUNCT
iajs-3630	79	1	table	table	NOUN
iajs-3630	79	2	2	2	NUM
iajs-3630	79	3	shows	show	VERB
iajs-3630	79	4	the	the	DET
iajs-3630	79	5	effect	effect	NOUN
iajs-3630	79	6	of	of	ADP
iajs-3630	79	7	gender	gender	NOUN
iajs-3630	79	8	on	on	ADP
iajs-3630	79	9	the	the	DET
iajs-3630	79	10	studied	studied	ADJ
iajs-3630	79	11	parameters	parameter	NOUN
iajs-3630	79	12	,	,	PUNCT
iajs-3630	79	13	including	include	VERB
iajs-3630	79	14	bmi	bmi	PROPN
iajs-3630	79	15	,	,	PUNCT
iajs-3630	79	16	whr	whr	PROPN
iajs-3630	79	17	,	,	PUNCT
iajs-3630	79	18	fbg	fbg	PROPN
iajs-3630	79	19	,	,	PUNCT
iajs-3630	79	20	and	and	CCONJ
iajs-3630	79	21	hba1c	hba1c	PROPN
iajs-3630	79	22	,	,	PUNCT
iajs-3630	79	23	in	in	ADP
iajs-3630	79	24	both	both	PRON
iajs-3630	79	25	t2	t2	NOUN
iajs-3630	79	26	dm	dm	PROPN
iajs-3630	79	27	and	and	CCONJ
iajs-3630	79	28	pre	pre	ADJ
iajs-3630	79	29	-	-	ADJ
iajs-3630	79	30	dm	dm	ADJ
iajs-3630	79	31	groups	group	NOUN
iajs-3630	79	32	.	.	PUNCT
iajs-3630	80	1	the	the	DET
iajs-3630	80	2	results	result	NOUN
iajs-3630	80	3	revealed	reveal	VERB
iajs-3630	80	4	that	that	SCONJ
iajs-3630	80	5	gender	gender	NOUN
iajs-3630	80	6	does	do	AUX
iajs-3630	80	7	not	not	PART
iajs-3630	80	8	affect	affect	VERB
iajs-3630	80	9	the	the	DET
iajs-3630	80	10	mentioned	mention	VERB
iajs-3630	80	11	parameters	parameter	NOUN
iajs-3630	80	12	in	in	ADP
iajs-3630	80	13	the	the	DET
iajs-3630	80	14	case	case	NOUN
iajs-3630	80	15	of	of	ADP
iajs-3630	80	16	pre	pre	NOUN
iajs-3630	80	17	-	-	NOUN
iajs-3630	80	18	dm	dm	ADJ
iajs-3630	80	19	.	.	PUNCT
iajs-3630	81	1	while	while	SCONJ
iajs-3630	81	2	bmi	bmi	NOUN
iajs-3630	81	3	is	be	AUX
iajs-3630	81	4	significantly	significantly	ADV
iajs-3630	81	5	affected	affect	VERB
iajs-3630	81	6	(	(	PUNCT
iajs-3630	81	7	p=0.0071	p=0.0071	PROPN
iajs-3630	81	8	)	)	PUNCT
iajs-3630	81	9	in	in	ADP
iajs-3630	81	10	the	the	DET
iajs-3630	81	11	case	case	NOUN
iajs-3630	81	12	of	of	ADP
iajs-3630	81	13	t2	t2	PROPN
iajs-3630	81	14	dm	dm	PROPN
iajs-3630	81	15	,	,	PUNCT
iajs-3630	81	16	no	no	DET
iajs-3630	81	17	other	other	ADJ
iajs-3630	81	18	parameters	parameter	NOUN
iajs-3630	81	19	are	be	AUX
iajs-3630	81	20	noted	note	VERB
iajs-3630	81	21	.	.	PUNCT
iajs-3630	82	1	table	table	NOUN
iajs-3630	82	2	2	2	NUM
iajs-3630	82	3	.	.	PUNCT
iajs-3630	82	4	effect	effect	NOUN
iajs-3630	82	5	of	of	ADP
iajs-3630	82	6	gender	gender	NOUN
iajs-3630	82	7	in	in	ADP
iajs-3630	82	8	parameters	parameter	NOUN
iajs-3630	82	9	for	for	ADP
iajs-3630	82	10	the	the	DET
iajs-3630	82	11	study	study	NOUN
iajs-3630	82	12	groups	group	NOUN
iajs-3630	82	13	.	.	PUNCT
iajs-3630	83	1	table	table	NOUN
iajs-3630	83	2	3	3	NUM
iajs-3630	83	3	shows	show	VERB
iajs-3630	83	4	the	the	DET
iajs-3630	83	5	results	result	NOUN
iajs-3630	83	6	of	of	ADP
iajs-3630	83	7	irisin	irisin	NOUN
iajs-3630	83	8	and	and	CCONJ
iajs-3630	83	9	insulin	insulin	NOUN
iajs-3630	83	10	for	for	ADP
iajs-3630	83	11	all	all	DET
iajs-3630	83	12	the	the	DET
iajs-3630	83	13	studied	studied	ADJ
iajs-3630	83	14	groups	group	NOUN
iajs-3630	83	15	;	;	PUNCT
iajs-3630	83	16	irisin	irisin	ADJ
iajs-3630	83	17	data	datum	NOUN
iajs-3630	83	18	revealed	reveal	VERB
iajs-3630	83	19	a	a	DET
iajs-3630	83	20	significant	significant	ADJ
iajs-3630	83	21	difference	difference	NOUN
iajs-3630	83	22	(	(	PUNCT
iajs-3630	83	23	p	p	NOUN
iajs-3630	83	24	=	=	NOUN
iajs-3630	83	25	0.0001	0.0001	NUM
iajs-3630	83	26	)	)	PUNCT
iajs-3630	83	27	between	between	ADP
iajs-3630	83	28	the	the	DET
iajs-3630	83	29	t2	t2	PROPN
iajs-3630	83	30	dm	dm	NOUN
iajs-3630	83	31	,	,	PUNCT
iajs-3630	83	32	pre	pre	ADJ
iajs-3630	83	33	-	-	NOUN
iajs-3630	83	34	diabetes	diabetes	ADJ
iajs-3630	83	35	,	,	PUNCT
iajs-3630	83	36	and	and	CCONJ
iajs-3630	83	37	control	control	NOUN
iajs-3630	83	38	groups	group	NOUN
iajs-3630	83	39	.	.	PUNCT
iajs-3630	84	1	irisin	irisin	VERB
iajs-3630	84	2	values	value	NOUN
iajs-3630	84	3	of	of	ADP
iajs-3630	84	4	the	the	DET
iajs-3630	84	5	mentioned	mention	VERB
iajs-3630	84	6	groups	group	NOUN
iajs-3630	84	7	were	be	AUX
iajs-3630	84	8	found	find	VERB
iajs-3630	84	9	to	to	PART
iajs-3630	84	10	be	be	AUX
iajs-3630	84	11	[	[	X
iajs-3630	84	12	(	(	PUNCT
iajs-3630	84	13	34.69	34.69	NUM
iajs-3630	84	14	±	±	NUM
iajs-3630	84	15	1.47	1.47	NUM
iajs-3630	84	16	)	)	PUNCT
iajs-3630	84	17	(	(	PUNCT
iajs-3630	84	18	18.51	18.51	NUM
iajs-3630	84	19	±	±	NUM
iajs-3630	84	20	0.76	0.76	NUM
iajs-3630	84	21	)	)	PUNCT
iajs-3630	84	22	(	(	PUNCT
iajs-3630	84	23	17.58	17.58	NUM
iajs-3630	84	24	±1.30	±1.30	NOUN
iajs-3630	84	25	)	)	PUNCT
iajs-3630	84	26	]	]	PUNCT
iajs-3630	84	27	respectively	respectively	ADV
iajs-3630	84	28	.	.	PUNCT
iajs-3630	85	1	on	on	ADP
iajs-3630	85	2	the	the	DET
iajs-3630	85	3	other	other	ADJ
iajs-3630	85	4	hand	hand	NOUN
iajs-3630	85	5	,	,	PUNCT
iajs-3630	85	6	the	the	DET
iajs-3630	85	7	insulin	insulin	NOUN
iajs-3630	85	8	results	result	NOUN
iajs-3630	85	9	of	of	ADP
iajs-3630	85	10	the	the	DET
iajs-3630	85	11	studied	study	VERB
iajs-3630	85	12	groups	group	NOUN
iajs-3630	85	13	,	,	PUNCT
iajs-3630	85	14	including	include	VERB
iajs-3630	85	15	t2	t2	NOUN
iajs-3630	85	16	dm	dm	NOUN
iajs-3630	85	17	,	,	PUNCT
iajs-3630	85	18	predm	predm	ADV
iajs-3630	85	19	,	,	PUNCT
iajs-3630	85	20	and	and	CCONJ
iajs-3630	85	21	control	control	NOUN
iajs-3630	85	22	,	,	PUNCT
iajs-3630	85	23	were	be	AUX
iajs-3630	85	24	found	find	VERB
iajs-3630	85	25	to	to	PART
iajs-3630	85	26	be	be	AUX
iajs-3630	85	27	[	[	X
iajs-3630	85	28	(	(	PUNCT
iajs-3630	85	29	4.02	4.02	NUM
iajs-3630	85	30	±	±	NUM
iajs-3630	85	31	0.20	0.20	NUM
iajs-3630	85	32	)	)	PUNCT
iajs-3630	85	33	(	(	PUNCT
iajs-3630	85	34	2.14	2.14	NUM
iajs-3630	85	35	±0.13	±0.13	NOUN
iajs-3630	85	36	)	)	PUNCT
iajs-3630	85	37	,	,	PUNCT
iajs-3630	85	38	(	(	PUNCT
iajs-3630	85	39	1.838	1.838	NUM
iajs-3630	85	40	±	±	NUM
iajs-3630	85	41	0.05	0.05	NUM
iajs-3630	85	42	)	)	PUNCT
iajs-3630	85	43	]	]	PUNCT
iajs-3630	85	44	respectively	respectively	ADV
iajs-3630	85	45	.	.	PUNCT
iajs-3630	86	1	they	they	PRON
iajs-3630	86	2	revealed	reveal	VERB
iajs-3630	86	3	a	a	DET
iajs-3630	86	4	significant	significant	ADJ
iajs-3630	86	5	difference	difference	NOUN
iajs-3630	86	6	(	(	PUNCT
iajs-3630	86	7	p=0.0001	p=0.0001	NOUN
iajs-3630	86	8	)	)	PUNCT
iajs-3630	86	9	between	between	ADP
iajs-3630	86	10	the	the	DET
iajs-3630	86	11	t2	t2	PROPN
iajs-3630	86	12	dm	dm	PROPN
iajs-3630	86	13	group	group	NOUN
iajs-3630	86	14	and	and	CCONJ
iajs-3630	86	15	the	the	DET
iajs-3630	86	16	other	other	ADJ
iajs-3630	86	17	two	two	NUM
iajs-3630	86	18	groups	group	NOUN
iajs-3630	86	19	,	,	PUNCT
iajs-3630	86	20	including	include	VERB
iajs-3630	86	21	pre	pre	VERB
iajs-3630	86	22	-	-	ADJ
iajs-3630	86	23	dm	dm	ADJ
iajs-3630	86	24	and	and	CCONJ
iajs-3630	86	25	control	control	NOUN
iajs-3630	86	26	groups	group	NOUN
iajs-3630	86	27	,	,	PUNCT
iajs-3630	86	28	but	but	CCONJ
iajs-3630	86	29	no	no	DET
iajs-3630	86	30	significant	significant	ADJ
iajs-3630	86	31	differences	difference	NOUN
iajs-3630	86	32	between	between	ADP
iajs-3630	86	33	pre	pre	ADJ
iajs-3630	86	34	-	-	ADJ
iajs-3630	86	35	dm	dm	ADJ
iajs-3630	86	36	and	and	CCONJ
iajs-3630	86	37	control	control	NOUN
iajs-3630	86	38	groups	group	NOUN
iajs-3630	86	39	.	.	PUNCT
iajs-3630	87	1	the	the	DET
iajs-3630	87	2	results	result	NOUN
iajs-3630	87	3	of	of	ADP
iajs-3630	87	4	fbg	fbg	NOUN
iajs-3630	87	5	,	,	PUNCT
iajs-3630	87	6	hba1,c	hba1,c	NOUN
iajs-3630	87	7	,	,	PUNCT
iajs-3630	87	8	and	and	CCONJ
iajs-3630	87	9	homa	homa	NOUN
iajs-3630	87	10	-	-	PUNCT
iajs-3630	87	11	is	be	AUX
iajs-3630	87	12	in	in	ADP
iajs-3630	87	13	all	all	DET
iajs-3630	87	14	the	the	DET
iajs-3630	87	15	mentioned	mention	VERB
iajs-3630	87	16	groups	group	NOUN
iajs-3630	87	17	were	be	AUX
iajs-3630	87	18	found	find	VERB
iajs-3630	87	19	to	to	PART
iajs-3630	87	20	be	be	AUX
iajs-3630	87	21	[	[	PUNCT
iajs-3630	87	22	(	(	PUNCT
iajs-3630	87	23	196.14	196.14	NUM
iajs-3630	87	24	±	±	NUM
iajs-3630	87	25	9.14	9.14	NUM
iajs-3630	87	26	)	)	PUNCT
iajs-3630	87	27	,	,	PUNCT
iajs-3630	87	28	(	(	PUNCT
iajs-3630	87	29	114.37	114.37	NUM
iajs-3630	87	30	±1.10	±1.10	PROPN
iajs-3630	87	31	)	)	PUNCT
iajs-3630	87	32	and	and	CCONJ
iajs-3630	87	33	(	(	PUNCT
iajs-3630	87	34	93.49	93.49	NUM
iajs-3630	87	35	±0.76	±0.76	PROPN
iajs-3630	87	36	)	)	PUNCT
iajs-3630	87	37	]	]	PUNCT
iajs-3630	87	38	respectively	respectively	ADV
iajs-3630	87	39	for	for	ADP
iajs-3630	87	40	fbg	fbg	NOUN
iajs-3630	87	41	,	,	PUNCT
iajs-3630	87	42	[	[	X
iajs-3630	87	43	(	(	PUNCT
iajs-3630	87	44	8.11	8.11	NUM
iajs-3630	87	45	±	±	NUM
iajs-3630	87	46	0.23	0.23	NUM
iajs-3630	87	47	)	)	PUNCT
iajs-3630	87	48	,	,	PUNCT
iajs-3630	87	49	(	(	PUNCT
iajs-3630	87	50	6.02	6.02	NUM
iajs-3630	87	51	±	±	NUM
iajs-3630	87	52	0.03	0.03	NUM
iajs-3630	87	53	)	)	PUNCT
iajs-3630	87	54	]	]	PUNCT
iajs-3630	87	55	,	,	PUNCT
iajs-3630	87	56	[	[	X
iajs-3630	87	57	(	(	PUNCT
iajs-3630	87	58	4.69	4.69	NUM
iajs-3630	87	59	±	±	NUM
iajs-3630	87	60	0.03	0.03	NUM
iajs-3630	87	61	)	)	PUNCT
iajs-3630	87	62	,	,	PUNCT
iajs-3630	87	63	respectively	respectively	ADV
iajs-3630	87	64	for	for	ADP
iajs-3630	87	65	hba1c	hba1c	PROPN
iajs-3630	87	66	and	and	CCONJ
iajs-3630	87	67	[	[	X
iajs-3630	87	68	(	(	PUNCT
iajs-3630	87	69	0.597	0.597	NUM
iajs-3630	87	70	±0.02),(1.89	±0.02),(1.89	NOUN
iajs-3630	87	71	±0.11	±0.11	NOUN
iajs-3630	87	72	)	)	PUNCT
iajs-3630	87	73	and	and	CCONJ
iajs-3630	87	74	(	(	PUNCT
iajs-3630	87	75	2.36	2.36	NUM
iajs-3630	87	76	±	±	NUM
iajs-3630	87	77	0.09	0.09	NUM
iajs-3630	87	78	)	)	PUNCT
iajs-3630	87	79	]	]	PUNCT
iajs-3630	87	80	respectively	respectively	ADV
iajs-3630	87	81	for	for	SCONJ
iajs-3630	87	82	homa	homa	NOUN
iajs-3630	87	83	-	-	PUNCT
iajs-3630	87	84	is	be	AUX
iajs-3630	87	85	.	.	PUNCT
iajs-3630	88	1	at	at	ADP
iajs-3630	88	2	the	the	DET
iajs-3630	88	3	same	same	ADJ
iajs-3630	88	4	time	time	NOUN
iajs-3630	88	5	,	,	PUNCT
iajs-3630	88	6	the	the	DET
iajs-3630	88	7	fbg	fbg	NOUN
iajs-3630	88	8	,	,	PUNCT
iajs-3630	88	9	hba1c	hba1c	PROPN
iajs-3630	88	10	,	,	PUNCT
iajs-3630	88	11	and	and	CCONJ
iajs-3630	88	12	homa	homa	NOUN
iajs-3630	88	13	-	-	PUNCT
iajs-3630	88	14	is	be	AUX
iajs-3630	88	15	results	result	NOUN
iajs-3630	88	16	revealed	reveal	VERB
iajs-3630	88	17	significant	significant	ADJ
iajs-3630	88	18	differences	difference	NOUN
iajs-3630	88	19	(	(	PUNCT
iajs-3630	88	20	p=0.0001	p=0.0001	NOUN
iajs-3630	88	21	)	)	PUNCT
iajs-3630	88	22	among	among	ADP
iajs-3630	88	23	the	the	DET
iajs-3630	88	24	studied	study	VERB
iajs-3630	88	25	groups	group	NOUN
iajs-3630	88	26	.	.	PUNCT
iajs-3630	89	1	the	the	DET
iajs-3630	89	2	values	value	NOUN
iajs-3630	89	3	of	of	ADP
iajs-3630	89	4	homo	homo	NOUN
iajs-3630	89	5	-	-	PUNCT
iajs-3630	89	6	ir	ir	NOUN
iajs-3630	89	7	for	for	ADP
iajs-3630	89	8	the	the	DET
iajs-3630	89	9	mentioned	mention	VERB
iajs-3630	89	10	groups	group	NOUN
iajs-3630	89	11	were	be	AUX
iajs-3630	89	12	recorded	record	VERB
iajs-3630	89	13	to	to	PART
iajs-3630	89	14	be	be	AUX
iajs-3630	89	15	[	[	X
iajs-3630	89	16	(	(	PUNCT
iajs-3630	89	17	1.97	1.97	NUM
iajs-3630	89	18	±	±	NUM
iajs-3630	89	19	0.15	0.15	NUM
iajs-3630	89	20	)	)	PUNCT
iajs-3630	89	21	,	,	PUNCT
iajs-3630	89	22	(	(	PUNCT
iajs-3630	89	23	0.603	0.603	NUM
iajs-3630	89	24	±	±	NUM
iajs-3630	89	25	0.04	0.04	NUM
iajs-3630	89	26	)	)	PUNCT
iajs-3630	89	27	,	,	PUNCT
iajs-3630	89	28	and	and	CCONJ
iajs-3630	89	29	(	(	PUNCT
iajs-3630	89	30	0.453	0.453	NUM
iajs-3630	89	31	±	±	NUM
iajs-3630	89	32	0.02	0.02	NUM
iajs-3630	89	33	)	)	PUNCT
iajs-3630	89	34	]	]	PUNCT
iajs-3630	90	1	parameters	parameter	NOUN
iajs-3630	90	2	mean	mean	VERB
iajs-3630	90	3	±sd	±sd	PRON
iajs-3630	90	4	pre	pre	ADJ
iajs-3630	90	5	-	-	ADJ
iajs-3630	90	6	dm	dm	ADJ
iajs-3630	90	7	group	group	NOUN
iajs-3630	90	8	t2	t2	NOUN
iajs-3630	90	9	dm	dm	PROPN
iajs-3630	90	10	group	group	NOUN
iajs-3630	90	11	male	male	ADJ
iajs-3630	90	12	female	female	ADJ
iajs-3630	90	13	p	p	NOUN
iajs-3630	90	14	-	-	PUNCT
iajs-3630	90	15	value	value	NOUN
iajs-3630	90	16	male	male	ADJ
iajs-3630	90	17	female	female	ADJ
iajs-3630	90	18	p	p	NOUN
iajs-3630	90	19	-	-	PUNCT
iajs-3630	90	20	value	value	NOUN
iajs-3630	90	21	bmi	bmi	NOUN
iajs-3630	90	22	(	(	PUNCT
iajs-3630	90	23	kg	kg	NOUN
iajs-3630	90	24	/	/	SYM
iajs-3630	90	25	m2	m2	PROPN
iajs-3630	90	26	)	)	PUNCT
iajs-3630	90	27	27.03	27.03	NUM
iajs-3630	90	28	±	±	NUM
iajs-3630	90	29	0.89	0.89	NUM
iajs-3630	90	30	27.72	27.72	NUM
iajs-3630	90	31	±	±	NUM
iajs-3630	90	32	0.94	0.94	NUM
iajs-3630	90	33	0.604	0.604	NUM
iajs-3630	90	34	ns	ns	NUM
iajs-3630	90	35	26.45	26.45	NUM
iajs-3630	90	36	±	±	NUM
iajs-3630	90	37	1.22	1.22	NUM
iajs-3630	90	38	31.43	31.43	NUM
iajs-3630	90	39	±	±	NUM
iajs-3630	90	40	1.22	1.22	NUM
iajs-3630	90	41	0.0071	0.0071	NUM
iajs-3630	90	42	*	*	PUNCT
iajs-3630	90	43	*	*	PUNCT
iajs-3630	90	44	whr	whr	PROPN
iajs-3630	90	45	0.914	0.914	NUM
iajs-3630	90	46	±	±	NUM
iajs-3630	90	47	0.01	0.01	NUM
iajs-3630	90	48	0.916	0.916	NUM
iajs-3630	90	49	±	±	NUM
iajs-3630	90	50	0.02	0.02	NUM
iajs-3630	90	51	0.922	0.922	NUM
iajs-3630	90	52	ns	ns	NUM
iajs-3630	90	53	0.956	0.956	NUM
iajs-3630	90	54	±	±	NUM
iajs-3630	90	55	0.02	0.02	NUM
iajs-3630	90	56	0.961	0.961	NUM
iajs-3630	90	57	±	±	NUM
iajs-3630	90	58	0.02	0.02	NUM
iajs-3630	90	59	0.849	0.849	NUM
iajs-3630	90	60	ns	ns	ADJ
iajs-3630	90	61	fbg	fbg	X
iajs-3630	90	62	(	(	PUNCT
iajs-3630	90	63	mg	mg	PROPN
iajs-3630	90	64	/	/	SYM
iajs-3630	90	65	dl	dl	NOUN
iajs-3630	90	66	)	)	PUNCT
iajs-3630	90	67	116.08	116.08	NUM
iajs-3630	90	68	±	±	NUM
iajs-3630	90	69	1.15	1.15	NUM
iajs-3630	90	70	112.94	112.94	NUM
iajs-3630	90	71	±	±	NUM
iajs-3630	90	72	1.76	1.76	NUM
iajs-3630	90	73	0.158	0.158	NUM
iajs-3630	90	74	ns	ns	NUM
iajs-3630	90	75	194.15	194.15	NUM
iajs-3630	90	76	±	±	NUM
iajs-3630	90	77	14.29	14.29	NUM
iajs-3630	90	78	198.74	198.74	NUM
iajs-3630	90	79	±	±	NUM
iajs-3630	90	80	10.21	10.21	NUM
iajs-3630	90	81	0.806	0.806	NUM
iajs-3630	90	82	ns	ns	NUM
iajs-3630	90	83	hba1c	hba1c	PROPN
iajs-3630	90	84	(	(	PUNCT
iajs-3630	90	85	%	%	INTJ
iajs-3630	90	86	)	)	PUNCT
iajs-3630	90	87	6.03	6.03	NUM
iajs-3630	90	88	±	±	NUM
iajs-3630	90	89	0.05	0.05	NUM
iajs-3630	90	90	6.01	6.01	NUM
iajs-3630	90	91	±	±	NUM
iajs-3630	90	92	0.04	0.04	NUM
iajs-3630	90	93	0.790	0.790	NUM
iajs-3630	90	94	ns	ns	NUM
iajs-3630	90	95	7.84	7.84	NUM
iajs-3630	90	96	±	±	NUM
iajs-3630	90	97	0.29	0.29	NUM
iajs-3630	90	98	8.45	8.45	NUM
iajs-3630	90	99	±	±	NUM
iajs-3630	90	100	0.36	0.36	NUM
iajs-3630	90	101	0.184	0.184	NUM
iajs-3630	90	102	ns	ns	NUM
iajs-3630	90	103	the	the	DET
iajs-3630	90	104	different	different	ADJ
iajs-3630	90	105	letters	letter	NOUN
iajs-3630	90	106	in	in	ADP
iajs-3630	90	107	the	the	DET
iajs-3630	90	108	same	same	ADJ
iajs-3630	90	109	column	column	NOUN
iajs-3630	90	110	mean	mean	VERB
iajs-3630	90	111	that	that	SCONJ
iajs-3630	90	112	they	they	PRON
iajs-3630	90	113	are	be	AUX
iajs-3630	90	114	differed	differ	VERB
iajs-3630	90	115	significantly	significantly	ADV
iajs-3630	90	116	,	,	PUNCT
iajs-3630	90	117	*	*	PUNCT
iajs-3630	90	118	*	*	PUNCT
iajs-3630	90	119	(	(	PUNCT
iajs-3630	90	120	p	p	NOUN
iajs-3630	90	121	≤	≤	NOUN
iajs-3630	90	122	0.01	0.01	NUM
iajs-3630	90	123	)	)	PUNCT
iajs-3630	90	124	,	,	PUNCT
iajs-3630	90	125	ns	ns	NUM
iajs-3630	90	126	:	:	PUNCT
iajs-3630	90	127	nonsignificant	nonsignificant	ADJ
iajs-3630	90	128	,	,	PUNCT
iajs-3630	90	129	t2	t2	PROPN
iajs-3630	90	130	dm	dm	NOUN
iajs-3630	90	131	:	:	PUNCT
iajs-3630	90	132	type	type	NOUN
iajs-3630	90	133	2	2	NUM
iajs-3630	90	134	diabetes	diabetes	NOUN
iajs-3630	90	135	mellitus	mellitus	NOUN
iajs-3630	90	136	,	,	PUNCT
iajs-3630	90	137	pre	pre	ADJ
iajs-3630	90	138	-	-	ADJ
iajs-3630	90	139	dm	dm	ADJ
iajs-3630	90	140	:	:	PUNCT
iajs-3630	90	141	pre	pre	ADJ
iajs-3630	90	142	-	-	ADJ
iajs-3630	90	143	diabetes	diabetes	ADJ
iajs-3630	90	144	mellitus	mellitus	NOUN
iajs-3630	90	145	.	.	PUNCT
iajs-3630	91	1	ihjpas	ihjpas	PROPN
iajs-3630	91	2	.	.	PUNCT
iajs-3630	92	1	2025	2025	NUM
iajs-3630	92	2	,	,	PUNCT
iajs-3630	92	3	38	38	NUM
iajs-3630	92	4	(	(	PUNCT
iajs-3630	92	5	1	1	NUM
iajs-3630	92	6	)	)	PUNCT
iajs-3630	92	7	306	306	NUM
iajs-3630	92	8	respectively	respectively	ADV
iajs-3630	92	9	.	.	PUNCT
iajs-3630	93	1	the	the	DET
iajs-3630	93	2	results	result	NOUN
iajs-3630	93	3	of	of	ADP
iajs-3630	93	4	homa	homa	NOUN
iajs-3630	93	5	-	-	PUNCT
iajs-3630	93	6	ir	ir	PROPN
iajs-3630	93	7	showed	show	VERB
iajs-3630	93	8	a	a	DET
iajs-3630	93	9	significant	significant	ADJ
iajs-3630	93	10	difference	difference	NOUN
iajs-3630	93	11	(	(	PUNCT
iajs-3630	93	12	p=0.0001	p=0.0001	NOUN
iajs-3630	93	13	)	)	PUNCT
iajs-3630	93	14	between	between	ADP
iajs-3630	93	15	the	the	DET
iajs-3630	93	16	t2	t2	PROPN
iajs-3630	93	17	dm	dm	PROPN
iajs-3630	93	18	group	group	NOUN
iajs-3630	93	19	and	and	CCONJ
iajs-3630	93	20	both	both	CCONJ
iajs-3630	93	21	the	the	DET
iajs-3630	93	22	pre	pre	NOUN
iajs-3630	93	23	-	-	ADJ
iajs-3630	93	24	dm	dm	ADJ
iajs-3630	93	25	and	and	CCONJ
iajs-3630	93	26	control	control	NOUN
iajs-3630	93	27	groups	group	NOUN
iajs-3630	93	28	,	,	PUNCT
iajs-3630	93	29	as	as	SCONJ
iajs-3630	93	30	shown	show	VERB
iajs-3630	93	31	in	in	ADP
iajs-3630	93	32	table	table	NOUN
iajs-3630	93	33	4	4	NUM
iajs-3630	93	34	.	.	PUNCT
iajs-3630	93	35	table	table	NOUN
iajs-3630	93	36	3	3	NUM
iajs-3630	93	37	.	.	X
iajs-3630	93	38	irisin	irisin	NOUN
iajs-3630	93	39	and	and	CCONJ
iajs-3630	93	40	insulin	insulin	NOUN
iajs-3630	93	41	levels	level	NOUN
iajs-3630	93	42	for	for	ADP
iajs-3630	93	43	the	the	DET
iajs-3630	93	44	study	study	NOUN
iajs-3630	93	45	groups	group	NOUN
iajs-3630	93	46	.	.	PUNCT
iajs-3630	94	1	groups	group	NOUN
iajs-3630	94	2	mean	mean	VERB
iajs-3630	94	3	±sd	±sd	PRON
iajs-3630	94	4	irisin	irisin	NOUN
iajs-3630	94	5	(	(	PUNCT
iajs-3630	94	6	ng	ng	NOUN
iajs-3630	94	7	/	/	SYM
iajs-3630	94	8	ml	ml	NOUN
iajs-3630	94	9	)	)	PUNCT
iajs-3630	94	10	insulin	insulin	NOUN
iajs-3630	94	11	(	(	PUNCT
iajs-3630	94	12	µu	µu	PROPN
iajs-3630	94	13	/	/	SYM
iajs-3630	94	14	ml	ml	NOUN
iajs-3630	94	15	)	)	PUNCT
iajs-3630	94	16	t2	t2	NOUN
iajs-3630	94	17	dm	dm	X
iajs-3630	94	18	(	(	PUNCT
iajs-3630	94	19	n	n	NOUN
iajs-3630	94	20	=	=	NOUN
iajs-3630	94	21	46	46	NUM
iajs-3630	94	22	)	)	PUNCT
iajs-3630	94	23	34.69	34.69	NUM
iajs-3630	94	24	±	±	NUM
iajs-3630	94	25	1.47	1.47	NUM
iajs-3630	94	26	a	a	DET
iajs-3630	94	27	4.02	4.02	NUM
iajs-3630	94	28	±	±	NUM
iajs-3630	94	29	0.20	0.20	NUM
iajs-3630	94	30	a	a	DET
iajs-3630	94	31	pre	pre	NOUN
iajs-3630	94	32	-	-	ADJ
iajs-3630	94	33	dm	dm	INTJ
iajs-3630	94	34	(	(	PUNCT
iajs-3630	94	35	n	n	NOUN
iajs-3630	94	36	=	=	NOUN
iajs-3630	94	37	46	46	NUM
iajs-3630	94	38	)	)	PUNCT
iajs-3630	94	39	18.51	18.51	NUM
iajs-3630	94	40	±	±	NUM
iajs-3630	94	41	0.76	0.76	NUM
iajs-3630	94	42	b	b	PROPN
iajs-3630	94	43	2.14	2.14	NUM
iajs-3630	94	44	±	±	NUM
iajs-3630	94	45	0.13	0.13	NUM
iajs-3630	94	46	b	b	NOUN
iajs-3630	94	47	control	control	NOUN
iajs-3630	94	48	(	(	PUNCT
iajs-3630	94	49	n	n	NOUN
iajs-3630	94	50	=	=	NOUN
iajs-3630	94	51	46	46	NUM
iajs-3630	94	52	)	)	PUNCT
iajs-3630	94	53	17.58	17.58	NUM
iajs-3630	94	54	±	±	NUM
iajs-3630	94	55	1.30	1.30	NUM
iajs-3630	94	56	b	b	NUM
iajs-3630	94	57	1.838	1.838	NUM
iajs-3630	94	58	±	±	NUM
iajs-3630	94	59	0.05	0.05	NUM
iajs-3630	94	60	b	b	NOUN
iajs-3630	94	61	lsd	lsd	NOUN
iajs-3630	94	62	3.412	3.412	NUM
iajs-3630	94	63	*	*	PUNCT
iajs-3630	94	64	*	*	PUNCT
iajs-3630	94	65	0.402	0.402	NUM
iajs-3630	94	66	*	*	PUNCT
iajs-3630	94	67	*	*	PUNCT
iajs-3630	94	68	p	p	X
iajs-3630	94	69	-	-	PUNCT
iajs-3630	94	70	value	value	NOUN
iajs-3630	94	71	0.0001	0.0001	NUM
iajs-3630	94	72	0.0001	0.0001	NUM
iajs-3630	94	73	the	the	DET
iajs-3630	94	74	different	different	ADJ
iajs-3630	94	75	letters	letter	NOUN
iajs-3630	94	76	in	in	ADP
iajs-3630	94	77	the	the	DET
iajs-3630	94	78	same	same	ADJ
iajs-3630	94	79	column	column	NOUN
iajs-3630	94	80	mean	mean	VERB
iajs-3630	94	81	that	that	SCONJ
iajs-3630	94	82	they	they	PRON
iajs-3630	94	83	are	be	AUX
iajs-3630	94	84	differed	differ	VERB
iajs-3630	94	85	significantly	significantly	ADV
iajs-3630	94	86	,	,	PUNCT
iajs-3630	94	87	*	*	PUNCT
iajs-3630	94	88	*	*	PUNCT
iajs-3630	94	89	(	(	PUNCT
iajs-3630	94	90	p	p	NOUN
iajs-3630	94	91	≤	≤	NUM
iajs-3630	94	92	0.0001	0.0001	NUM
iajs-3630	94	93	)	)	PUNCT
iajs-3630	94	94	,	,	PUNCT
iajs-3630	94	95	t2	t2	NOUN
iajs-3630	94	96	dm	dm	NOUN
iajs-3630	94	97	:	:	PUNCT
iajs-3630	94	98	type	type	NOUN
iajs-3630	94	99	2	2	NUM
iajs-3630	94	100	diabetes	diabetes	NOUN
iajs-3630	94	101	mellitus	mellitus	NOUN
iajs-3630	94	102	,	,	PUNCT
iajs-3630	94	103	pre	pre	ADJ
iajs-3630	94	104	-	-	ADJ
iajs-3630	94	105	dm	dm	ADJ
iajs-3630	94	106	:	:	PUNCT
iajs-3630	94	107	pre	pre	ADJ
iajs-3630	94	108	-	-	ADJ
iajs-3630	94	109	diabetes	diabetes	ADJ
iajs-3630	94	110	mellitus	mellitus	NOUN
iajs-3630	94	111	.	.	PUNCT
iajs-3630	95	1	table	table	NOUN
iajs-3630	95	2	4	4	NUM
iajs-3630	95	3	.	.	PUNCT
iajs-3630	96	1	the	the	DET
iajs-3630	96	2	fbg	fbg	PROPN
iajs-3630	96	3	,	,	PUNCT
iajs-3630	96	4	hba1c	hba1c	PROPN
iajs-3630	96	5	,	,	PUNCT
iajs-3630	96	6	homa	homa	NOUN
iajs-3630	96	7	-	-	PUNCT
iajs-3630	96	8	ir	ir	PROPN
iajs-3630	96	9	and	and	CCONJ
iajs-3630	96	10	homa	homa	NOUN
iajs-3630	96	11	-	-	PUNCT
iajs-3630	96	12	is	be	AUX
iajs-3630	96	13	values	value	NOUN
iajs-3630	96	14	for	for	ADP
iajs-3630	96	15	the	the	DET
iajs-3630	96	16	study	study	NOUN
iajs-3630	96	17	groups	group	NOUN
iajs-3630	96	18	.	.	PUNCT
iajs-3630	97	1	groups	group	NOUN
iajs-3630	97	2	mean	mean	VERB
iajs-3630	97	3	±sd	±sd	PRON
iajs-3630	97	4	fbg	fbg	PROPN
iajs-3630	97	5	(	(	PUNCT
iajs-3630	97	6	mg	mg	PROPN
iajs-3630	97	7	/	/	SYM
iajs-3630	97	8	dl	dl	PROPN
iajs-3630	97	9	)	)	PUNCT
iajs-3630	97	10	hba1c	hba1c	PROPN
iajs-3630	97	11	(	(	PUNCT
iajs-3630	97	12	%	%	INTJ
iajs-3630	97	13	)	)	PUNCT
iajs-3630	97	14	homa	homa	NOUN
iajs-3630	97	15	-	-	PUNCT
iajs-3630	97	16	ir	ir	NOUN
iajs-3630	97	17	homa	homa	NOUN
iajs-3630	97	18	-	-	PUNCT
iajs-3630	97	19	is	be	AUX
iajs-3630	97	20	t2	t2	NOUN
iajs-3630	97	21	dm	dm	X
iajs-3630	97	22	(	(	PUNCT
iajs-3630	97	23	n	n	NOUN
iajs-3630	97	24	=	=	NOUN
iajs-3630	97	25	46	46	NUM
iajs-3630	97	26	)	)	PUNCT
iajs-3630	97	27	196.14	196.14	NUM
iajs-3630	97	28	±	±	NUM
iajs-3630	97	29	9.14	9.14	NUM
iajs-3630	97	30	a	a	DET
iajs-3630	97	31	8.11	8.11	NUM
iajs-3630	97	32	±	±	NUM
iajs-3630	97	33	0.23	0.23	NUM
iajs-3630	97	34	a	a	DET
iajs-3630	97	35	1.97	1.97	NUM
iajs-3630	97	36	±	±	NUM
iajs-3630	97	37	0.15	0.15	NUM
iajs-3630	97	38	a	a	DET
iajs-3630	97	39	0.597	0.597	NUM
iajs-3630	97	40	±	±	NUM
iajs-3630	97	41	0.02	0.02	NUM
iajs-3630	97	42	c	c	NOUN
iajs-3630	97	43	pre	pre	VERB
iajs-3630	97	44	-	-	ADJ
iajs-3630	97	45	dm	dm	INTJ
iajs-3630	97	46	(	(	PUNCT
iajs-3630	97	47	n	n	NOUN
iajs-3630	97	48	=	=	NOUN
iajs-3630	97	49	46	46	NUM
iajs-3630	97	50	)	)	PUNCT
iajs-3630	98	1	114.37	114.37	NUM
iajs-3630	98	2	±	±	NUM
iajs-3630	98	3	1.10	1.10	NUM
iajs-3630	98	4	b	b	SYM
iajs-3630	98	5	6.02	6.02	NUM
iajs-3630	98	6	±	±	NUM
iajs-3630	98	7	0.03	0.03	NUM
iajs-3630	98	8	b	b	NUM
iajs-3630	98	9	0.603	0.603	NUM
iajs-3630	98	10	±	±	NUM
iajs-3630	98	11	0.04	0.04	NUM
iajs-3630	98	12	b	b	NUM
iajs-3630	98	13	1.89	1.89	NUM
iajs-3630	98	14	±	±	NUM
iajs-3630	98	15	0.11	0.11	NUM
iajs-3630	98	16	b	b	NOUN
iajs-3630	98	17	control	control	NOUN
iajs-3630	98	18	(	(	PUNCT
iajs-3630	98	19	n	n	NOUN
iajs-3630	98	20	=	=	NOUN
iajs-3630	98	21	46	46	NUM
iajs-3630	98	22	)	)	PUNCT
iajs-3630	98	23	93.49	93.49	NUM
iajs-3630	98	24	±	±	NUM
iajs-3630	98	25	0.76	0.76	NUM
iajs-3630	98	26	c	c	NOUN
iajs-3630	98	27	4.69	4.69	NUM
iajs-3630	98	28	±	±	NUM
iajs-3630	98	29	0.03	0.03	NUM
iajs-3630	98	30	c	c	PROPN
iajs-3630	98	31	0.453	0.453	NUM
iajs-3630	98	32	±	±	NUM
iajs-3630	98	33	0.02	0.02	NUM
iajs-3630	98	34	b	b	NUM
iajs-3630	98	35	2.36	2.36	NUM
iajs-3630	98	36	±	±	NOUN
iajs-3630	98	37	0.09	0.09	NUM
iajs-3630	98	38	a	a	DET
iajs-3630	98	39	lsd	lsd	NOUN
iajs-3630	98	40	14.907	14.907	NUM
iajs-3630	98	41	*	*	PUNCT
iajs-3630	98	42	*	*	PUNCT
iajs-3630	98	43	0.380	0.380	NUM
iajs-3630	98	44	*	*	PUNCT
iajs-3630	98	45	*	*	PUNCT
iajs-3630	98	46	0.258	0.258	NUM
iajs-3630	98	47	*	*	PUNCT
iajs-3630	98	48	*	*	PUNCT
iajs-3630	98	49	0.242	0.242	NUM
iajs-3630	98	50	*	*	PUNCT
iajs-3630	98	51	*	*	PUNCT
iajs-3630	98	52	p	p	ADJ
iajs-3630	98	53	–	–	PUNCT
iajs-3630	98	54	value	value	NOUN
iajs-3630	98	55	0.0001	0.0001	NUM
iajs-3630	98	56	0.0001	0.0001	NUM
iajs-3630	98	57	0.0001	0.0001	NUM
iajs-3630	98	58	0.0001	0.0001	NUM
iajs-3630	98	59	the	the	DET
iajs-3630	98	60	different	different	ADJ
iajs-3630	98	61	letters	letter	NOUN
iajs-3630	98	62	in	in	ADP
iajs-3630	98	63	the	the	DET
iajs-3630	98	64	same	same	ADJ
iajs-3630	98	65	column	column	NOUN
iajs-3630	98	66	mean	mean	VERB
iajs-3630	98	67	that	that	SCONJ
iajs-3630	98	68	they	they	PRON
iajs-3630	98	69	are	be	AUX
iajs-3630	98	70	differed	differ	VERB
iajs-3630	98	71	significantly	significantly	ADV
iajs-3630	98	72	,	,	PUNCT
iajs-3630	98	73	*	*	PUNCT
iajs-3630	98	74	*	*	PUNCT
iajs-3630	98	75	(	(	PUNCT
iajs-3630	98	76	p	p	NOUN
iajs-3630	98	77	≤	≤	NOUN
iajs-3630	98	78	0.01	0.01	NUM
iajs-3630	98	79	)	)	PUNCT
iajs-3630	98	80	,	,	PUNCT
iajs-3630	98	81	t2	t2	NOUN
iajs-3630	98	82	dm	dm	NOUN
iajs-3630	98	83	:	:	PUNCT
iajs-3630	98	84	type	type	NOUN
iajs-3630	98	85	2	2	NUM
iajs-3630	98	86	diabetes	diabetes	NOUN
iajs-3630	98	87	mellitus	mellitus	NOUN
iajs-3630	98	88	,	,	PUNCT
iajs-3630	98	89	pre	pre	ADJ
iajs-3630	98	90	-	-	ADJ
iajs-3630	98	91	dm	dm	ADJ
iajs-3630	98	92	:	:	PUNCT
iajs-3630	98	93	pre	pre	ADJ
iajs-3630	98	94	-	-	ADJ
iajs-3630	98	95	diabetes	diabetes	ADJ
iajs-3630	98	96	mellitus	mellitus	NOUN
iajs-3630	98	97	.	.	PUNCT
iajs-3630	99	1	values	value	NOUN
iajs-3630	99	2	of	of	ADP
iajs-3630	99	3	cholesterol	cholesterol	NOUN
iajs-3630	99	4	,	,	PUNCT
iajs-3630	99	5	tgs	tgs	PROPN
iajs-3630	99	6	,	,	PUNCT
iajs-3630	99	7	hdl	hdl	PROPN
iajs-3630	99	8	,	,	PUNCT
iajs-3630	99	9	ldl	ldl	NOUN
iajs-3630	99	10	,	,	PUNCT
iajs-3630	99	11	and	and	CCONJ
iajs-3630	99	12	vldl	vldl	NOUN
iajs-3630	99	13	in	in	ADP
iajs-3630	99	14	groups	group	NOUN
iajs-3630	99	15	of	of	ADP
iajs-3630	99	16	t2	t2	PROPN
iajs-3630	99	17	dm	dm	PROPN
iajs-3630	99	18	,	,	PUNCT
iajs-3630	99	19	pre	pre	ADJ
iajs-3630	99	20	-	-	ADJ
iajs-3630	99	21	dm	dm	ADJ
iajs-3630	99	22	,	,	PUNCT
iajs-3630	99	23	and	and	CCONJ
iajs-3630	99	24	control	control	NOUN
iajs-3630	99	25	were	be	AUX
iajs-3630	99	26	[	[	PUNCT
iajs-3630	99	27	(	(	PUNCT
iajs-3630	99	28	182.81	182.81	NUM
iajs-3630	99	29	±6.62	±6.62	NOUN
iajs-3630	99	30	)	)	PUNCT
iajs-3630	99	31	(	(	PUNCT
iajs-3630	99	32	191.22	191.22	NUM
iajs-3630	99	33	±5.33	±5.33	PROPN
iajs-3630	99	34	)	)	PUNCT
iajs-3630	99	35	(	(	PUNCT
iajs-3630	99	36	162.67	162.67	NUM
iajs-3630	99	37	±5.32	±5.32	NOUN
iajs-3630	99	38	)	)	PUNCT
iajs-3630	99	39	]	]	PUNCT
iajs-3630	99	40	,	,	PUNCT
iajs-3630	99	41	respectively	respectively	ADV
iajs-3630	99	42	,	,	PUNCT
iajs-3630	99	43	for	for	ADP
iajs-3630	99	44	cholesterol	cholesterol	NOUN
iajs-3630	99	45	,	,	PUNCT
iajs-3630	99	46	[	[	X
iajs-3630	99	47	(	(	PUNCT
iajs-3630	99	48	171.82	171.82	NUM
iajs-3630	99	49	±	±	NUM
iajs-3630	99	50	13.46	13.46	NUM
iajs-3630	99	51	)	)	PUNCT
iajs-3630	99	52	,	,	PUNCT
iajs-3630	99	53	(	(	PUNCT
iajs-3630	99	54	168.56	168.56	NUM
iajs-3630	99	55	±11.46	±11.46	NOUN
iajs-3630	99	56	)	)	PUNCT
iajs-3630	99	57	and	and	CCONJ
iajs-3630	99	58	(	(	PUNCT
iajs-3630	99	59	110.84	110.84	NUM
iajs-3630	99	60	±4.28	±4.28	NOUN
iajs-3630	99	61	)	)	PUNCT
iajs-3630	99	62	,	,	PUNCT
iajs-3630	99	63	respectively	respectively	ADV
iajs-3630	99	64	for	for	ADP
iajs-3630	99	65	tgs	tgs	PROPN
iajs-3630	99	66	,	,	PUNCT
iajs-3630	99	67	[	[	X
iajs-3630	99	68	(	(	PUNCT
iajs-3630	99	69	44.98	44.98	NUM
iajs-3630	99	70	±1.62	±1.62	NOUN
iajs-3630	99	71	)	)	PUNCT
iajs-3630	99	72	,	,	PUNCT
iajs-3630	99	73	(	(	PUNCT
iajs-3630	99	74	46.87	46.87	NUM
iajs-3630	99	75	±1.96	±1.96	PROPN
iajs-3630	99	76	)	)	PUNCT
iajs-3630	99	77	and	and	CCONJ
iajs-3630	99	78	(	(	PUNCT
iajs-3630	99	79	49.78	49.78	NUM
iajs-3630	99	80	±1.61	±1.61	NOUN
iajs-3630	99	81	)	)	PUNCT
iajs-3630	99	82	]	]	PUNCT
iajs-3630	99	83	respectively	respectively	ADV
iajs-3630	99	84	,	,	PUNCT
iajs-3630	99	85	for	for	ADP
iajs-3630	99	86	hdl	hdl	PROPN
iajs-3630	99	87	,	,	PUNCT
iajs-3630	99	88	[	[	X
iajs-3630	99	89	(	(	PUNCT
iajs-3630	99	90	34.36	34.36	NUM
iajs-3630	99	91	±2.69	±2.69	NOUN
iajs-3630	99	92	)	)	PUNCT
iajs-3630	99	93	,	,	PUNCT
iajs-3630	99	94	(	(	PUNCT
iajs-3630	99	95	33.71	33.71	NUM
iajs-3630	99	96	±2.29	±2.29	NOUN
iajs-3630	99	97	)	)	PUNCT
iajs-3630	99	98	and	and	CCONJ
iajs-3630	99	99	(	(	PUNCT
iajs-3630	99	100	22.53	22.53	NUM
iajs-3630	99	101	±0.98	±0.98	NOUN
iajs-3630	99	102	)	)	PUNCT
iajs-3630	99	103	]	]	PUNCT
iajs-3630	99	104	respectively	respectively	ADV
iajs-3630	99	105	for	for	ADP
iajs-3630	99	106	vldl	vldl	NOUN
iajs-3630	99	107	and	and	CCONJ
iajs-3630	99	108	[	[	X
iajs-3630	99	109	(	(	PUNCT
iajs-3630	99	110	103.46	103.46	NUM
iajs-3630	99	111	±5.39	±5.39	NOUN
iajs-3630	99	112	)	)	PUNCT
iajs-3630	99	113	,	,	PUNCT
iajs-3630	99	114	(	(	PUNCT
iajs-3630	99	115	110.63	110.63	NUM
iajs-3630	99	116	±4.78	±4.78	NOUN
iajs-3630	99	117	)	)	PUNCT
iajs-3630	99	118	and	and	CCONJ
iajs-3630	99	119	(	(	PUNCT
iajs-3630	99	120	94.14	94.14	NUM
iajs-3630	99	121	±4.21	±4.21	PROPN
iajs-3630	99	122	)	)	PUNCT
iajs-3630	99	123	]	]	PUNCT
iajs-3630	99	124	respectively	respectively	ADV
iajs-3630	99	125	for	for	ADP
iajs-3630	99	126	ldl	ldl	NOUN
iajs-3630	99	127	as	as	SCONJ
iajs-3630	99	128	noticed	notice	VERB
iajs-3630	99	129	in	in	ADP
iajs-3630	99	130	table	table	NOUN
iajs-3630	99	131	5	5	NUM
iajs-3630	99	132	.	.	PUNCT
iajs-3630	100	1	the	the	DET
iajs-3630	100	2	results	result	NOUN
iajs-3630	100	3	showed	show	VERB
iajs-3630	100	4	that	that	SCONJ
iajs-3630	100	5	cholesterol	cholesterol	NOUN
iajs-3630	100	6	,	,	PUNCT
iajs-3630	100	7	tgs	tgs	PROPN
iajs-3630	100	8	and	and	CCONJ
iajs-3630	100	9	vldl	vldl	PROPN
iajs-3630	100	10	in	in	ADP
iajs-3630	100	11	both	both	DET
iajs-3630	100	12	groups	group	NOUN
iajs-3630	100	13	of	of	ADP
iajs-3630	100	14	t2	t2	NOUN
iajs-3630	100	15	dm	dm	PROPN
iajs-3630	100	16	and	and	CCONJ
iajs-3630	100	17	pre	pre	ADJ
iajs-3630	100	18	-	-	ADJ
iajs-3630	100	19	dm	dm	ADJ
iajs-3630	100	20	possess	possess	VERB
iajs-3630	100	21	high	high	ADJ
iajs-3630	100	22	significant	significant	ADJ
iajs-3630	100	23	differences	difference	NOUN
iajs-3630	100	24	(	(	PUNCT
iajs-3630	100	25	p	p	NOUN
iajs-3630	100	26	≤	≤	NOUN
iajs-3630	100	27	0.01	0.01	NUM
iajs-3630	100	28	)	)	PUNCT
iajs-3630	100	29	of	of	ADP
iajs-3630	100	30	both	both	PRON
iajs-3630	100	31	t2	t2	NOUN
iajs-3630	100	32	dm	dm	PROPN
iajs-3630	100	33	and	and	CCONJ
iajs-3630	100	34	pre	pre	ADJ
iajs-3630	100	35	-	-	ADJ
iajs-3630	100	36	dm	dm	ADJ
iajs-3630	100	37	groups	group	NOUN
iajs-3630	100	38	in	in	ADP
iajs-3630	100	39	comparison	comparison	NOUN
iajs-3630	100	40	with	with	ADP
iajs-3630	100	41	control	control	NOUN
iajs-3630	100	42	group	group	NOUN
iajs-3630	100	43	.	.	PUNCT
iajs-3630	101	1	whereas	whereas	SCONJ
iajs-3630	101	2	there	there	PRON
iajs-3630	101	3	is	be	VERB
iajs-3630	101	4	no	no	DET
iajs-3630	101	5	significant	significant	ADJ
iajs-3630	101	6	difference	difference	NOUN
iajs-3630	101	7	among	among	ADP
iajs-3630	101	8	all	all	DET
iajs-3630	101	9	the	the	DET
iajs-3630	101	10	studied	study	VERB
iajs-3630	101	11	in	in	ADP
iajs-3630	101	12	case	case	NOUN
iajs-3630	101	13	of	of	ADP
iajs-3630	101	14	hdl	hdl	PROPN
iajs-3630	101	15	.	.	PUNCT
iajs-3630	102	1	also	also	ADV
iajs-3630	102	2	,	,	PUNCT
iajs-3630	102	3	the	the	DET
iajs-3630	102	4	results	result	NOUN
iajs-3630	102	5	of	of	ADP
iajs-3630	102	6	ldl	ldl	NOUN
iajs-3630	102	7	revealed	reveal	VERB
iajs-3630	102	8	significant	significant	ADJ
iajs-3630	102	9	difference	difference	NOUN
iajs-3630	102	10	between	between	ADP
iajs-3630	102	11	control	control	NOUN
iajs-3630	102	12	and	and	CCONJ
iajs-3630	102	13	both	both	PRON
iajs-3630	102	14	of	of	ADP
iajs-3630	102	15	t2	t2	NOUN
iajs-3630	102	16	dm	dm	PROPN
iajs-3630	102	17	and	and	CCONJ
iajs-3630	102	18	pre	pre	ADJ
iajs-3630	102	19	-	-	ADJ
iajs-3630	102	20	dm	dm	ADJ
iajs-3630	102	21	groups	group	NOUN
iajs-3630	102	22	as	as	SCONJ
iajs-3630	102	23	recorded	record	VERB
iajs-3630	102	24	in	in	ADP
iajs-3630	102	25	table	table	NOUN
iajs-3630	102	26	5	5	NUM
iajs-3630	102	27	.	.	PUNCT
iajs-3630	102	28	in	in	ADP
iajs-3630	102	29	table	table	NOUN
iajs-3630	102	30	6	6	NUM
iajs-3630	102	31	,	,	PUNCT
iajs-3630	102	32	data	datum	NOUN
iajs-3630	102	33	revealed	reveal	VERB
iajs-3630	102	34	the	the	DET
iajs-3630	102	35	effect	effect	NOUN
iajs-3630	102	36	of	of	ADP
iajs-3630	102	37	gender	gender	NOUN
iajs-3630	102	38	on	on	ADP
iajs-3630	102	39	lipid	lipid	NOUN
iajs-3630	102	40	profile	profile	NOUN
iajs-3630	102	41	in	in	ADP
iajs-3630	102	42	both	both	PRON
iajs-3630	102	43	t2	t2	NOUN
iajs-3630	102	44	dm	dm	PROPN
iajs-3630	102	45	and	and	CCONJ
iajs-3630	102	46	pre	pre	ADJ
iajs-3630	102	47	-	-	ADJ
iajs-3630	102	48	dm	dm	ADJ
iajs-3630	102	49	groups	group	NOUN
iajs-3630	102	50	.	.	PUNCT
iajs-3630	103	1	the	the	DET
iajs-3630	103	2	results	result	NOUN
iajs-3630	103	3	showed	show	VERB
iajs-3630	103	4	significant	significant	ADJ
iajs-3630	103	5	differences	difference	NOUN
iajs-3630	103	6	between	between	ADP
iajs-3630	103	7	males	male	NOUN
iajs-3630	103	8	and	and	CCONJ
iajs-3630	103	9	females	female	NOUN
iajs-3630	103	10	for	for	ADP
iajs-3630	103	11	only	only	ADV
iajs-3630	103	12	tgs	tgs	PROPN
iajs-3630	103	13	,	,	PUNCT
iajs-3630	103	14	hdl	hdl	PROPN
iajs-3630	103	15	,	,	PUNCT
iajs-3630	103	16	and	and	CCONJ
iajs-3630	103	17	vldl	vldl	NOUN
iajs-3630	103	18	parameters	parameter	NOUN
iajs-3630	103	19	in	in	ADP
iajs-3630	103	20	pre	pre	NOUN
iajs-3630	103	21	-	-	NOUN
iajs-3630	103	22	diabetes	diabetes	NOUN
iajs-3630	103	23	.	.	PUNCT
iajs-3630	104	1	in	in	ADP
iajs-3630	104	2	contrast	contrast	NOUN
iajs-3630	104	3	,	,	PUNCT
iajs-3630	104	4	gender	gender	NOUN
iajs-3630	104	5	does	do	AUX
iajs-3630	104	6	not	not	PART
iajs-3630	104	7	affect	affect	VERB
iajs-3630	104	8	any	any	DET
iajs-3630	104	9	lipid	lipid	NOUN
iajs-3630	104	10	profile	profile	NOUN
iajs-3630	104	11	parameter	parameter	NOUN
iajs-3630	104	12	in	in	ADP
iajs-3630	104	13	t2	t2	PROPN
iajs-3630	104	14	dm	dm	PROPN
iajs-3630	104	15	.	.	PUNCT
iajs-3630	104	16	ihjpas	ihjpas	PROPN
iajs-3630	104	17	.	.	PUNCT
iajs-3630	105	1	2025	2025	NUM
iajs-3630	105	2	,	,	PUNCT
iajs-3630	105	3	38	38	NUM
iajs-3630	105	4	(	(	PUNCT
iajs-3630	105	5	1	1	NUM
iajs-3630	105	6	)	)	PUNCT
iajs-3630	105	7	307	307	NUM
iajs-3630	105	8	table	table	NOUN
iajs-3630	105	9	5	5	NUM
iajs-3630	105	10	.	.	PUNCT
iajs-3630	105	11	lipid	lipid	NOUN
iajs-3630	105	12	profile	profile	NOUN
iajs-3630	105	13	of	of	ADP
iajs-3630	105	14	the	the	DET
iajs-3630	105	15	study	study	NOUN
iajs-3630	105	16	groups	group	NOUN
iajs-3630	105	17	.	.	PUNCT
iajs-3630	106	1	groups	group	NOUN
iajs-3630	106	2	mean	mean	VERB
iajs-3630	106	3	±sd	±sd	DET
iajs-3630	106	4	cholesterol	cholesterol	NOUN
iajs-3630	106	5	tg	tg	PROPN
iajs-3630	106	6	hdl	hdl	PROPN
iajs-3630	106	7	ldl	ldl	PROPN
iajs-3630	106	8	vldl	vldl	PROPN
iajs-3630	106	9	t2	t2	PROPN
iajs-3630	106	10	dm	dm	PROPN
iajs-3630	106	11	(	(	PUNCT
iajs-3630	106	12	n	n	NOUN
iajs-3630	106	13	=	=	NOUN
iajs-3630	106	14	46	46	NUM
iajs-3630	106	15	)	)	PUNCT
iajs-3630	106	16	182.81	182.81	NUM
iajs-3630	106	17	±	±	NUM
iajs-3630	106	18	6.62a	6.62a	NUM
iajs-3630	106	19	171.82	171.82	NUM
iajs-3630	106	20	±	±	NUM
iajs-3630	106	21	13.46a	13.46a	NUM
iajs-3630	106	22	44.98	44.98	NUM
iajs-3630	106	23	±	±	NUM
iajs-3630	106	24	1.62	1.62	NUM
iajs-3630	106	25	103.46	103.46	NUM
iajs-3630	106	26	±	±	NUM
iajs-3630	106	27	5.39ab	5.39ab	NOUN
iajs-3630	106	28	34.36	34.36	NUM
iajs-3630	106	29	±	±	NUM
iajs-3630	106	30	2.69a	2.69a	NUM
iajs-3630	106	31	pre	pre	NOUN
iajs-3630	106	32	-	-	ADJ
iajs-3630	106	33	dm	dm	INTJ
iajs-3630	106	34	(	(	PUNCT
iajs-3630	106	35	n	n	NOUN
iajs-3630	106	36	=	=	NOUN
iajs-3630	106	37	46	46	NUM
iajs-3630	106	38	)	)	PUNCT
iajs-3630	106	39	191.22	191.22	NUM
iajs-3630	106	40	±	±	NUM
iajs-3630	106	41	5.33a	5.33a	NUM
iajs-3630	106	42	168.56	168.56	NUM
iajs-3630	106	43	±	±	NOUN
iajs-3630	106	44	11.46a	11.46a	NUM
iajs-3630	106	45	46.87	46.87	NUM
iajs-3630	106	46	±	±	NUM
iajs-3630	106	47	1.96	1.96	NUM
iajs-3630	106	48	110.63	110.63	NUM
iajs-3630	106	49	±	±	NUM
iajs-3630	106	50	4.78a	4.78a	NUM
iajs-3630	106	51	33.71	33.71	NUM
iajs-3630	106	52	±	±	NUM
iajs-3630	106	53	2.29a	2.29a	NUM
iajs-3630	106	54	control	control	NOUN
iajs-3630	106	55	(	(	PUNCT
iajs-3630	106	56	n=46	n=46	NOUN
iajs-3630	106	57	)	)	PUNCT
iajs-3630	106	58	162.67	162.67	NUM
iajs-3630	106	59	±	±	NUM
iajs-3630	106	60	5.32b	5.32b	NUM
iajs-3630	106	61	110.84	110.84	NUM
iajs-3630	106	62	±	±	NUM
iajs-3630	106	63	4.28b	4.28b	NOUN
iajs-3630	106	64	49.78	49.78	NUM
iajs-3630	106	65	±	±	NUM
iajs-3630	106	66	1.61	1.61	NUM
iajs-3630	106	67	94.14	94.14	NUM
iajs-3630	106	68	±	±	NUM
iajs-3630	107	1	4.21b	4.21b	NUM
iajs-3630	107	2	22.53	22.53	NUM
iajs-3630	107	3	±	±	NUM
iajs-3630	107	4	0.98b	0.98b	NOUN
iajs-3630	107	5	lsd	lsd	NOUN
iajs-3630	107	6	16.201	16.201	NUM
iajs-3630	107	7	*	*	PUNCT
iajs-3630	107	8	*	*	PUNCT
iajs-3630	107	9	29.384	29.384	NUM
iajs-3630	107	10	*	*	PUNCT
iajs-3630	107	11	*	*	PUNCT
iajs-3630	107	12	4.864	4.864	NUM
iajs-3630	107	13	ns	ns	NUM
iajs-3630	107	14	13.48	13.48	NUM
iajs-3630	107	15	*	*	PUNCT
iajs-3630	107	16	5.927	5.927	NUM
iajs-3630	107	17	*	*	PUNCT
iajs-3630	107	18	*	*	PUNCT
iajs-3630	107	19	p	p	X
iajs-3630	107	20	-	-	PUNCT
iajs-3630	107	21	value	value	NOUN
iajs-3630	107	22	0.0022	0.0022	NUM
iajs-3630	107	23	0.0001	0.0001	NUM
iajs-3630	107	24	0.148	0.148	NUM
iajs-3630	107	25	0.050	0.050	NUM
iajs-3630	107	26	0.0001	0.0001	NUM
iajs-3630	107	27	the	the	DET
iajs-3630	107	28	different	different	ADJ
iajs-3630	107	29	letters	letter	NOUN
iajs-3630	107	30	in	in	ADP
iajs-3630	107	31	the	the	DET
iajs-3630	107	32	same	same	ADJ
iajs-3630	107	33	column	column	NOUN
iajs-3630	107	34	mean	mean	VERB
iajs-3630	107	35	that	that	SCONJ
iajs-3630	107	36	they	they	PRON
iajs-3630	107	37	are	be	AUX
iajs-3630	107	38	differed	differ	VERB
iajs-3630	107	39	significantly	significantly	ADV
iajs-3630	107	40	,	,	PUNCT
iajs-3630	107	41	*	*	PUNCT
iajs-3630	107	42	*	*	PUNCT
iajs-3630	107	43	(	(	PUNCT
iajs-3630	107	44	p≤0.01	p≤0.01	NOUN
iajs-3630	107	45	)	)	PUNCT
iajs-3630	107	46	,	,	PUNCT
iajs-3630	107	47	*	*	PUNCT
iajs-3630	107	48	(	(	PUNCT
iajs-3630	107	49	p≤0.05	p≤0.05	NOUN
iajs-3630	107	50	)	)	PUNCT
iajs-3630	107	51	,	,	PUNCT
iajs-3630	107	52	t2	t2	NOUN
iajs-3630	107	53	dm	dm	NOUN
iajs-3630	107	54	:	:	PUNCT
iajs-3630	107	55	type	type	NOUN
iajs-3630	107	56	2	2	NUM
iajs-3630	107	57	diabetes	diabetes	NOUN
iajs-3630	107	58	mellitus	mellitus	NOUN
iajs-3630	107	59	,	,	PUNCT
iajs-3630	107	60	pre	pre	ADJ
iajs-3630	107	61	-	-	ADJ
iajs-3630	107	62	dm	dm	ADJ
iajs-3630	107	63	:	:	PUNCT
iajs-3630	107	64	pre	pre	ADJ
iajs-3630	107	65	-	-	ADJ
iajs-3630	107	66	diabetes	diabetes	ADJ
iajs-3630	107	67	mellitus	mellitus	NOUN
iajs-3630	107	68	,	,	PUNCT
iajs-3630	107	69	tg	tg	PRON
iajs-3630	107	70	:	:	PUNCT
iajs-3630	107	71	triglycerides	triglyceride	NOUN
iajs-3630	107	72	,	,	PUNCT
iajs-3630	107	73	hdl	hdl	NOUN
iajs-3630	107	74	:	:	PUNCT
iajs-3630	107	75	high	high	ADJ
iajs-3630	107	76	density	density	NOUN
iajs-3630	107	77	lipoprotein	lipoprotein	ADJ
iajs-3630	107	78	,	,	PUNCT
iajs-3630	107	79	ldl	ldl	NOUN
iajs-3630	107	80	:	:	PUNCT
iajs-3630	107	81	low	low	ADJ
iajs-3630	107	82	density	density	NOUN
iajs-3630	107	83	lipoprotein	lipoprotein	ADJ
iajs-3630	107	84	,	,	PUNCT
iajs-3630	107	85	vldl	vldl	NOUN
iajs-3630	107	86	:	:	PUNCT
iajs-3630	107	87	very	very	ADV
iajs-3630	107	88	low	low	ADJ
iajs-3630	107	89	density	density	NOUN
iajs-3630	107	90	lipoprotein	lipoprotein	ADJ
iajs-3630	107	91	.	.	PUNCT
iajs-3630	108	1	table	table	NOUN
iajs-3630	108	2	6	6	NUM
iajs-3630	108	3	.	.	PUNCT
iajs-3630	108	4	effect	effect	NOUN
iajs-3630	108	5	of	of	ADP
iajs-3630	108	6	gender	gender	NOUN
iajs-3630	108	7	in	in	ADP
iajs-3630	108	8	lipid	lipid	NOUN
iajs-3630	108	9	profile	profile	NOUN
iajs-3630	108	10	in	in	ADP
iajs-3630	108	11	the	the	DET
iajs-3630	108	12	study	study	NOUN
iajs-3630	108	13	groups	group	NOUN
iajs-3630	108	14	.	.	PUNCT
iajs-3630	109	1	mean	mean	VERB
iajs-3630	109	2	±sd	±sd	PRON
iajs-3630	109	3	parameters	parameter	NOUN
iajs-3630	109	4	predm	predm	PROPN
iajs-3630	109	5	group	group	NOUN
iajs-3630	109	6	t2	t2	PROPN
iajs-3630	109	7	dm	dm	PROPN
iajs-3630	109	8	group	group	NOUN
iajs-3630	109	9	male	male	ADJ
iajs-3630	109	10	female	female	ADJ
iajs-3630	109	11	p	p	NOUN
iajs-3630	109	12	-	-	PUNCT
iajs-3630	109	13	value	value	NOUN
iajs-3630	109	14	male	male	ADJ
iajs-3630	109	15	female	female	ADJ
iajs-3630	109	16	p	p	NOUN
iajs-3630	109	17	-	-	PUNCT
iajs-3630	109	18	value	value	NOUN
iajs-3630	109	19	cholesterol	cholesterol	NOUN
iajs-3630	109	20	(	(	PUNCT
iajs-3630	109	21	mg	mg	PROPN
iajs-3630	109	22	/	/	SYM
iajs-3630	109	23	dl	dl	NOUN
iajs-3630	109	24	)	)	PUNCT
iajs-3630	109	25	192.66	192.66	NUM
iajs-3630	109	26	±	±	NUM
iajs-3630	109	27	8.05	8.05	NUM
iajs-3630	109	28	190.01	190.01	NUM
iajs-3630	109	29	±7.25	±7.25	PROPN
iajs-3630	109	30	0.807	0.807	NUM
iajs-3630	109	31	ns	ns	NUM
iajs-3630	109	32	184.02	184.02	NUM
iajs-3630	109	33	±9.28	±9.28	PROPN
iajs-3630	109	34	181.25	181.25	NUM
iajs-3630	109	35	±9.53	±9.53	NOUN
iajs-3630	109	36	0.838	0.838	NUM
iajs-3630	109	37	ns	ns	NUM
iajs-3630	109	38	tg	tg	X
iajs-3630	109	39	(	(	PUNCT
iajs-3630	109	40	mg	mg	PROPN
iajs-3630	109	41	/	/	SYM
iajs-3630	109	42	dl	dl	PROPN
iajs-3630	109	43	)	)	PUNCT
iajs-3630	109	44	200.30±16.18	200.30±16.18	NUM
iajs-3630	109	45	141.88	141.88	NUM
iajs-3630	109	46	±4.32	±4.32	PROPN
iajs-3630	109	47	0.0095	0.0095	NUM
iajs-3630	109	48	*	*	PUNCT
iajs-3630	109	49	*	*	PUNCT
iajs-3630	110	1	171.45±19.63	171.45±19.63	NUM
iajs-3630	110	2	172.30±18.12	172.30±18.12	NUM
iajs-3630	110	3	0.975	0.975	NUM
iajs-3630	110	4	ns	ns	NUM
iajs-3630	110	5	hdl	hdl	PROPN
iajs-3630	110	6	(	(	PUNCT
iajs-3630	110	7	mg	mg	PROPN
iajs-3630	110	8	/	/	SYM
iajs-3630	110	9	dl	dl	PROPN
iajs-3630	110	10	)	)	PUNCT
iajs-3630	110	11	41.76	41.76	NUM
iajs-3630	110	12	±3.58	±3.58	PROPN
iajs-3630	110	13	51.16	51.16	NUM
iajs-3630	110	14	±1.60	±1.60	PROPN
iajs-3630	110	15	0.021	0.021	NUM
iajs-3630	110	16	*	*	SYM
iajs-3630	110	17	44.90	44.90	NUM
iajs-3630	110	18	±2.51	±2.51	NOUN
iajs-3630	110	19	45.10	45.10	NUM
iajs-3630	110	20	±1.90	±1.90	NOUN
iajs-3630	110	21	0.952	0.952	NUM
iajs-3630	110	22	ns	ns	NUM
iajs-3630	110	23	ldl	ldl	NOUN
iajs-3630	110	24	(	(	PUNCT
iajs-3630	110	25	mg	mg	PROPN
iajs-3630	110	26	/	/	SYM
iajs-3630	110	27	dl	dl	NOUN
iajs-3630	110	28	)	)	PUNCT
iajs-3630	110	29	110.83	110.83	NUM
iajs-3630	110	30	±7.30	±7.30	VERB
iajs-3630	110	31	110.47±6.44	110.47±6.44	NUM
iajs-3630	110	32	0.970	0.970	NUM
iajs-3630	110	33	ns	ns	NUM
iajs-3630	110	34	104.83	104.83	NUM
iajs-3630	110	35	±7.34	±7.34	NOUN
iajs-3630	110	36	101.69	101.69	NUM
iajs-3630	110	37	±8.11	±8.11	PROPN
iajs-3630	110	38	0.776	0.776	NUM
iajs-3630	110	39	ns	ns	NUM
iajs-3630	110	40	vldl	vldl	NOUN
iajs-3630	110	41	(	(	PUNCT
iajs-3630	110	42	mg	mg	PROPN
iajs-3630	110	43	/	/	SYM
iajs-3630	110	44	dl	dl	PROPN
iajs-3630	110	45	)	)	PUNCT
iajs-3630	110	46	40.06	40.06	NUM
iajs-3630	110	47	±3.23	±3.23	PROPN
iajs-3630	110	48	28.38	28.38	NUM
iajs-3630	110	49	±2.86	±2.86	PROPN
iajs-3630	110	50	0.0096	0.0096	NUM
iajs-3630	110	51	*	*	PUNCT
iajs-3630	110	52	*	*	PROPN
iajs-3630	110	53	34.29	34.29	NUM
iajs-3630	110	54	±3.92	±3.92	PROPN
iajs-3630	110	55	34.46	34.46	NUM
iajs-3630	110	56	±3.62	±3.62	PROPN
iajs-3630	110	57	0.975	0.975	NUM
iajs-3630	110	58	ns	ns	NUM
iajs-3630	110	59	the	the	DET
iajs-3630	110	60	different	different	ADJ
iajs-3630	110	61	letters	letter	NOUN
iajs-3630	110	62	in	in	ADP
iajs-3630	110	63	the	the	DET
iajs-3630	110	64	same	same	ADJ
iajs-3630	110	65	column	column	NOUN
iajs-3630	110	66	mean	mean	VERB
iajs-3630	110	67	that	that	SCONJ
iajs-3630	110	68	they	they	PRON
iajs-3630	110	69	are	be	AUX
iajs-3630	110	70	differed	differ	VERB
iajs-3630	110	71	significantly	significantly	ADV
iajs-3630	110	72	*	*	PUNCT
iajs-3630	110	73	*	*	PUNCT
iajs-3630	110	74	(	(	PUNCT
iajs-3630	110	75	p≤0.01	p≤0.01	NOUN
iajs-3630	110	76	)	)	PUNCT
iajs-3630	110	77	*	*	PUNCT
iajs-3630	110	78	(	(	PUNCT
iajs-3630	110	79	p≤0.05	p≤0.05	NOUN
iajs-3630	110	80	)	)	PUNCT
iajs-3630	110	81	ns	ns	NUM
iajs-3630	110	82	:	:	PUNCT
iajs-3630	110	83	nonsignificant	nonsignificant	ADJ
iajs-3630	110	84	,	,	PUNCT
iajs-3630	110	85	tg	tg	PRON
iajs-3630	110	86	:	:	PUNCT
iajs-3630	110	87	triglycerides	triglyceride	NOUN
iajs-3630	110	88	,	,	PUNCT
iajs-3630	110	89	hdl	hdl	NOUN
iajs-3630	110	90	:	:	PUNCT
iajs-3630	110	91	high	high	ADJ
iajs-3630	110	92	density	density	NOUN
iajs-3630	110	93	lipoproteins	lipoprotein	NOUN
iajs-3630	110	94	,	,	PUNCT
iajs-3630	110	95	ldl	ldl	NOUN
iajs-3630	110	96	:	:	PUNCT
iajs-3630	110	97	low	low	ADJ
iajs-3630	110	98	density	density	NOUN
iajs-3630	110	99	lipoproteins	lipoprotein	NOUN
iajs-3630	110	100	,	,	PUNCT
iajs-3630	110	101	vldl	vldl	NOUN
iajs-3630	110	102	:	:	PUNCT
iajs-3630	110	103	very	very	ADV
iajs-3630	110	104	low	low	ADJ
iajs-3630	110	105	density	density	NOUN
iajs-3630	110	106	lipoproteins	lipoprotein	NOUN
iajs-3630	110	107	,	,	PUNCT
iajs-3630	110	108	pre	pre	ADJ
iajs-3630	110	109	-	-	ADJ
iajs-3630	110	110	dm	dm	ADJ
iajs-3630	110	111	:	:	PUNCT
iajs-3630	110	112	pre	pre	ADJ
iajs-3630	110	113	-	-	ADJ
iajs-3630	110	114	diabetes	diabetes	ADJ
iajs-3630	110	115	mellitus	mellitus	NOUN
iajs-3630	110	116	,	,	PUNCT
iajs-3630	110	117	t2	t2	NOUN
iajs-3630	110	118	dm	dm	NOUN
iajs-3630	110	119	:	:	PUNCT
iajs-3630	110	120	type	type	NOUN
iajs-3630	110	121	2	2	NUM
iajs-3630	110	122	diabetes	diabetes	NOUN
iajs-3630	110	123	mellitus	mellitus	VERB
iajs-3630	110	124	the	the	DET
iajs-3630	110	125	roc	roc	PROPN
iajs-3630	110	126	test	test	NOUN
iajs-3630	110	127	for	for	ADP
iajs-3630	110	128	the	the	DET
iajs-3630	110	129	irisin	irisin	NOUN
iajs-3630	110	130	marker	marker	NOUN
iajs-3630	110	131	showed	show	VERB
iajs-3630	110	132	an	an	DET
iajs-3630	110	133	obvious	obvious	ADJ
iajs-3630	110	134	cut	cut	NOUN
iajs-3630	110	135	-	-	PUNCT
iajs-3630	110	136	off	off	ADP
iajs-3630	110	137	value	value	NOUN
iajs-3630	110	138	(	(	PUNCT
iajs-3630	110	139	>	>	X
iajs-3630	110	140	18.57	18.57	NUM
iajs-3630	110	141	)	)	PUNCT
iajs-3630	110	142	with	with	ADP
iajs-3630	110	143	auc	auc	NOUN
iajs-3630	110	144	of	of	ADP
iajs-3630	110	145	0.987	0.987	NUM
iajs-3630	110	146	,	,	PUNCT
iajs-3630	110	147	0.978	0.978	NUM
iajs-3630	110	148	for	for	ADP
iajs-3630	110	149	sensitivity	sensitivity	NOUN
iajs-3630	110	150	,	,	PUNCT
iajs-3630	110	151	and	and	CCONJ
iajs-3630	110	152	0.087	0.087	NUM
iajs-3630	110	153	for	for	ADP
iajs-3630	110	154	1	1	NUM
iajs-3630	110	155	-	-	PUNCT
iajs-3630	110	156	specificity	specificity	NOUN
iajs-3630	110	157	indicated	indicate	VERB
iajs-3630	110	158	irisin	irisin	NOUN
iajs-3630	110	159	is	be	AUX
iajs-3630	110	160	considered	consider	VERB
iajs-3630	110	161	an	an	DET
iajs-3630	110	162	excellent	excellent	ADJ
iajs-3630	110	163	diagnostic	diagnostic	ADJ
iajs-3630	110	164	marker	marker	NOUN
iajs-3630	110	165	for	for	ADP
iajs-3630	110	166	diagnosis	diagnosis	NOUN
iajs-3630	110	167	of	of	ADP
iajs-3630	110	168	the	the	DET
iajs-3630	110	169	study	study	NOUN
iajs-3630	110	170	case	case	NOUN
iajs-3630	110	171	,	,	PUNCT
iajs-3630	110	172	as	as	SCONJ
iajs-3630	110	173	shown	show	VERB
iajs-3630	110	174	in	in	ADP
iajs-3630	110	175	table	table	NOUN
iajs-3630	110	176	7	7	NUM
iajs-3630	110	177	and	and	CCONJ
iajs-3630	110	178	figure	figure	VERB
iajs-3630	110	179	1	1	NUM
iajs-3630	110	180	.	.	PUNCT
iajs-3630	110	181	table	table	NOUN
iajs-3630	110	182	7	7	NUM
iajs-3630	110	183	.	.	PUNCT
iajs-3630	111	1	the	the	DET
iajs-3630	111	2	roc	roc	PROPN
iajs-3630	111	3	data	datum	NOUN
iajs-3630	111	4	analysis	analysis	NOUN
iajs-3630	111	5	for	for	ADP
iajs-3630	111	6	irisin	irisin	NOUN
iajs-3630	111	7	.	.	PUNCT
iajs-3630	112	1	characteristics	characteristic	NOUN
iajs-3630	112	2	test	test	NOUN
iajs-3630	112	3	result	result	VERB
iajs-3630	112	4	variable	variable	ADJ
iajs-3630	112	5	irisin	irisin	NOUN
iajs-3630	112	6	(	(	PUNCT
iajs-3630	112	7	ng	ng	NOUN
iajs-3630	112	8	/	/	SYM
iajs-3630	112	9	ml	ml	PROPN
iajs-3630	112	10	)	)	PUNCT
iajs-3630	112	11	>	>	X
iajs-3630	113	1	18.57	18.57	NUM
iajs-3630	113	2	asymptotic	asymptotic	ADJ
iajs-3630	113	3	sig.b	sig.b	PROPN
iajs-3630	113	4	0.001	0.001	NUM
iajs-3630	113	5	sea	sea	NOUN
iajs-3630	113	6	0.010	0.010	NUM
iajs-3630	113	7	sensitivity	sensitivity	NOUN
iajs-3630	113	8	0.978	0.978	NUM
iajs-3630	113	9	1	1	NUM
iajs-3630	113	10	-	-	PUNCT
iajs-3630	113	11	specificity	specificity	NOUN
iajs-3630	113	12	0.087	0.087	NUM
iajs-3630	113	13	auc	auc	NOUN
iajs-3630	113	14	(	(	PUNCT
iajs-3630	113	15	95	95	NUM
iajs-3630	113	16	%	%	NOUN
iajs-3630	113	17	ci	ci	NOUN
iajs-3630	113	18	)	)	PUNCT
iajs-3630	113	19	0.987	0.987	NUM
iajs-3630	113	20	(	(	PUNCT
iajs-3630	113	21	0.968	0.968	NUM
iajs-3630	113	22	-	-	SYM
iajs-3630	113	23	1.000	1.000	NUM
iajs-3630	113	24	)	)	PUNCT
iajs-3630	113	25	ci	ci	NOUN
iajs-3630	113	26	:	:	PUNCT
iajs-3630	113	27	confidence	confidence	NOUN
iajs-3630	113	28	interval	interval	NOUN
iajs-3630	113	29	,	,	PUNCT
iajs-3630	113	30	auc	auc	NOUN
iajs-3630	113	31	:	:	PUNCT
iajs-3630	113	32	area	area	NOUN
iajs-3630	113	33	under	under	ADP
iajs-3630	113	34	curve	curve	NOUN
iajs-3630	113	35	.	.	PUNCT
iajs-3630	114	1	data	datum	NOUN
iajs-3630	114	2	of	of	ADP
iajs-3630	114	3	roc	roc	PROPN
iajs-3630	114	4	analysis	analysis	NOUN
iajs-3630	114	5	for	for	ADP
iajs-3630	114	6	homa	homa	NOUN
iajs-3630	114	7	-	-	PUNCT
iajs-3630	114	8	is	be	AUX
iajs-3630	114	9	showed	show	VERB
iajs-3630	114	10	high	high	ADJ
iajs-3630	114	11	auc	auc	NOUN
iajs-3630	114	12	(	(	PUNCT
iajs-3630	114	13	0.901	0.901	NUM
iajs-3630	114	14	)	)	PUNCT
iajs-3630	114	15	with	with	ADP
iajs-3630	114	16	cut	cut	NOUN
iajs-3630	114	17	-	-	PUNCT
iajs-3630	114	18	off	off	NOUN
iajs-3630	114	19	(	(	PUNCT
iajs-3630	114	20	>	>	X
iajs-3630	114	21	1.95	1.95	NUM
iajs-3630	114	22	)	)	PUNCT
iajs-3630	114	23	,	,	PUNCT
iajs-3630	114	24	sensitivity	sensitivity	NOUN
iajs-3630	114	25	(	(	PUNCT
iajs-3630	114	26	0.891	0.891	NUM
iajs-3630	114	27	)	)	PUNCT
iajs-3630	114	28	and	and	CCONJ
iajs-3630	114	29	specificity	specificity	NOUN
iajs-3630	114	30	(	(	PUNCT
iajs-3630	114	31	0.217	0.217	NUM
iajs-3630	114	32	)	)	PUNCT
iajs-3630	114	33	.	.	PUNCT
iajs-3630	115	1	accordingly	accordingly	ADV
iajs-3630	115	2	,	,	PUNCT
iajs-3630	115	3	as	as	SCONJ
iajs-3630	115	4	shown	show	VERB
iajs-3630	115	5	in	in	ADP
iajs-3630	115	6	table	table	NOUN
iajs-3630	115	7	8	8	NUM
iajs-3630	115	8	and	and	CCONJ
iajs-3630	115	9	figure	figure	NOUN
iajs-3630	115	10	2	2	NUM
iajs-3630	115	11	,	,	PUNCT
iajs-3630	115	12	homa	homa	NOUN
iajs-3630	115	13	-	-	PUNCT
iajs-3630	115	14	is	be	AUX
iajs-3630	115	15	represented	represent	VERB
iajs-3630	115	16	an	an	DET
iajs-3630	115	17	excellent	excellent	ADJ
iajs-3630	115	18	diagnostic	diagnostic	ADJ
iajs-3630	115	19	marker	marker	NOUN
iajs-3630	115	20	.	.	PUNCT
iajs-3630	116	1	ihjpas	ihjpas	PROPN
iajs-3630	116	2	.	.	PUNCT
iajs-3630	117	1	2025	2025	NUM
iajs-3630	117	2	,	,	PUNCT
iajs-3630	117	3	38	38	NUM
iajs-3630	117	4	(	(	PUNCT
iajs-3630	117	5	1	1	NUM
iajs-3630	117	6	)	)	PUNCT
iajs-3630	117	7	308	308	NUM
iajs-3630	117	8	figure	figure	NOUN
iajs-3630	117	9	1	1	NUM
iajs-3630	117	10	.	.	PUNCT
iajs-3630	118	1	the	the	DET
iajs-3630	118	2	roc	roc	PROPN
iajs-3630	118	3	of	of	ADP
iajs-3630	118	4	irisin	irisin	PROPN
iajs-3630	118	5	.	.	PUNCT
iajs-3630	119	1	table	table	NOUN
iajs-3630	119	2	8	8	NUM
iajs-3630	119	3	.	.	PUNCT
iajs-3630	120	1	the	the	DET
iajs-3630	120	2	roc	roc	PROPN
iajs-3630	120	3	data	datum	NOUN
iajs-3630	120	4	for	for	ADP
iajs-3630	120	5	homa	homa	NOUN
iajs-3630	120	6	-	-	PUNCT
iajs-3630	120	7	is	be	AUX
iajs-3630	120	8	.	.	PUNCT
iajs-3630	121	1	characteristics	characteristic	NOUN
iajs-3630	121	2	test	test	NOUN
iajs-3630	121	3	result	result	VERB
iajs-3630	121	4	variable	variable	ADJ
iajs-3630	121	5	homa	homa	NOUN
iajs-3630	121	6	is	be	AUX
iajs-3630	121	7	>	>	X
iajs-3630	121	8	1.95	1.95	NUM
iajs-3630	121	9	asymptotic	asymptotic	ADJ
iajs-3630	121	10	sig.b	sig.b	PROPN
iajs-3630	121	11	0.001	0.001	NUM
iajs-3630	121	12	std	std	NOUN
iajs-3630	121	13	.	.	PUNCT
iajs-3630	122	1	errora	errora	VERB
iajs-3630	122	2	0.029	0.029	NUM
iajs-3630	122	3	sensitivity	sensitivity	NOUN
iajs-3630	122	4	0.891	0.891	NUM
iajs-3630	122	5	1	1	NUM
iajs-3630	122	6	-	-	PUNCT
iajs-3630	122	7	specificity	specificity	NOUN
iajs-3630	122	8	0.217	0.217	NUM
iajs-3630	122	9	auc	auc	NOUN
iajs-3630	122	10	(	(	PUNCT
iajs-3630	122	11	95	95	NUM
iajs-3630	122	12	%	%	NOUN
iajs-3630	122	13	ci	ci	NOUN
iajs-3630	122	14	)	)	PUNCT
iajs-3630	122	15	0.901	0.901	NUM
iajs-3630	122	16	(	(	PUNCT
iajs-3630	122	17	0.8470.951	0.8470.951	PROPN
iajs-3630	122	18	)	)	PUNCT
iajs-3630	122	19	ci	ci	NOUN
iajs-3630	122	20	:	:	PUNCT
iajs-3630	122	21	confidence	confidence	NOUN
iajs-3630	122	22	interval	interval	NOUN
iajs-3630	122	23	,	,	PUNCT
iajs-3630	122	24	auc	auc	NOUN
iajs-3630	122	25	:	:	PUNCT
iajs-3630	122	26	area	area	NOUN
iajs-3630	122	27	under	under	ADP
iajs-3630	122	28	curve	curve	NOUN
iajs-3630	122	29	figure	figure	NOUN
iajs-3630	122	30	2	2	NUM
iajs-3630	122	31	.	.	PUNCT
iajs-3630	123	1	the	the	DET
iajs-3630	123	2	roc	roc	PROPN
iajs-3630	123	3	curve	curve	NOUN
iajs-3630	123	4	of	of	ADP
iajs-3630	123	5	homa	homa	NOUN
iajs-3630	123	6	-	-	PUNCT
iajs-3630	123	7	is	be	AUX
iajs-3630	123	8	.	.	PUNCT
iajs-3630	123	9	ihjpas	ihjpas	PROPN
iajs-3630	123	10	.	.	PUNCT
iajs-3630	124	1	2025	2025	NUM
iajs-3630	124	2	,	,	PUNCT
iajs-3630	124	3	38	38	NUM
iajs-3630	124	4	(	(	PUNCT
iajs-3630	124	5	1	1	NUM
iajs-3630	124	6	)	)	PUNCT
iajs-3630	124	7	309	309	NUM
iajs-3630	124	8	4	4	NUM
iajs-3630	124	9	.	.	PUNCT
iajs-3630	124	10	discussion	discussion	NOUN
iajs-3630	124	11	in	in	ADP
iajs-3630	124	12	the	the	DET
iajs-3630	124	13	current	current	ADJ
iajs-3630	124	14	study	study	NOUN
iajs-3630	124	15	,	,	PUNCT
iajs-3630	124	16	the	the	DET
iajs-3630	124	17	age	age	NOUN
iajs-3630	124	18	distribution	distribution	NOUN
iajs-3630	124	19	results	result	NOUN
iajs-3630	124	20	showed	show	VERB
iajs-3630	124	21	a	a	DET
iajs-3630	124	22	significant	significant	ADJ
iajs-3630	124	23	difference	difference	NOUN
iajs-3630	124	24	between	between	ADP
iajs-3630	124	25	the	the	DET
iajs-3630	124	26	control	control	NOUN
iajs-3630	124	27	group	group	NOUN
iajs-3630	124	28	and	and	CCONJ
iajs-3630	124	29	both	both	DET
iajs-3630	124	30	groups	group	NOUN
iajs-3630	124	31	of	of	ADP
iajs-3630	124	32	t2	t2	NOUN
iajs-3630	124	33	dm	dm	PROPN
iajs-3630	124	34	and	and	CCONJ
iajs-3630	124	35	pre	pre	ADJ
iajs-3630	124	36	-	-	ADJ
iajs-3630	124	37	dm	dm	ADJ
iajs-3630	124	38	.	.	PUNCT
iajs-3630	125	1	this	this	DET
iajs-3630	125	2	result	result	NOUN
iajs-3630	125	3	may	may	AUX
iajs-3630	125	4	be	be	AUX
iajs-3630	125	5	attributed	attribute	VERB
iajs-3630	125	6	to	to	ADP
iajs-3630	125	7	the	the	DET
iajs-3630	125	8	slow	slow	ADJ
iajs-3630	125	9	progression	progression	NOUN
iajs-3630	125	10	of	of	ADP
iajs-3630	125	11	t2	t2	PROPN
iajs-3630	125	12	dm	dm	PROPN
iajs-3630	125	13	,	,	PUNCT
iajs-3630	125	14	which	which	PRON
iajs-3630	125	15	frequently	frequently	ADV
iajs-3630	125	16	does	do	AUX
iajs-3630	125	17	not	not	PART
iajs-3630	125	18	occur	occur	VERB
iajs-3630	125	19	in	in	ADP
iajs-3630	125	20	the	the	DET
iajs-3630	125	21	early	early	ADJ
iajs-3630	125	22	stages	stage	NOUN
iajs-3630	125	23	for	for	SCONJ
iajs-3630	125	24	the	the	DET
iajs-3630	125	25	patient	patient	NOUN
iajs-3630	125	26	to	to	PART
iajs-3630	125	27	detect	detect	VERB
iajs-3630	125	28	the	the	DET
iajs-3630	125	29	symptoms	symptom	NOUN
iajs-3630	125	30	of	of	ADP
iajs-3630	125	31	typical	typical	ADJ
iajs-3630	125	32	dm	dm	NOUN
iajs-3630	125	33	.	.	PUNCT
iajs-3630	126	1	it	it	PRON
iajs-3630	126	2	is	be	AUX
iajs-3630	126	3	well	well	ADV
iajs-3630	126	4	known	know	VERB
iajs-3630	126	5	that	that	SCONJ
iajs-3630	126	6	t2	t2	NOUN
iajs-3630	126	7	dm	dm	PRON
iajs-3630	126	8	often	often	ADV
iajs-3630	126	9	begins	begin	VERB
iajs-3630	126	10	for	for	ADP
iajs-3630	126	11	many	many	ADJ
iajs-3630	126	12	years	year	NOUN
iajs-3630	126	13	without	without	ADP
iajs-3630	126	14	being	be	AUX
iajs-3630	126	15	diagnosed	diagnose	VERB
iajs-3630	126	16	significantly	significantly	ADV
iajs-3630	126	17	since	since	SCONJ
iajs-3630	126	18	the	the	DET
iajs-3630	126	19	risk	risk	NOUN
iajs-3630	126	20	of	of	ADP
iajs-3630	126	21	t2	t2	NOUN
iajs-3630	126	22	dm	dm	NOUN
iajs-3630	126	23	increases	increase	NOUN
iajs-3630	126	24	with	with	ADP
iajs-3630	126	25	age	age	NOUN
iajs-3630	126	26	,	,	PUNCT
iajs-3630	126	27	obesity	obesity	NOUN
iajs-3630	126	28	,	,	PUNCT
iajs-3630	126	29	and	and	CCONJ
iajs-3630	126	30	inactivity	inactivity	NOUN
iajs-3630	126	31	(	(	PUNCT
iajs-3630	126	32	15	15	NUM
iajs-3630	126	33	)	)	PUNCT
iajs-3630	126	34	.	.	PUNCT
iajs-3630	127	1	the	the	DET
iajs-3630	127	2	bmi	bmi	PROPN
iajs-3630	127	3	results	result	NOUN
iajs-3630	127	4	confirmed	confirm	VERB
iajs-3630	127	5	the	the	DET
iajs-3630	127	6	existence	existence	NOUN
iajs-3630	127	7	of	of	ADP
iajs-3630	127	8	significant	significant	ADJ
iajs-3630	127	9	differences	difference	NOUN
iajs-3630	127	10	between	between	ADP
iajs-3630	127	11	the	the	DET
iajs-3630	127	12	patients	patient	NOUN
iajs-3630	127	13	and	and	CCONJ
iajs-3630	127	14	healthy	healthy	ADJ
iajs-3630	127	15	groups	group	NOUN
iajs-3630	127	16	,	,	PUNCT
iajs-3630	127	17	which	which	PRON
iajs-3630	127	18	enhances	enhance	VERB
iajs-3630	127	19	the	the	DET
iajs-3630	127	20	consistency	consistency	NOUN
iajs-3630	127	21	of	of	ADP
iajs-3630	127	22	the	the	DET
iajs-3630	127	23	current	current	ADJ
iajs-3630	127	24	study	study	NOUN
iajs-3630	127	25	with	with	ADP
iajs-3630	127	26	previous	previous	ADJ
iajs-3630	127	27	studies	study	NOUN
iajs-3630	127	28	.	.	PUNCT
iajs-3630	128	1	the	the	DET
iajs-3630	128	2	progression	progression	NOUN
iajs-3630	128	3	of	of	ADP
iajs-3630	128	4	dm	dm	NOUN
iajs-3630	128	5	and	and	CCONJ
iajs-3630	128	6	obesity	obesity	NOUN
iajs-3630	128	7	has	have	AUX
iajs-3630	128	8	gained	gain	VERB
iajs-3630	128	9	substantial	substantial	ADJ
iajs-3630	128	10	attention	attention	NOUN
iajs-3630	128	11	in	in	ADP
iajs-3630	128	12	many	many	ADJ
iajs-3630	128	13	studies	study	NOUN
iajs-3630	128	14	(	(	PUNCT
iajs-3630	128	15	16	16	NUM
iajs-3630	128	16	)	)	PUNCT
iajs-3630	128	17	.	.	PUNCT
iajs-3630	129	1	obesity	obesity	NOUN
iajs-3630	129	2	exceeds	exceed	VERB
iajs-3630	129	3	30	30	NUM
iajs-3630	129	4	kg	kg	NOUN
iajs-3630	129	5	/	/	SYM
iajs-3630	129	6	m2	m2	PROPN
iajs-3630	129	7	of	of	ADP
iajs-3630	129	8	bmi	bmi	PROPN
iajs-3630	129	9	value	value	NOUN
iajs-3630	129	10	,	,	PUNCT
iajs-3630	129	11	while	while	SCONJ
iajs-3630	129	12	it	it	PRON
iajs-3630	129	13	falls	fall	VERB
iajs-3630	129	14	within	within	ADP
iajs-3630	129	15	the	the	DET
iajs-3630	129	16	normal	normal	ADJ
iajs-3630	129	17	bmi	bmi	NOUN
iajs-3630	129	18	range	range	NOUN
iajs-3630	129	19	of	of	ADP
iajs-3630	129	20	18.5	18.5	NUM
iajs-3630	129	21	-	-	SYM
iajs-3630	129	22	24.9	24.9	NUM
iajs-3630	129	23	kg	kg	NOUN
iajs-3630	129	24	/	/	SYM
iajs-3630	129	25	m2	m2	PROPN
iajs-3630	129	26	(	(	PUNCT
iajs-3630	129	27	17	17	NUM
iajs-3630	129	28	)	)	PUNCT
iajs-3630	129	29	.	.	PUNCT
iajs-3630	130	1	according	accord	VERB
iajs-3630	130	2	to	to	ADP
iajs-3630	130	3	joshi	joshi	PROPN
iajs-3630	130	4	et	et	PROPN
iajs-3630	130	5	al	al	PROPN
iajs-3630	130	6	.	.	PROPN
iajs-3630	130	7	,	,	PUNCT
iajs-3630	130	8	who	who	PRON
iajs-3630	130	9	discovered	discover	VERB
iajs-3630	130	10	that	that	SCONJ
iajs-3630	130	11	diabetic	diabetic	ADJ
iajs-3630	130	12	patients	patient	NOUN
iajs-3630	130	13	'	'	PART
iajs-3630	130	14	bmi	bmi	NOUN
iajs-3630	130	15	was	be	AUX
iajs-3630	130	16	significantly	significantly	ADV
iajs-3630	130	17	higher	high	ADJ
iajs-3630	130	18	than	than	ADP
iajs-3630	130	19	that	that	PRON
iajs-3630	130	20	of	of	ADP
iajs-3630	130	21	non	non	ADJ
iajs-3630	130	22	-	-	ADJ
iajs-3630	130	23	diabetic	diabetic	ADJ
iajs-3630	130	24	patients	patient	NOUN
iajs-3630	130	25	(	(	PUNCT
iajs-3630	130	26	18	18	NUM
iajs-3630	130	27	)	)	PUNCT
iajs-3630	130	28	.	.	PUNCT
iajs-3630	131	1	the	the	DET
iajs-3630	131	2	current	current	ADJ
iajs-3630	131	3	study	study	NOUN
iajs-3630	131	4	's	's	PART
iajs-3630	131	5	whr	whr	PROPN
iajs-3630	131	6	results	result	NOUN
iajs-3630	131	7	agreed	agree	VERB
iajs-3630	131	8	with	with	ADP
iajs-3630	131	9	those	those	PRON
iajs-3630	131	10	of	of	ADP
iajs-3630	131	11	other	other	ADJ
iajs-3630	131	12	studies	study	NOUN
iajs-3630	131	13	,	,	PUNCT
iajs-3630	131	14	which	which	PRON
iajs-3630	131	15	found	find	VERB
iajs-3630	131	16	that	that	SCONJ
iajs-3630	131	17	this	this	DET
iajs-3630	131	18	ratio	ratio	NOUN
iajs-3630	131	19	is	be	AUX
iajs-3630	131	20	high	high	ADJ
iajs-3630	131	21	in	in	ADP
iajs-3630	131	22	patient	patient	ADJ
iajs-3630	131	23	groups	group	NOUN
iajs-3630	131	24	relative	relative	ADJ
iajs-3630	131	25	to	to	ADP
iajs-3630	131	26	healthy	healthy	ADJ
iajs-3630	131	27	people	people	NOUN
iajs-3630	131	28	.	.	PUNCT
iajs-3630	132	1	this	this	DET
iajs-3630	132	2	ratio	ratio	NOUN
iajs-3630	132	3	is	be	AUX
iajs-3630	132	4	also	also	ADV
iajs-3630	132	5	associated	associate	VERB
iajs-3630	132	6	with	with	ADP
iajs-3630	132	7	mets	met	NOUN
iajs-3630	132	8	and	and	CCONJ
iajs-3630	132	9	high	high	ADJ
iajs-3630	132	10	blood	blood	NOUN
iajs-3630	132	11	pressure	pressure	NOUN
iajs-3630	132	12	(	(	PUNCT
iajs-3630	132	13	19	19	NUM
iajs-3630	132	14	)	)	PUNCT
iajs-3630	132	15	.	.	PUNCT
iajs-3630	133	1	furthermore	furthermore	ADV
iajs-3630	133	2	,	,	PUNCT
iajs-3630	133	3	other	other	ADJ
iajs-3630	133	4	studies	study	NOUN
iajs-3630	133	5	have	have	AUX
iajs-3630	133	6	indicated	indicate	VERB
iajs-3630	133	7	that	that	SCONJ
iajs-3630	133	8	the	the	DET
iajs-3630	133	9	whr	whr	PROPN
iajs-3630	133	10	is	be	AUX
iajs-3630	133	11	better	well	ADJ
iajs-3630	133	12	than	than	ADP
iajs-3630	133	13	bmi	bmi	VERB
iajs-3630	133	14	in	in	ADP
iajs-3630	133	15	obesity	obesity	NOUN
iajs-3630	133	16	in	in	ADP
iajs-3630	133	17	people	people	NOUN
iajs-3630	133	18	with	with	ADP
iajs-3630	133	19	cardiovascular	cardiovascular	ADJ
iajs-3630	133	20	disease	disease	NOUN
iajs-3630	133	21	.	.	PUNCT
iajs-3630	134	1	in	in	ADP
iajs-3630	134	2	addition	addition	NOUN
iajs-3630	134	3	,	,	PUNCT
iajs-3630	134	4	each	each	DET
iajs-3630	134	5	whr	whr	PROPN
iajs-3630	134	6	and	and	CCONJ
iajs-3630	134	7	bmi	bmi	NOUN
iajs-3630	134	8	are	be	AUX
iajs-3630	134	9	critical	critical	ADJ
iajs-3630	134	10	sensitive	sensitive	ADJ
iajs-3630	134	11	indicators	indicator	NOUN
iajs-3630	134	12	in	in	ADP
iajs-3630	134	13	the	the	DET
iajs-3630	134	14	case	case	NOUN
iajs-3630	134	15	of	of	ADP
iajs-3630	134	16	diabetes	diabetes	NOUN
iajs-3630	134	17	(	(	PUNCT
iajs-3630	134	18	20	20	NUM
iajs-3630	134	19	)	)	PUNCT
iajs-3630	134	20	.	.	PUNCT
iajs-3630	135	1	international	international	ADJ
iajs-3630	135	2	standards	standard	NOUN
iajs-3630	135	3	were	be	AUX
iajs-3630	135	4	adopted	adopt	VERB
iajs-3630	135	5	in	in	ADP
iajs-3630	135	6	collecting	collect	VERB
iajs-3630	135	7	the	the	DET
iajs-3630	135	8	current	current	ADJ
iajs-3630	135	9	study	study	NOUN
iajs-3630	135	10	models	model	NOUN
iajs-3630	135	11	,	,	PUNCT
iajs-3630	135	12	which	which	PRON
iajs-3630	135	13	are	be	AUX
iajs-3630	135	14	based	base	VERB
iajs-3630	135	15	on	on	ADP
iajs-3630	135	16	the	the	DET
iajs-3630	135	17	levels	level	NOUN
iajs-3630	135	18	of	of	ADP
iajs-3630	135	19	fbg	fbg	PROPN
iajs-3630	135	20	and	and	CCONJ
iajs-3630	135	21	hba1c	hba1c	PROPN
iajs-3630	135	22	to	to	PART
iajs-3630	135	23	describe	describe	VERB
iajs-3630	135	24	the	the	DET
iajs-3630	135	25	condition	condition	NOUN
iajs-3630	135	26	of	of	ADP
iajs-3630	135	27	patients	patient	NOUN
iajs-3630	135	28	with	with	ADP
iajs-3630	135	29	t2	t2	PROPN
iajs-3630	135	30	dm	dm	PROPN
iajs-3630	135	31	and	and	CCONJ
iajs-3630	135	32	pre	pre	ADJ
iajs-3630	135	33	-	-	ADJ
iajs-3630	135	34	dm	dm	INTJ
iajs-3630	135	35	.	.	PUNCT
iajs-3630	136	1	subsequently	subsequently	ADV
iajs-3630	136	2	,	,	PUNCT
iajs-3630	136	3	the	the	DET
iajs-3630	136	4	results	result	NOUN
iajs-3630	136	5	of	of	ADP
iajs-3630	136	6	the	the	DET
iajs-3630	136	7	current	current	ADJ
iajs-3630	136	8	study	study	NOUN
iajs-3630	136	9	are	be	AUX
iajs-3630	136	10	consistent	consistent	ADJ
iajs-3630	136	11	with	with	ADP
iajs-3630	136	12	previous	previous	ADJ
iajs-3630	136	13	studies	study	NOUN
iajs-3630	136	14	(	(	PUNCT
iajs-3630	136	15	21,22	21,22	NOUN
iajs-3630	136	16	)	)	PUNCT
iajs-3630	136	17	.	.	PUNCT
iajs-3630	137	1	the	the	DET
iajs-3630	137	2	current	current	ADJ
iajs-3630	137	3	study	study	NOUN
iajs-3630	137	4	showed	show	VERB
iajs-3630	137	5	a	a	DET
iajs-3630	137	6	significant	significant	ADJ
iajs-3630	137	7	increase	increase	NOUN
iajs-3630	137	8	in	in	ADP
iajs-3630	137	9	the	the	DET
iajs-3630	137	10	level	level	NOUN
iajs-3630	137	11	of	of	ADP
iajs-3630	137	12	insulin	insulin	NOUN
iajs-3630	137	13	hormone	hormone	NOUN
iajs-3630	137	14	and	and	CCONJ
iajs-3630	137	15	homo	homo	NOUN
iajs-3630	137	16	-	-	PUNCT
iajs-3630	137	17	ir	ir	NOUN
iajs-3630	137	18	in	in	ADP
iajs-3630	137	19	the	the	DET
iajs-3630	137	20	patients	patient	NOUN
iajs-3630	137	21	group	group	NOUN
iajs-3630	137	22	with	with	ADP
iajs-3630	137	23	t2	t2	PROPN
iajs-3630	137	24	dm	dm	PROPN
iajs-3630	137	25	compared	compare	VERB
iajs-3630	137	26	to	to	ADP
iajs-3630	137	27	the	the	DET
iajs-3630	137	28	healthy	healthy	ADJ
iajs-3630	137	29	group	group	NOUN
iajs-3630	137	30	.	.	PUNCT
iajs-3630	138	1	in	in	ADP
iajs-3630	138	2	contrast	contrast	NOUN
iajs-3630	138	3	,	,	PUNCT
iajs-3630	138	4	no	no	DET
iajs-3630	138	5	significant	significant	ADJ
iajs-3630	138	6	difference	difference	NOUN
iajs-3630	138	7	was	be	AUX
iajs-3630	138	8	found	find	VERB
iajs-3630	138	9	between	between	ADP
iajs-3630	138	10	pre	pre	ADJ
iajs-3630	138	11	-	-	ADJ
iajs-3630	138	12	dm	dm	ADJ
iajs-3630	138	13	and	and	CCONJ
iajs-3630	138	14	control	control	NOUN
iajs-3630	138	15	groups	group	NOUN
iajs-3630	138	16	.	.	PUNCT
iajs-3630	139	1	at	at	ADP
iajs-3630	139	2	the	the	DET
iajs-3630	139	3	same	same	ADJ
iajs-3630	139	4	time	time	NOUN
iajs-3630	139	5	,	,	PUNCT
iajs-3630	139	6	the	the	DET
iajs-3630	139	7	homa	homa	NOUN
iajs-3630	139	8	-	-	PUNCT
iajs-3630	139	9	is	be	AUX
iajs-3630	139	10	level	level	NOUN
iajs-3630	139	11	revealed	reveal	VERB
iajs-3630	139	12	highly	highly	ADV
iajs-3630	139	13	significant	significant	ADJ
iajs-3630	139	14	differences	difference	NOUN
iajs-3630	139	15	among	among	ADP
iajs-3630	139	16	the	the	DET
iajs-3630	139	17	three	three	NUM
iajs-3630	139	18	studied	studied	ADJ
iajs-3630	139	19	groups	group	NOUN
iajs-3630	139	20	.	.	PUNCT
iajs-3630	140	1	this	this	DET
iajs-3630	140	2	result	result	NOUN
iajs-3630	140	3	agrees	agree	VERB
iajs-3630	140	4	with	with	ADP
iajs-3630	140	5	the	the	DET
iajs-3630	140	6	study	study	NOUN
iajs-3630	140	7	of	of	ADP
iajs-3630	140	8	mohsen	mohsen	PROPN
iajs-3630	140	9	et	et	PROPN
iajs-3630	140	10	al	al	PROPN
iajs-3630	140	11	.	.	PUNCT
iajs-3630	141	1	(	(	PUNCT
iajs-3630	141	2	23	23	NUM
iajs-3630	141	3	)	)	PUNCT
iajs-3630	141	4	,	,	PUNCT
iajs-3630	141	5	who	who	PRON
iajs-3630	141	6	showed	show	VERB
iajs-3630	141	7	that	that	SCONJ
iajs-3630	141	8	patients	patient	NOUN
iajs-3630	141	9	with	with	ADP
iajs-3630	141	10	t2	t2	PROPN
iajs-3630	141	11	dm	dm	PROPN
iajs-3630	141	12	had	have	VERB
iajs-3630	141	13	elevated	elevate	VERB
iajs-3630	141	14	homa	homa	NOUN
iajs-3630	141	15	-	-	PUNCT
iajs-3630	141	16	ir	ir	PROPN
iajs-3630	141	17	together	together	ADV
iajs-3630	141	18	with	with	ADP
iajs-3630	141	19	insulin	insulin	NOUN
iajs-3630	141	20	and	and	CCONJ
iajs-3630	141	21	low	low	ADJ
iajs-3630	141	22	levels	level	NOUN
iajs-3630	141	23	of	of	ADP
iajs-3630	141	24	homa	homa	NOUN
iajs-3630	141	25	-	-	PUNCT
iajs-3630	141	26	is	be	AUX
iajs-3630	141	27	compared	compare	VERB
iajs-3630	141	28	to	to	ADP
iajs-3630	141	29	the	the	DET
iajs-3630	141	30	control	control	NOUN
iajs-3630	141	31	group	group	NOUN
iajs-3630	141	32	.	.	PUNCT
iajs-3630	142	1	this	this	DET
iajs-3630	142	2	result	result	NOUN
iajs-3630	142	3	can	can	AUX
iajs-3630	142	4	be	be	AUX
iajs-3630	142	5	explained	explain	VERB
iajs-3630	142	6	by	by	ADP
iajs-3630	142	7	the	the	DET
iajs-3630	142	8	fact	fact	NOUN
iajs-3630	142	9	that	that	SCONJ
iajs-3630	142	10	ir	ir	PROPN
iajs-3630	142	11	is	be	AUX
iajs-3630	142	12	most	most	ADV
iajs-3630	142	13	likely	likely	ADJ
iajs-3630	142	14	the	the	DET
iajs-3630	142	15	initial	initial	ADJ
iajs-3630	142	16	metabolic	metabolic	NOUN
iajs-3630	142	17	aberration	aberration	NOUN
iajs-3630	142	18	in	in	ADP
iajs-3630	142	19	t2	t2	PROPN
iajs-3630	142	20	dm	dm	PROPN
iajs-3630	142	21	.	.	PUNCT
iajs-3630	143	1	raised	raise	VERB
iajs-3630	143	2	serum	serum	NOUN
iajs-3630	143	3	glucose	glucose	NOUN
iajs-3630	143	4	levels	level	NOUN
iajs-3630	143	5	brought	bring	VERB
iajs-3630	143	6	on	on	ADP
iajs-3630	143	7	by	by	ADP
iajs-3630	143	8	ir	ir	PROPN
iajs-3630	143	9	led	lead	VERB
iajs-3630	143	10	to	to	ADP
iajs-3630	143	11	the	the	DET
iajs-3630	143	12	pancreas	pancrea	NOUN
iajs-3630	143	13	's	's	PART
iajs-3630	143	14	overproduction	overproduction	NOUN
iajs-3630	143	15	of	of	ADP
iajs-3630	143	16	insulin	insulin	NOUN
iajs-3630	143	17	.	.	PUNCT
iajs-3630	144	1	when	when	SCONJ
iajs-3630	144	2	hyperglycemia	hyperglycemia	NOUN
iajs-3630	144	3	is	be	AUX
iajs-3630	144	4	continuous	continuous	ADJ
iajs-3630	144	5	and	and	CCONJ
iajs-3630	144	6	chronic	chronic	ADJ
iajs-3630	144	7	,	,	PUNCT
iajs-3630	144	8	the	the	DET
iajs-3630	144	9	pancreatic	pancreatic	ADJ
iajs-3630	144	10	cells	cell	NOUN
iajs-3630	144	11	are	be	AUX
iajs-3630	144	12	damaged	damage	VERB
iajs-3630	144	13	and	and	CCONJ
iajs-3630	144	14	cease	cease	VERB
iajs-3630	144	15	functioning	function	VERB
iajs-3630	144	16	(	(	PUNCT
iajs-3630	144	17	24	24	NUM
iajs-3630	144	18	)	)	PUNCT
iajs-3630	144	19	.	.	PUNCT
iajs-3630	145	1	current	current	ADJ
iajs-3630	145	2	lipid	lipid	NOUN
iajs-3630	145	3	profile	profile	NOUN
iajs-3630	145	4	levels	level	NOUN
iajs-3630	145	5	showed	show	VERB
iajs-3630	145	6	highly	highly	ADV
iajs-3630	145	7	significant	significant	ADJ
iajs-3630	145	8	differences	difference	NOUN
iajs-3630	145	9	in	in	ADP
iajs-3630	145	10	cholesterol	cholesterol	NOUN
iajs-3630	145	11	and	and	CCONJ
iajs-3630	145	12	tg	tg	PROPN
iajs-3630	145	13	.	.	PUNCT
iajs-3630	146	1	in	in	ADP
iajs-3630	146	2	contrast	contrast	NOUN
iajs-3630	146	3	,	,	PUNCT
iajs-3630	146	4	the	the	DET
iajs-3630	146	5	serum	serum	NOUN
iajs-3630	146	6	hdl	hdl	PROPN
iajs-3630	146	7	-	-	PUNCT
iajs-3630	146	8	c	c	NOUN
iajs-3630	146	9	level	level	NOUN
iajs-3630	146	10	was	be	AUX
iajs-3630	146	11	lower	low	ADJ
iajs-3630	146	12	in	in	ADP
iajs-3630	146	13	t2	t2	NOUN
iajs-3630	146	14	dm	dm	NUM
iajs-3630	146	15	than	than	ADP
iajs-3630	146	16	in	in	ADP
iajs-3630	146	17	the	the	DET
iajs-3630	146	18	control	control	NOUN
iajs-3630	146	19	group	group	NOUN
iajs-3630	146	20	,	,	PUNCT
iajs-3630	146	21	but	but	CCONJ
iajs-3630	146	22	there	there	PRON
iajs-3630	146	23	was	be	VERB
iajs-3630	146	24	no	no	DET
iajs-3630	146	25	significant	significant	ADJ
iajs-3630	146	26	difference	difference	NOUN
iajs-3630	146	27	between	between	ADP
iajs-3630	146	28	the	the	DET
iajs-3630	146	29	two	two	NUM
iajs-3630	146	30	groups	group	NOUN
iajs-3630	146	31	of	of	ADP
iajs-3630	146	32	dm	dm	PROPN
iajs-3630	146	33	and	and	CCONJ
iajs-3630	146	34	pre	pre	ADJ
iajs-3630	146	35	-	-	ADJ
iajs-3630	146	36	dm	dm	X
iajs-3630	146	37	compared	compare	VERB
iajs-3630	146	38	to	to	ADP
iajs-3630	146	39	the	the	DET
iajs-3630	146	40	control	control	NOUN
iajs-3630	146	41	group	group	NOUN
iajs-3630	146	42	.	.	PUNCT
iajs-3630	147	1	this	this	DET
iajs-3630	147	2	result	result	NOUN
iajs-3630	147	3	agrees	agree	VERB
iajs-3630	147	4	with	with	ADP
iajs-3630	147	5	previous	previous	ADJ
iajs-3630	147	6	studies	study	NOUN
iajs-3630	147	7	(	(	PUNCT
iajs-3630	147	8	26	26	NUM
iajs-3630	147	9	,	,	PUNCT
iajs-3630	147	10	27	27	NUM
iajs-3630	147	11	)	)	PUNCT
iajs-3630	147	12	.	.	PUNCT
iajs-3630	148	1	in	in	ADP
iajs-3630	148	2	the	the	DET
iajs-3630	148	3	current	current	ADJ
iajs-3630	148	4	study	study	NOUN
iajs-3630	148	5	,	,	PUNCT
iajs-3630	148	6	the	the	DET
iajs-3630	148	7	results	result	NOUN
iajs-3630	148	8	of	of	ADP
iajs-3630	148	9	irisin	irisin	NOUN
iajs-3630	148	10	levels	level	NOUN
iajs-3630	148	11	showed	show	VERB
iajs-3630	148	12	a	a	DET
iajs-3630	148	13	statistically	statistically	ADV
iajs-3630	148	14	significant	significant	ADJ
iajs-3630	148	15	increase	increase	NOUN
iajs-3630	148	16	in	in	ADP
iajs-3630	148	17	the	the	DET
iajs-3630	148	18	group	group	NOUN
iajs-3630	148	19	of	of	ADP
iajs-3630	148	20	patients	patient	NOUN
iajs-3630	148	21	with	with	ADP
iajs-3630	148	22	t2	t2	PROPN
iajs-3630	148	23	dm	dm	NUM
iajs-3630	148	24	compared	compare	VERB
iajs-3630	148	25	with	with	ADP
iajs-3630	148	26	the	the	DET
iajs-3630	148	27	control	control	NOUN
iajs-3630	148	28	group	group	NOUN
iajs-3630	148	29	and	and	CCONJ
iajs-3630	148	30	the	the	DET
iajs-3630	148	31	pre	pre	ADJ
iajs-3630	148	32	-	-	ADJ
iajs-3630	148	33	dm	dm	ADJ
iajs-3630	148	34	group	group	NOUN
iajs-3630	148	35	.	.	PUNCT
iajs-3630	149	1	the	the	DET
iajs-3630	149	2	presence	presence	NOUN
iajs-3630	149	3	of	of	ADP
iajs-3630	149	4	higher	high	ADJ
iajs-3630	149	5	circulating	circulate	VERB
iajs-3630	149	6	levels	level	NOUN
iajs-3630	149	7	of	of	ADP
iajs-3630	149	8	irisin	irisin	NOUN
iajs-3630	149	9	in	in	ADP
iajs-3630	149	10	t2	t2	NOUN
iajs-3630	149	11	dm	dm	NUM
iajs-3630	149	12	subjects	subject	NOUN
iajs-3630	149	13	may	may	AUX
iajs-3630	149	14	indicate	indicate	VERB
iajs-3630	149	15	irisin	irisin	ADJ
iajs-3630	149	16	dysregulation	dysregulation	NOUN
iajs-3630	149	17	.	.	PUNCT
iajs-3630	150	1	however	however	ADV
iajs-3630	150	2	,	,	PUNCT
iajs-3630	150	3	a	a	DET
iajs-3630	150	4	few	few	ADJ
iajs-3630	150	5	studies	study	NOUN
iajs-3630	150	6	have	have	AUX
iajs-3630	150	7	suggested	suggest	VERB
iajs-3630	150	8	that	that	SCONJ
iajs-3630	150	9	metabolic	metabolic	NOUN
iajs-3630	150	10	disease	disease	NOUN
iajs-3630	150	11	states	state	NOUN
iajs-3630	150	12	have	have	VERB
iajs-3630	150	13	low	low	ADJ
iajs-3630	150	14	irisin	irisin	NOUN
iajs-3630	150	15	levels	level	NOUN
iajs-3630	150	16	(	(	PUNCT
iajs-3630	150	17	28	28	NUM
iajs-3630	150	18	-	-	SYM
iajs-3630	150	19	30	30	NUM
iajs-3630	150	20	)	)	PUNCT
iajs-3630	150	21	.	.	PUNCT
iajs-3630	151	1	other	other	ADJ
iajs-3630	151	2	studies	study	NOUN
iajs-3630	151	3	revealed	reveal	VERB
iajs-3630	151	4	that	that	SCONJ
iajs-3630	151	5	t2	t2	NOUN
iajs-3630	151	6	dm	dm	NOUN
iajs-3630	151	7	and	and	CCONJ
iajs-3630	151	8	other	other	ADJ
iajs-3630	151	9	metabolic	metabolic	NOUN
iajs-3630	151	10	disorders	disorder	NOUN
iajs-3630	151	11	have	have	VERB
iajs-3630	151	12	higher	high	ADJ
iajs-3630	151	13	irisin	irisin	NOUN
iajs-3630	151	14	levels	level	NOUN
iajs-3630	151	15	(	(	PUNCT
iajs-3630	151	16	31,32	31,32	NUM
iajs-3630	151	17	)	)	PUNCT
iajs-3630	151	18	.	.	PUNCT
iajs-3630	152	1	recently	recently	ADV
iajs-3630	152	2	,	,	PUNCT
iajs-3630	152	3	it	it	PRON
iajs-3630	152	4	has	have	AUX
iajs-3630	152	5	been	be	AUX
iajs-3630	152	6	found	find	VERB
iajs-3630	152	7	that	that	SCONJ
iajs-3630	152	8	people	people	NOUN
iajs-3630	152	9	with	with	ADP
iajs-3630	152	10	mets	met	NOUN
iajs-3630	152	11	have	have	VERB
iajs-3630	152	12	considerably	considerably	ADV
iajs-3630	152	13	greater	great	ADJ
iajs-3630	152	14	irisin	irisin	ADJ
iajs-3630	152	15	levels	level	NOUN
iajs-3630	152	16	than	than	ADP
iajs-3630	152	17	those	those	PRON
iajs-3630	152	18	without	without	ADP
iajs-3630	152	19	.	.	PUNCT
iajs-3630	153	1	they	they	PRON
iajs-3630	153	2	proposed	propose	VERB
iajs-3630	153	3	that	that	SCONJ
iajs-3630	153	4	the	the	DET
iajs-3630	153	5	uncontrolled	uncontrolled	ADJ
iajs-3630	153	6	release	release	NOUN
iajs-3630	153	7	of	of	ADP
iajs-3630	153	8	irisin	irisin	NOUN
iajs-3630	153	9	may	may	AUX
iajs-3630	153	10	ihjpas	ihjpas	VERB
iajs-3630	153	11	.	.	PUNCT
iajs-3630	154	1	2025	2025	NUM
iajs-3630	154	2	,	,	PUNCT
iajs-3630	154	3	38	38	NUM
iajs-3630	154	4	(	(	PUNCT
iajs-3630	154	5	1	1	NUM
iajs-3630	154	6	)	)	PUNCT
iajs-3630	154	7	310	310	NUM
iajs-3630	154	8	have	have	AUX
iajs-3630	154	9	been	be	AUX
iajs-3630	154	10	caused	cause	VERB
iajs-3630	154	11	by	by	ADP
iajs-3630	154	12	compromised	compromise	VERB
iajs-3630	154	13	irisin	irisin	NOUN
iajs-3630	154	14	signaling	signal	VERB
iajs-3630	154	15	in	in	ADP
iajs-3630	154	16	mets	met	NOUN
iajs-3630	154	17	(	(	PUNCT
iajs-3630	154	18	33	33	NUM
iajs-3630	154	19	)	)	PUNCT
iajs-3630	154	20	.	.	PUNCT
iajs-3630	155	1	5	5	X
iajs-3630	155	2	.	.	X
iajs-3630	155	3	conclusion	conclusion	NOUN
iajs-3630	155	4	according	accord	VERB
iajs-3630	155	5	to	to	ADP
iajs-3630	155	6	the	the	DET
iajs-3630	155	7	current	current	ADJ
iajs-3630	155	8	study	study	NOUN
iajs-3630	155	9	,	,	PUNCT
iajs-3630	155	10	irisin	irisin	NOUN
iajs-3630	155	11	is	be	AUX
iajs-3630	155	12	an	an	DET
iajs-3630	155	13	excellent	excellent	ADJ
iajs-3630	155	14	marker	marker	NOUN
iajs-3630	155	15	for	for	ADP
iajs-3630	155	16	diagnosing	diagnose	VERB
iajs-3630	155	17	the	the	DET
iajs-3630	155	18	case	case	NOUN
iajs-3630	155	19	studied	study	VERB
iajs-3630	155	20	.	.	PUNCT
iajs-3630	156	1	this	this	DET
iajs-3630	156	2	result	result	NOUN
iajs-3630	156	3	was	be	AUX
iajs-3630	156	4	supported	support	VERB
iajs-3630	156	5	by	by	ADP
iajs-3630	156	6	roc	roc	PROPN
iajs-3630	156	7	data	datum	NOUN
iajs-3630	156	8	analysis	analysis	NOUN
iajs-3630	156	9	,	,	PUNCT
iajs-3630	156	10	which	which	PRON
iajs-3630	156	11	showed	show	VERB
iajs-3630	156	12	the	the	DET
iajs-3630	156	13	value	value	NOUN
iajs-3630	156	14	of	of	ADP
iajs-3630	156	15	auc	auc	NOUN
iajs-3630	156	16	equal	equal	ADJ
iajs-3630	156	17	to	to	ADP
iajs-3630	156	18	0.987	0.987	NUM
iajs-3630	156	19	.	.	PUNCT
iajs-3630	157	1	the	the	DET
iajs-3630	157	2	patient	patient	NOUN
iajs-3630	157	3	's	's	PART
iajs-3630	157	4	group	group	NOUN
iajs-3630	157	5	had	have	VERB
iajs-3630	157	6	a	a	DET
iajs-3630	157	7	significantly	significantly	ADV
iajs-3630	157	8	higher	high	ADJ
iajs-3630	157	9	level	level	NOUN
iajs-3630	157	10	of	of	ADP
iajs-3630	157	11	insulin	insulin	NOUN
iajs-3630	157	12	hormone	hormone	NOUN
iajs-3630	157	13	and	and	CCONJ
iajs-3630	157	14	homo	homo	NOUN
iajs-3630	157	15	-	-	PUNCT
iajs-3630	157	16	ir	ir	PROPN
iajs-3630	157	17	than	than	ADP
iajs-3630	157	18	the	the	DET
iajs-3630	157	19	healthy	healthy	ADJ
iajs-3630	157	20	group	group	NOUN
iajs-3630	157	21	.	.	PUNCT
iajs-3630	158	1	at	at	ADP
iajs-3630	158	2	the	the	DET
iajs-3630	158	3	same	same	ADJ
iajs-3630	158	4	time	time	NOUN
iajs-3630	158	5	,	,	PUNCT
iajs-3630	158	6	the	the	DET
iajs-3630	158	7	homa	homa	NOUN
iajs-3630	158	8	-	-	PUNCT
iajs-3630	158	9	is	be	AUX
iajs-3630	158	10	level	level	NOUN
iajs-3630	158	11	revealed	reveal	VERB
iajs-3630	158	12	highly	highly	ADV
iajs-3630	158	13	significant	significant	ADJ
iajs-3630	158	14	differences	difference	NOUN
iajs-3630	158	15	among	among	ADP
iajs-3630	158	16	the	the	DET
iajs-3630	158	17	three	three	NUM
iajs-3630	158	18	studied	study	VERB
iajs-3630	158	19	groups	group	NOUN
iajs-3630	158	20	.	.	PUNCT
iajs-3630	159	1	roc	roc	PROPN
iajs-3630	159	2	data	data	PROPN
iajs-3630	159	3	analysis	analysis	NOUN
iajs-3630	159	4	supported	support	VERB
iajs-3630	159	5	this	this	DET
iajs-3630	159	6	result	result	NOUN
iajs-3630	159	7	,	,	PUNCT
iajs-3630	159	8	which	which	PRON
iajs-3630	159	9	showed	show	VERB
iajs-3630	159	10	the	the	DET
iajs-3630	159	11	value	value	NOUN
iajs-3630	159	12	of	of	ADP
iajs-3630	159	13	auc	auc	NOUN
iajs-3630	159	14	equal	equal	ADJ
iajs-3630	159	15	to	to	ADP
iajs-3630	159	16	0.901	0.901	NUM
iajs-3630	159	17	.	.	PUNCT
iajs-3630	160	1	acknowledgment	acknowledgment	NOUN
iajs-3630	160	2	the	the	DET
iajs-3630	160	3	authors	author	NOUN
iajs-3630	160	4	express	express	VERB
iajs-3630	160	5	their	their	PRON
iajs-3630	160	6	sincere	sincere	ADJ
iajs-3630	160	7	appreciation	appreciation	NOUN
iajs-3630	160	8	to	to	ADP
iajs-3630	160	9	the	the	DET
iajs-3630	160	10	department	department	NOUN
iajs-3630	160	11	of	of	ADP
iajs-3630	160	12	chemistry	chemistry	NOUN
iajs-3630	160	13	,	,	PUNCT
iajs-3630	160	14	college	college	NOUN
iajs-3630	160	15	of	of	ADP
iajs-3630	160	16	science	science	NOUN
iajs-3630	160	17	for	for	ADP
iajs-3630	160	18	women	woman	NOUN
iajs-3630	160	19	,	,	PUNCT
iajs-3630	160	20	university	university	NOUN
iajs-3630	160	21	of	of	ADP
iajs-3630	160	22	baghdad	baghdad	PROPN
iajs-3630	160	23	,	,	PUNCT
iajs-3630	160	24	for	for	ADP
iajs-3630	160	25	supporting	support	VERB
iajs-3630	160	26	this	this	DET
iajs-3630	160	27	study	study	NOUN
iajs-3630	160	28	,	,	PUNCT
iajs-3630	160	29	and	and	CCONJ
iajs-3630	160	30	thanks	thank	NOUN
iajs-3630	160	31	to	to	ADP
iajs-3630	160	32	the	the	DET
iajs-3630	160	33	workers	worker	NOUN
iajs-3630	160	34	at	at	ADP
iajs-3630	160	35	national	national	ADJ
iajs-3630	160	36	diabetes	diabetes	NOUN
iajs-3630	160	37	center	center	NOUN
iajs-3630	160	38	/	/	SYM
iajs-3630	160	39	al	al	PROPN
iajs-3630	160	40	-	-	PUNCT
iajs-3630	160	41	mustansyriah	mustansyriah	PROPN
iajs-3630	160	42	university	university	NOUN
iajs-3630	160	43	for	for	ADP
iajs-3630	160	44	their	their	PRON
iajs-3630	160	45	efforts	effort	NOUN
iajs-3630	160	46	and	and	CCONJ
iajs-3630	160	47	facilities	facility	NOUN
iajs-3630	160	48	to	to	PART
iajs-3630	160	49	carry	carry	VERB
iajs-3630	160	50	out	out	ADP
iajs-3630	160	51	this	this	DET
iajs-3630	160	52	work	work	NOUN
iajs-3630	160	53	.	.	PUNCT
iajs-3630	161	1	conflict	conflict	NOUN
iajs-3630	161	2	of	of	ADP
iajs-3630	161	3	interest	interest	NOUN
iajs-3630	161	4	the	the	DET
iajs-3630	161	5	authors	author	NOUN
iajs-3630	161	6	declare	declare	VERB
iajs-3630	161	7	that	that	SCONJ
iajs-3630	161	8	they	they	PRON
iajs-3630	161	9	have	have	VERB
iajs-3630	161	10	no	no	DET
iajs-3630	161	11	conflicts	conflict	NOUN
iajs-3630	161	12	of	of	ADP
iajs-3630	161	13	interest	interest	NOUN
iajs-3630	161	14	.	.	PUNCT
iajs-3630	162	1	funding	funding	NOUN
iajs-3630	162	2	there	there	PRON
iajs-3630	162	3	is	be	VERB
iajs-3630	162	4	no	no	DET
iajs-3630	162	5	funding	funding	NOUN
iajs-3630	162	6	for	for	ADP
iajs-3630	162	7	the	the	DET
iajs-3630	162	8	article	article	NOUN
iajs-3630	162	9	.	.	PUNCT
iajs-3630	163	1	ethical	ethical	ADJ
iajs-3630	163	2	clearance	clearance	NOUN
iajs-3630	163	3	this	this	DET
iajs-3630	163	4	study	study	NOUN
iajs-3630	163	5	was	be	AUX
iajs-3630	163	6	approved	approve	VERB
iajs-3630	163	7	by	by	ADP
iajs-3630	163	8	a	a	DET
iajs-3630	163	9	local	local	ADJ
iajs-3630	163	10	ethics	ethic	NOUN
iajs-3630	163	11	committee	committee	NOUN
iajs-3630	163	12	at	at	ADP
iajs-3630	163	13	the	the	DET
iajs-3630	163	14	department	department	NOUN
iajs-3630	163	15	of	of	ADP
iajs-3630	163	16	chemistry/	chemistry/	NUM
iajs-3630	163	17	college	college	NOUN
iajs-3630	163	18	of	of	ADP
iajs-3630	163	19	science	science	NOUN
iajs-3630	163	20	for	for	ADP
iajs-3630	163	21	women/	women/	NUM
iajs-3630	163	22	university	university	NOUN
iajs-3630	163	23	of	of	ADP
iajs-3630	163	24	baghdad	baghdad	PROPN
iajs-3630	163	25	.	.	PUNCT
iajs-3630	164	1	they	they	PRON
iajs-3630	164	2	reviewed	review	VERB
iajs-3630	164	3	and	and	CCONJ
iajs-3630	164	4	approved	approve	VERB
iajs-3630	164	5	the	the	DET
iajs-3630	164	6	study	study	NOUN
iajs-3630	164	7	protocol	protocol	NOUN
iajs-3630	164	8	,	,	PUNCT
iajs-3630	164	9	subject	subject	ADJ
iajs-3630	164	10	information	information	NOUN
iajs-3630	164	11	,	,	PUNCT
iajs-3630	164	12	and	and	CCONJ
iajs-3630	164	13	consent	consent	VERB
iajs-3630	164	14	form	form	NOUN
iajs-3630	164	15	according	accord	VERB
iajs-3630	164	16	to	to	ADP
iajs-3630	164	17	document	document	NOUN
iajs-3630	164	18	number	number	NOUN
iajs-3630	164	19	6364/22	6364/22	NUM
iajs-3630	164	20	on	on	ADP
iajs-3630	164	21	5/	5/	NUM
iajs-3630	164	22	december	december	PROPN
iajs-3630	164	23	/2022	/2022	PUNCT
iajs-3630	164	24	.	.	PUNCT
iajs-3630	165	1	references	reference	NOUN
iajs-3630	165	2	1	1	NUM
iajs-3630	165	3	.	.	PUNCT
iajs-3630	166	1	van	van	PROPN
iajs-3630	166	2	sloten	sloten	PROPN
iajs-3630	166	3	tt	tt	PROPN
iajs-3630	166	4	,	,	PUNCT
iajs-3630	166	5	sedaghat	sedaghat	PRON
iajs-3630	166	6	s	s	VERB
iajs-3630	166	7	,	,	PUNCT
iajs-3630	166	8	carnethon	carnethon	VERB
iajs-3630	166	9	mr	mr	PROPN
iajs-3630	166	10	,	,	PUNCT
iajs-3630	166	11	launer	launer	NOUN
iajs-3630	166	12	lj	lj	PROPN
iajs-3630	166	13	,	,	PUNCT
iajs-3630	166	14	stehouwer	stehouwer	PROPN
iajs-3630	166	15	cd	cd	PROPN
iajs-3630	166	16	.	.	PROPN
iajs-3630	167	1	cerebral	cerebral	ADJ
iajs-3630	167	2	microvascular	microvascular	ADJ
iajs-3630	167	3	complications	complication	NOUN
iajs-3630	167	4	of	of	ADP
iajs-3630	167	5	type	type	NOUN
iajs-3630	167	6	2	2	NUM
iajs-3630	167	7	diabetes	diabetes	NOUN
iajs-3630	167	8	:	:	PUNCT
iajs-3630	167	9	stroke	stroke	NOUN
iajs-3630	167	10	,	,	PUNCT
iajs-3630	167	11	cognitive	cognitive	ADJ
iajs-3630	167	12	dysfunction	dysfunction	NOUN
iajs-3630	167	13	,	,	PUNCT
iajs-3630	167	14	and	and	CCONJ
iajs-3630	167	15	depression	depression	NOUN
iajs-3630	167	16	.	.	PUNCT
iajs-3630	168	1	lancet	lancet	NOUN
iajs-3630	168	2	diabetes	diabetes	NOUN
iajs-3630	168	3	endocrinol	endocrinol	NOUN
iajs-3630	168	4	.	.	PUNCT
iajs-3630	169	1	2020	2020	NUM
iajs-3630	169	2	;	;	PUNCT
iajs-3630	169	3	8(4):325	8(4):325	NUM
iajs-3630	169	4	-	-	SYM
iajs-3630	169	5	336	336	NUM
iajs-3630	169	6	.	.	PUNCT
iajs-3630	170	1	https://doi.org/10.1016/s2213-8587(19)30405-x	https://doi.org/10.1016/s2213-8587(19)30405-x	PROPN
iajs-3630	170	2	khan	khan	PROPN
iajs-3630	170	3	rmm	rmm	PROPN
iajs-3630	170	4	,	,	PUNCT
iajs-3630	170	5	chua	chua	PROPN
iajs-3630	170	6	zjy	zjy	PROPN
iajs-3630	170	7	,	,	PUNCT
iajs-3630	170	8	tan	tan	PROPN
iajs-3630	170	9	jc	jc	PROPN
iajs-3630	170	10	,	,	PUNCT
iajs-3630	170	11	yang	yang	PROPN
iajs-3630	170	12	y	y	PROPN
iajs-3630	170	13	,	,	PUNCT
iajs-3630	170	14	liao	liao	PROPN
iajs-3630	170	15	z	z	PROPN
iajs-3630	170	16	,	,	PUNCT
iajs-3630	170	17	zhao	zhao	PROPN
iajs-3630	170	18	y.	y.	PROPN
iajs-3630	170	19	from	from	ADP
iajs-3630	170	20	pre	pre	ADJ
iajs-3630	170	21	-	-	NOUN
iajs-3630	170	22	diabetes	diabetes	NOUN
iajs-3630	170	23	to	to	ADP
iajs-3630	170	24	diabetes	diabetes	NOUN
iajs-3630	170	25	:	:	PUNCT
iajs-3630	170	26	diagnosis	diagnosis	NOUN
iajs-3630	170	27	,	,	PUNCT
iajs-3630	170	28	treatments	treatment	NOUN
iajs-3630	170	29	,	,	PUNCT
iajs-3630	170	30	and	and	CCONJ
iajs-3630	170	31	translational	translational	ADJ
iajs-3630	170	32	research	research	NOUN
iajs-3630	170	33	.	.	PUNCT
iajs-3630	171	1	medicina	medicina	PROPN
iajs-3630	171	2	(	(	PUNCT
iajs-3630	171	3	kaunas	kaunas	PROPN
iajs-3630	171	4	)	)	PUNCT
iajs-3630	171	5	.	.	PUNCT
iajs-3630	172	1	2019	2019	NUM
iajs-3630	172	2	;	;	PUNCT
iajs-3630	172	3	55(9):546	55(9):546	NUM
iajs-3630	172	4	.	.	PUNCT
iajs-3630	173	1	https://doi.org/10.3390/medicina55090546	https://doi.org/10.3390/medicina55090546	PROPN
iajs-3630	173	2	2	2	NUM
iajs-3630	173	3	.	.	PUNCT
iajs-3630	173	4	khaleel	khaleel	PROPN
iajs-3630	173	5	fm	fm	PROPN
iajs-3630	173	6	,	,	PUNCT
iajs-3630	173	7	murtadha	murtadha	PROPN
iajs-3630	173	8	jh	jh	PROPN
iajs-3630	173	9	,	,	PUNCT
iajs-3630	173	10	abdulrazzaq	abdulrazzaq	PROPN
iajs-3630	173	11	h.	h.	PROPN
iajs-3630	173	12	estimation	estimation	NOUN
iajs-3630	173	13	of	of	ADP
iajs-3630	173	14	blood	blood	NOUN
iajs-3630	173	15	(	(	PUNCT
iajs-3630	173	16	tg	tg	PROPN
iajs-3630	173	17	,	,	PUNCT
iajs-3630	173	18	tc	tc	NOUN
iajs-3630	173	19	,	,	PUNCT
iajs-3630	173	20	and	and	CCONJ
iajs-3630	173	21	ldl	ldl	NOUN
iajs-3630	173	22	)	)	PUNCT
iajs-3630	173	23	as	as	ADP
iajs-3630	173	24	markers	marker	NOUN
iajs-3630	173	25	of	of	ADP
iajs-3630	173	26	lipid	lipid	NOUN
iajs-3630	173	27	profile	profile	NOUN
iajs-3630	173	28	and	and	CCONJ
iajs-3630	173	29	urea	urea	NOUN
iajs-3630	173	30	,	,	PUNCT
iajs-3630	173	31	uric	uric	ADJ
iajs-3630	173	32	acid	acid	NOUN
iajs-3630	173	33	,	,	PUNCT
iajs-3630	173	34	and	and	CCONJ
iajs-3630	173	35	creatinine	creatinine	NOUN
iajs-3630	173	36	as	as	ADP
iajs-3630	173	37	markers	marker	NOUN
iajs-3630	173	38	of	of	ADP
iajs-3630	173	39	kidney	kidney	NOUN
iajs-3630	173	40	function	function	NOUN
iajs-3630	173	41	in	in	ADP
iajs-3630	173	42	diabetic	diabetic	ADJ
iajs-3630	173	43	patients	patient	NOUN
iajs-3630	173	44	.	.	PUNCT
iajs-3630	174	1	res	re	NOUN
iajs-3630	174	2	j	j	PROPN
iajs-3630	174	3	pharm	pharm	PROPN
iajs-3630	174	4	biol	biol	PROPN
iajs-3630	174	5	chem	chem	PROPN
iajs-3630	174	6	sci	sci	PROPN
iajs-3630	174	7	.	.	PROPN
iajs-3630	174	8	2019	2019	NUM
iajs-3630	174	9	;	;	PUNCT
iajs-3630	174	10	10(1):79	10(1):79	NUM
iajs-3630	174	11	-	-	SYM
iajs-3630	174	12	84	84	NUM
iajs-3630	174	13	.	.	PUNCT
iajs-3630	175	1	https://www.researchgate.net/publication/345877333	https://www.researchgate.net/publication/345877333	PROPN
iajs-3630	175	2	3	3	NUM
iajs-3630	175	3	.	.	PUNCT
iajs-3630	175	4	han	han	PROPN
iajs-3630	175	5	ym	ym	PROPN
iajs-3630	175	6	,	,	PUNCT
iajs-3630	175	7	yang	yang	PROPN
iajs-3630	175	8	h	h	PROPN
iajs-3630	175	9	,	,	PUNCT
iajs-3630	175	10	huang	huang	PROPN
iajs-3630	175	11	ql	ql	PROPN
iajs-3630	175	12	,	,	PUNCT
iajs-3630	175	13	sun	sun	PROPN
iajs-3630	175	14	zj	zj	PROPN
iajs-3630	175	15	,	,	PUNCT
iajs-3630	175	16	li	li	PROPN
iajs-3630	175	17	ml	ml	PROPN
iajs-3630	175	18	,	,	PUNCT
iajs-3630	175	19	zhang	zhang	PROPN
iajs-3630	175	20	jb	jb	PROPN
iajs-3630	175	21	,	,	PUNCT
iajs-3630	175	22	deng	deng	PROPN
iajs-3630	175	23	kj	kj	PROPN
iajs-3630	175	24	,	,	PUNCT
iajs-3630	175	25	chen	chen	PROPN
iajs-3630	175	26	s	s	PROPN
iajs-3630	175	27	,	,	PUNCT
iajs-3630	175	28	lin	lin	PROPN
iajs-3630	175	29	h.	h.	PROPN
iajs-3630	175	30	risk	risk	NOUN
iajs-3630	175	31	prediction	prediction	NOUN
iajs-3630	175	32	of	of	ADP
iajs-3630	175	33	diabetes	diabetes	NOUN
iajs-3630	175	34	and	and	CCONJ
iajs-3630	175	35	pre	pre	NOUN
iajs-3630	175	36	-	-	NOUN
iajs-3630	175	37	diabetes	diabetes	NOUN
iajs-3630	175	38	based	base	VERB
iajs-3630	175	39	on	on	ADP
iajs-3630	175	40	physical	physical	ADJ
iajs-3630	175	41	examination	examination	NOUN
iajs-3630	175	42	data	datum	NOUN
iajs-3630	175	43	.	.	PUNCT
iajs-3630	176	1	math	math	PROPN
iajs-3630	176	2	biosci	biosci	PROPN
iajs-3630	176	3	eng	eng	PROPN
iajs-3630	176	4	.	.	PUNCT
iajs-3630	177	1	2022;19(4):35973600	2022;19(4):35973600	NUM
iajs-3630	177	2	.	.	PUNCT
iajs-3630	178	1	https://doi.org/10.3934/mbe.2022166	https://doi.org/10.3934/mbe.2022166	ADJ
iajs-3630	178	2	4	4	NUM
iajs-3630	178	3	.	.	PUNCT
iajs-3630	178	4	farhan	farhan	PROPN
iajs-3630	178	5	lo	lo	PROPN
iajs-3630	178	6	.	.	PUNCT
iajs-3630	179	1	determination	determination	NOUN
iajs-3630	179	2	of	of	ADP
iajs-3630	179	3	several	several	ADJ
iajs-3630	179	4	biochemical	biochemical	ADJ
iajs-3630	179	5	parameters	parameter	NOUN
iajs-3630	179	6	in	in	ADP
iajs-3630	179	7	sera	sera	NOUN
iajs-3630	179	8	of	of	ADP
iajs-3630	179	9	iraqi	iraqi	ADJ
iajs-3630	179	10	patients	patient	NOUN
iajs-3630	179	11	with	with	ADP
iajs-3630	179	12	type	type	NOUN
iajs-3630	179	13	2	2	NUM
iajs-3630	179	14	diabetes	diabetes	NOUN
iajs-3630	179	15	.	.	PUNCT
iajs-3630	180	1	baghdad	baghdad	PROPN
iajs-3630	180	2	sci	sci	PROPN
iajs-3630	180	3	j.	j.	PROPN
iajs-3630	180	4	2015	2015	NUM
iajs-3630	180	5	;	;	PUNCT
iajs-3630	180	6	12(2):362	12(2):362	NUM
iajs-3630	180	7	-	-	SYM
iajs-3630	180	8	370	370	NUM
iajs-3630	180	9	.	.	PUNCT
iajs-3630	181	1	https://doi.org/10.21123/bsj.12.2.362.370	https://doi.org/10.21123/bsj.12.2.362.370	PROPN
iajs-3630	181	2	https://doi.org/10.1016/s2213-8587(19)30405-x	https://doi.org/10.1016/s2213-8587(19)30405-x	PROPN
iajs-3630	181	3	https://doi.org/10.3390/medicina55090546	https://doi.org/10.3390/medicina55090546	PROPN
iajs-3630	181	4	.	.	PUNCT
iajs-3630	182	1	https://www.researchgate.net/publication/345877333	https://www.researchgate.net/publication/345877333	NOUN
iajs-3630	182	2	.	.	PUNCT
iajs-3630	183	1	https://doi.org/10.3934/mbe.2022166	https://doi.org/10.3934/mbe.2022166	PROPN
iajs-3630	183	2	.	.	PUNCT
iajs-3630	184	1	https://doi.org/10.21123/bsj.12.2.362.370	https://doi.org/10.21123/bsj.12.2.362.370	PROPN
iajs-3630	184	2	https://doi.org/10.21123/bsj.12.2.362.370	https://doi.org/10.21123/bsj.12.2.362.370	PROPN
iajs-3630	184	3	ihjpas	ihjpas	PROPN
iajs-3630	184	4	.	.	PUNCT
iajs-3630	185	1	2025	2025	NUM
iajs-3630	185	2	,	,	PUNCT
iajs-3630	185	3	38	38	NUM
iajs-3630	185	4	(	(	PUNCT
iajs-3630	185	5	1	1	NUM
iajs-3630	185	6	)	)	PUNCT
iajs-3630	185	7	311	311	NUM
iajs-3630	185	8	5	5	NUM
iajs-3630	185	9	.	.	PUNCT
iajs-3630	186	1	hamid	hamid	PROPN
iajs-3630	186	2	gs	gs	PROPN
iajs-3630	186	3	,	,	PUNCT
iajs-3630	186	4	allawi	allawi	ADJ
iajs-3630	186	5	aa	aa	NOUN
iajs-3630	186	6	,	,	PUNCT
iajs-3630	186	7	ghudhaib	ghudhaib	PROPN
iajs-3630	186	8	kk	kk	PROPN
iajs-3630	186	9	.	.	PROPN
iajs-3630	186	10	correlation	correlation	NOUN
iajs-3630	186	11	of	of	ADP
iajs-3630	186	12	pentosidine	pentosidine	NOUN
iajs-3630	186	13	with	with	ADP
iajs-3630	186	14	kidney	kidney	NOUN
iajs-3630	186	15	diseases	disease	NOUN
iajs-3630	186	16	in	in	ADP
iajs-3630	186	17	iraqi	iraqi	ADJ
iajs-3630	186	18	patients	patient	NOUN
iajs-3630	186	19	with	with	ADP
iajs-3630	186	20	diabetic	diabetic	ADJ
iajs-3630	186	21	nephropathy	nephropathy	NOUN
iajs-3630	186	22	.	.	PUNCT
iajs-3630	187	1	iraqi	iraqi	ADJ
iajs-3630	187	2	j	j	PROPN
iajs-3630	187	3	sci	sci	PROPN
iajs-3630	187	4	.	.	PROPN
iajs-3630	187	5	2021	2021	NUM
iajs-3630	187	6	;	;	PUNCT
iajs-3630	187	7	62:34363442.https://doi.org/10.24996	62:34363442.https://doi.org/10.24996	X
iajs-3630	187	8	/	/	SYM
iajs-3630	187	9	ijs.2021.62.10.2	ijs.2021.62.10.2	NOUN
iajs-3630	187	10	6	6	NUM
iajs-3630	187	11	.	.	X
iajs-3630	187	12	salman	salman	PROPN
iajs-3630	187	13	za	za	PROPN
iajs-3630	187	14	,	,	PUNCT
iajs-3630	187	15	ghudhaib	ghudhaib	PROPN
iajs-3630	187	16	kk	kk	PROPN
iajs-3630	187	17	.	.	PROPN
iajs-3630	187	18	association	association	PROPN
iajs-3630	187	19	of	of	ADP
iajs-3630	187	20	osteopontin	osteopontin	PROPN
iajs-3630	187	21	and	and	CCONJ
iajs-3630	187	22	alkaline	alkaline	ADJ
iajs-3630	187	23	phosphatase	phosphatase	NOUN
iajs-3630	187	24	in	in	ADP
iajs-3630	187	25	male	male	ADJ
iajs-3630	187	26	patients	patient	NOUN
iajs-3630	187	27	with	with	ADP
iajs-3630	187	28	diabetes	diabetes	NOUN
iajs-3630	187	29	mellitus	mellitus	NOUN
iajs-3630	187	30	type	type	VERB
iajs-3630	187	31	2	2	NUM
iajs-3630	187	32	and	and	CCONJ
iajs-3630	187	33	periodontitis	periodontitis	NOUN
iajs-3630	187	34	.	.	PUNCT
iajs-3630	188	1	iran	iran	PROPN
iajs-3630	188	2	j	j	PROPN
iajs-3630	188	3	war	war	PROPN
iajs-3630	188	4	public	public	ADJ
iajs-3630	188	5	health	health	NOUN
iajs-3630	188	6	.	.	PUNCT
iajs-3630	189	1	2022	2022	NUM
iajs-3630	189	2	;	;	PUNCT
iajs-3630	189	3	14(1):105	14(1):105	NUM
iajs-3630	189	4	-	-	PUNCT
iajs-3630	189	5	109	109	NUM
iajs-3630	189	6	.	.	PUNCT
iajs-3630	190	1	https://doi.org/10.29252/ijwph.14.1.105	https://doi.org/10.29252/ijwph.14.1.105	PROPN
iajs-3630	190	2	7	7	NUM
iajs-3630	190	3	.	.	PROPN
iajs-3630	190	4	salman	salman	PROPN
iajs-3630	190	5	za	za	PROPN
iajs-3630	190	6	,	,	PUNCT
iajs-3630	190	7	ghudhaib	ghudhaib	VERB
iajs-3630	190	8	kk	kk	PROPN
iajs-3630	190	9	,	,	PUNCT
iajs-3630	190	10	fadhil	fadhil	PROPN
iajs-3630	190	11	r.	r.	PROPN
iajs-3630	190	12	evaluating	evaluate	VERB
iajs-3630	190	13	osteocalcin	osteocalcin	PROPN
iajs-3630	190	14	and	and	CCONJ
iajs-3630	190	15	osteonectin	osteonectin	VERB
iajs-3630	190	16	in	in	ADP
iajs-3630	190	17	serum	serum	NOUN
iajs-3630	190	18	of	of	ADP
iajs-3630	190	19	male	male	ADJ
iajs-3630	190	20	patients	patient	NOUN
iajs-3630	190	21	with	with	ADP
iajs-3630	190	22	type	type	NOUN
iajs-3630	190	23	2	2	NUM
iajs-3630	190	24	diabetes	diabetes	NOUN
iajs-3630	190	25	mellitus	mellitus	NOUN
iajs-3630	190	26	and	and	CCONJ
iajs-3630	190	27	periodontitis	periodontitis	NOUN
iajs-3630	190	28	.	.	PUNCT
iajs-3630	191	1	eurasian	eurasian	ADJ
iajs-3630	191	2	chem	chem	PROPN
iajs-3630	191	3	commun	commun	PROPN
iajs-3630	191	4	.	.	PUNCT
iajs-3630	192	1	2022	2022	NUM
iajs-3630	192	2	;	;	PUNCT
iajs-3630	192	3	4(4):295	4(4):295	NUM
iajs-3630	192	4	-	-	SYM
iajs-3630	192	5	302	302	NUM
iajs-3630	192	6	.	.	PUNCT
iajs-3630	193	1	https://doi.org/10.22034/ecc.2022.325049.1307	https://doi.org/10.22034/ecc.2022.325049.1307	SYM
iajs-3630	193	2	8	8	NUM
iajs-3630	193	3	.	.	PUNCT
iajs-3630	194	1	shabir	shabir	PROPN
iajs-3630	194	2	k	k	PROPN
iajs-3630	194	3	,	,	PUNCT
iajs-3630	194	4	brown	brown	PROPN
iajs-3630	194	5	je	je	PROPN
iajs-3630	194	6	,	,	PUNCT
iajs-3630	194	7	afzal	afzal	PROPN
iajs-3630	194	8	i	i	PRON
iajs-3630	194	9	,	,	PUNCT
iajs-3630	194	10	gharanei	gharanei	VERB
iajs-3630	194	11	s	s	PROPN
iajs-3630	194	12	,	,	PUNCT
iajs-3630	194	13	weickert	weickert	PROPN
iajs-3630	194	14	mo	mo	PROPN
iajs-3630	194	15	,	,	PUNCT
iajs-3630	194	16	barber	barber	PROPN
iajs-3630	194	17	tm	tm	PROPN
iajs-3630	194	18	,	,	PUNCT
iajs-3630	194	19	kyrou	kyrou	PROPN
iajs-3630	195	1	i	i	PROPN
iajs-3630	195	2	,	,	PUNCT
iajs-3630	195	3	randeva	randeva	VERB
iajs-3630	195	4	hs	hs	PROPN
iajs-3630	195	5	.	.	PROPN
iajs-3630	195	6	asprosin	asprosin	PROPN
iajs-3630	195	7	,	,	PUNCT
iajs-3630	195	8	a	a	DET
iajs-3630	195	9	novel	novel	ADJ
iajs-3630	195	10	pleiotropic	pleiotropic	ADJ
iajs-3630	195	11	adipokine	adipokine	NOUN
iajs-3630	195	12	implicated	implicate	VERB
iajs-3630	195	13	in	in	ADP
iajs-3630	195	14	fasting	fasting	NOUN
iajs-3630	195	15	and	and	CCONJ
iajs-3630	195	16	obesity	obesity	NOUN
iajs-3630	195	17	-	-	PUNCT
iajs-3630	195	18	related	relate	VERB
iajs-3630	195	19	cardio	cardio	NOUN
iajs-3630	195	20	-	-	PUNCT
iajs-3630	195	21	metabolic	metabolic	NOUN
iajs-3630	195	22	disease	disease	NOUN
iajs-3630	195	23	:	:	PUNCT
iajs-3630	195	24	comprehensive	comprehensive	ADJ
iajs-3630	195	25	review	review	NOUN
iajs-3630	195	26	of	of	ADP
iajs-3630	195	27	preclinical	preclinical	ADJ
iajs-3630	195	28	and	and	CCONJ
iajs-3630	195	29	clinical	clinical	ADJ
iajs-3630	195	30	evidence	evidence	NOUN
iajs-3630	195	31	.	.	PUNCT
iajs-3630	196	1	cytokine	cytokine	ADJ
iajs-3630	196	2	growth	growth	NOUN
iajs-3630	196	3	factor	factor	NOUN
iajs-3630	196	4	rev	rev	VERB
iajs-3630	196	5	.	.	PROPN
iajs-3630	196	6	2021	2021	NUM
iajs-3630	196	7	;	;	PUNCT
iajs-3630	197	1	60	60	NUM
iajs-3630	197	2	:	:	SYM
iajs-3630	197	3	120	120	NUM
iajs-3630	197	4	-	-	SYM
iajs-3630	197	5	132	132	NUM
iajs-3630	197	6	.	.	PUNCT
iajs-3630	197	7	https://doi.org/10.1016/j.cytogfr.2021.05.002	https://doi.org/10.1016/j.cytogfr.2021.05.002	NOUN
iajs-3630	197	8	9	9	NUM
iajs-3630	197	9	.	.	PUNCT
iajs-3630	198	1	miao	miao	PROPN
iajs-3630	198	2	z	z	PROPN
iajs-3630	198	3	,	,	PUNCT
iajs-3630	198	4	alvarez	alvarez	PROPN
iajs-3630	198	5	m	m	PROPN
iajs-3630	198	6	,	,	PUNCT
iajs-3630	198	7	ko	ko	PROPN
iajs-3630	198	8	a	a	PROPN
iajs-3630	198	9	,	,	PUNCT
iajs-3630	198	10	bhagat	bhagat	PROPN
iajs-3630	198	11	y	y	PROPN
iajs-3630	198	12	,	,	PUNCT
iajs-3630	198	13	rahmani	rahmani	X
iajs-3630	198	14	e	e	NOUN
iajs-3630	198	15	,	,	PUNCT
iajs-3630	198	16	jew	jew	PROPN
iajs-3630	198	17	b	b	PROPN
iajs-3630	198	18	,	,	PUNCT
iajs-3630	198	19	heinonen	heinonen	PROPN
iajs-3630	198	20	s	s	PROPN
iajs-3630	198	21	,	,	PUNCT
iajs-3630	198	22	munoz	munoz	PROPN
iajs-3630	198	23	-	-	PUNCT
iajs-3630	198	24	hernandez	hernandez	PROPN
iajs-3630	198	25	ll	ll	PROPN
iajs-3630	198	26	,	,	PUNCT
iajs-3630	198	27	herrerahernandez	herrerahernandez	PROPN
iajs-3630	198	28	m	m	PROPN
iajs-3630	198	29	,	,	PUNCT
iajs-3630	198	30	aguilar	aguilar	PROPN
iajs-3630	198	31	-	-	PUNCT
iajs-3630	198	32	salinas	salinas	PROPN
iajs-3630	198	33	c	c	PROPN
iajs-3630	198	34	,	,	PUNCT
iajs-3630	198	35	tusie	tusie	PROPN
iajs-3630	198	36	-	-	PUNCT
iajs-3630	198	37	luna	luna	PROPN
iajs-3630	198	38	t.	t.	PROPN
iajs-3630	198	39	the	the	DET
iajs-3630	198	40	causal	causal	ADJ
iajs-3630	198	41	effect	effect	NOUN
iajs-3630	198	42	of	of	ADP
iajs-3630	198	43	obesity	obesity	NOUN
iajs-3630	198	44	on	on	ADP
iajs-3630	198	45	prediabetes	prediabete	NOUN
iajs-3630	198	46	and	and	CCONJ
iajs-3630	198	47	insulin	insulin	NOUN
iajs-3630	198	48	resistance	resistance	NOUN
iajs-3630	198	49	reveals	reveal	VERB
iajs-3630	198	50	the	the	DET
iajs-3630	198	51	important	important	ADJ
iajs-3630	198	52	role	role	NOUN
iajs-3630	198	53	of	of	ADP
iajs-3630	198	54	adipose	adipose	ADJ
iajs-3630	198	55	tissue	tissue	NOUN
iajs-3630	198	56	in	in	ADP
iajs-3630	198	57	insulin	insulin	NOUN
iajs-3630	198	58	resistance	resistance	NOUN
iajs-3630	198	59	.	.	PUNCT
iajs-3630	199	1	plos	plos	PROPN
iajs-3630	199	2	genet	genet	PROPN
iajs-3630	199	3	.	.	PUNCT
iajs-3630	200	1	2020	2020	NUM
iajs-3630	200	2	;	;	PUNCT
iajs-3630	200	3	16(9):e1009018	16(9):e1009018	NUM
iajs-3630	200	4	.	.	PUNCT
iajs-3630	201	1	https://doi.org/10.1371/journal.pgen.1009018	https://doi.org/10.1371/journal.pgen.1009018	NOUN
iajs-3630	201	2	10	10	NUM
iajs-3630	201	3	.	.	PUNCT
iajs-3630	202	1	echouffo	echouffo	NOUN
iajs-3630	202	2	-	-	PUNCT
iajs-3630	202	3	tcheugui	tcheugui	PROPN
iajs-3630	202	4	jb	jb	PROPN
iajs-3630	202	5	,	,	PUNCT
iajs-3630	202	6	selvin	selvin	PROPN
iajs-3630	202	7	e.	e.	PROPN
iajs-3630	202	8	prediabetes	prediabetes	PROPN
iajs-3630	202	9	and	and	CCONJ
iajs-3630	202	10	what	what	PRON
iajs-3630	202	11	it	it	PRON
iajs-3630	202	12	means	mean	VERB
iajs-3630	202	13	:	:	PUNCT
iajs-3630	202	14	the	the	DET
iajs-3630	202	15	epidemiological	epidemiological	ADJ
iajs-3630	202	16	evidence	evidence	NOUN
iajs-3630	202	17	.	.	PUNCT
iajs-3630	203	1	annu	annu	NOUN
iajs-3630	203	2	rev	rev	VERB
iajs-3630	203	3	public	public	ADJ
iajs-3630	203	4	health	health	NOUN
iajs-3630	203	5	.	.	PUNCT
iajs-3630	204	1	2021	2021	NUM
iajs-3630	204	2	;	;	PUNCT
iajs-3630	204	3	42(1):59	42(1):59	PROPN
iajs-3630	204	4	-	-	NOUN
iajs-3630	204	5	77	77	NUM
iajs-3630	204	6	.	.	PUNCT
iajs-3630	205	1	https://doi.org/10.1146/annurev-publhealth-090419-102644	https://doi.org/10.1146/annurev-publhealth-090419-102644	PROPN
iajs-3630	205	2	11	11	NUM
iajs-3630	205	3	.	.	PUNCT
iajs-3630	206	1	zheng	zheng	PROPN
iajs-3630	206	2	y	y	PROPN
iajs-3630	206	3	,	,	PUNCT
iajs-3630	206	4	ley	ley	VERB
iajs-3630	206	5	sh	sh	PROPN
iajs-3630	206	6	,	,	PUNCT
iajs-3630	206	7	hu	hu	PROPN
iajs-3630	207	1	fb	fb	INTJ
iajs-3630	207	2	.	.	PUNCT
iajs-3630	207	3	global	global	ADJ
iajs-3630	207	4	aetiology	aetiology	NOUN
iajs-3630	207	5	and	and	CCONJ
iajs-3630	207	6	epidemiology	epidemiology	NOUN
iajs-3630	207	7	of	of	ADP
iajs-3630	207	8	type	type	NOUN
iajs-3630	207	9	2	2	NUM
iajs-3630	207	10	diabetes	diabetes	NOUN
iajs-3630	207	11	mellitus	mellitus	NOUN
iajs-3630	207	12	and	and	CCONJ
iajs-3630	207	13	its	its	PRON
iajs-3630	207	14	complications	complication	NOUN
iajs-3630	207	15	.	.	PUNCT
iajs-3630	208	1	nat	nat	PROPN
iajs-3630	208	2	rev	rev	PROPN
iajs-3630	208	3	endocrinol	endocrinol	NOUN
iajs-3630	208	4	.	.	PUNCT
iajs-3630	208	5	2018	2018	NUM
iajs-3630	208	6	;	;	PUNCT
iajs-3630	208	7	14(2):88	14(2):88	NUM
iajs-3630	208	8	-	-	SYM
iajs-3630	208	9	98	98	NUM
iajs-3630	208	10	.	.	PUNCT
iajs-3630	209	1	https://doi.org/10.1038/nrendo.2017.151	https://doi.org/10.1038/nrendo.2017.151	PROPN
iajs-3630	209	2	12	12	NUM
iajs-3630	209	3	.	.	PUNCT
iajs-3630	210	1	liu	liu	PROPN
iajs-3630	210	2	r	r	PROPN
iajs-3630	210	3	,	,	PUNCT
iajs-3630	210	4	zhang	zhang	PROPN
iajs-3630	210	5	q	q	PROPN
iajs-3630	210	6	,	,	PUNCT
iajs-3630	210	7	peng	peng	PROPN
iajs-3630	210	8	n	n	CCONJ
iajs-3630	210	9	,	,	PUNCT
iajs-3630	210	10	xu	xu	PROPN
iajs-3630	210	11	s	s	PROPN
iajs-3630	210	12	,	,	PUNCT
iajs-3630	210	13	zhang	zhang	PROPN
iajs-3630	210	14	m	m	PROPN
iajs-3630	210	15	,	,	PUNCT
iajs-3630	210	16	hu	hu	PROPN
iajs-3630	210	17	y	y	PROPN
iajs-3630	210	18	,	,	PUNCT
iajs-3630	210	19	chen	chen	PROPN
iajs-3630	210	20	z	z	PROPN
iajs-3630	210	21	,	,	PUNCT
iajs-3630	210	22	tang	tang	PROPN
iajs-3630	211	1	k	k	NOUN
iajs-3630	211	2	,	,	PUNCT
iajs-3630	211	3	he	he	PRON
iajs-3630	211	4	x	x	PROPN
iajs-3630	211	5	,	,	PUNCT
iajs-3630	211	6	li	li	PROPN
iajs-3630	211	7	y	y	PROPN
iajs-3630	211	8	,	,	PUNCT
iajs-3630	211	9	shi	shi	PROPN
iajs-3630	211	10	l.	l.	PROPN
iajs-3630	211	11	inverse	inverse	PROPN
iajs-3630	211	12	correlation	correlation	NOUN
iajs-3630	211	13	between	between	ADP
iajs-3630	211	14	serum	serum	NOUN
iajs-3630	211	15	irisin	irisin	NOUN
iajs-3630	211	16	and	and	CCONJ
iajs-3630	211	17	cardiovascular	cardiovascular	ADJ
iajs-3630	211	18	risk	risk	NOUN
iajs-3630	211	19	factors	factor	NOUN
iajs-3630	211	20	among	among	ADP
iajs-3630	211	21	chinese	chinese	ADJ
iajs-3630	211	22	overweight	overweight	ADJ
iajs-3630	211	23	/	/	SYM
iajs-3630	211	24	obese	obese	ADJ
iajs-3630	211	25	population	population	NOUN
iajs-3630	211	26	.	.	PUNCT
iajs-3630	212	1	bmc	bmc	PROPN
iajs-3630	212	2	cardiovasc	cardiovasc	PROPN
iajs-3630	212	3	disord	disord	PROPN
iajs-3630	212	4	.	.	PUNCT
iajs-3630	213	1	2021	2021	NUM
iajs-3630	213	2	;	;	PUNCT
iajs-3630	213	3	21:1	21:1	NUM
iajs-3630	213	4	-	-	SYM
iajs-3630	213	5	8	8	NUM
iajs-3630	213	6	.	.	PUNCT
iajs-3630	214	1	https://doi.org/10.1186/s12872-021-02380-0	https://doi.org/10.1186/s12872-021-02380-0	ADJ
iajs-3630	214	2	13	13	NUM
iajs-3630	214	3	.	.	PUNCT
iajs-3630	215	1	zaki	zaki	PROPN
iajs-3630	215	2	m	m	PROPN
iajs-3630	215	3	,	,	PUNCT
iajs-3630	215	4	abdallah	abdallah	PROPN
iajs-3630	215	5	hr	hr	PROPN
iajs-3630	215	6	,	,	PUNCT
iajs-3630	215	7	el	el	PROPN
iajs-3630	215	8	-	-	PUNCT
iajs-3630	215	9	bassyouni	bassyouni	PROPN
iajs-3630	215	10	ht	ht	PROPN
iajs-3630	215	11	,	,	PUNCT
iajs-3630	215	12	tawfeek	tawfeek	PROPN
iajs-3630	215	13	hm	hm	INTJ
iajs-3630	215	14	,	,	PUNCT
iajs-3630	215	15	hanna	hanna	PROPN
iajs-3630	215	16	h	h	PROPN
iajs-3630	215	17	,	,	PUNCT
iajs-3630	215	18	ashour	ashour	PROPN
iajs-3630	215	19	mn	mn	PROPN
iajs-3630	215	20	,	,	PUNCT
iajs-3630	215	21	youness	youness	NOUN
iajs-3630	215	22	er	er	INTJ
iajs-3630	215	23	.	.	PUNCT
iajs-3630	216	1	circulating	circulate	VERB
iajs-3630	216	2	irisin	irisin	NOUN
iajs-3630	216	3	in	in	ADP
iajs-3630	216	4	relation	relation	NOUN
iajs-3630	216	5	to	to	ADP
iajs-3630	216	6	obesity	obesity	NOUN
iajs-3630	216	7	and	and	CCONJ
iajs-3630	216	8	anorexia	anorexia	ADJ
iajs-3630	216	9	nervosa	nervosa	NOUN
iajs-3630	216	10	in	in	ADP
iajs-3630	216	11	patients	patient	NOUN
iajs-3630	216	12	with	with	ADP
iajs-3630	216	13	type	type	NOUN
iajs-3630	216	14	2	2	NUM
iajs-3630	216	15	diabetes	diabetes	NOUN
iajs-3630	216	16	.	.	PUNCT
iajs-3630	217	1	egypt	egypt	PROPN
iajs-3630	217	2	j	j	PROPN
iajs-3630	217	3	chem	chem	PROPN
iajs-3630	217	4	.	.	PUNCT
iajs-3630	218	1	2022	2022	NUM
iajs-3630	218	2	;	;	PUNCT
iajs-3630	218	3	65(12):175	65(12):175	NUM
iajs-3630	218	4	-	-	SYM
iajs-3630	218	5	180	180	NUM
iajs-3630	218	6	.	.	PUNCT
iajs-3630	219	1	https://doi.org/10.21608/ejchem.2022.112977.5143	https://doi.org/10.21608/ejchem.2022.112977.5143	NOUN
iajs-3630	219	2	14	14	NUM
iajs-3630	219	3	.	.	PUNCT
iajs-3630	220	1	al	al	PROPN
iajs-3630	220	2	-	-	PUNCT
iajs-3630	220	3	attaby	attaby	PROPN
iajs-3630	220	4	ak	ak	PROPN
iajs-3630	220	5	,	,	PUNCT
iajs-3630	220	6	al	al	PROPN
iajs-3630	220	7	-	-	PUNCT
iajs-3630	220	8	lami	lami	PROPN
iajs-3630	220	9	mq	mq	PROPN
iajs-3630	220	10	.	.	PROPN
iajs-3630	220	11	effect	effect	NOUN
iajs-3630	220	12	of	of	ADP
iajs-3630	220	13	age	age	NOUN
iajs-3630	220	14	and	and	CCONJ
iajs-3630	220	15	gender	gender	NOUN
iajs-3630	220	16	on	on	ADP
iajs-3630	220	17	some	some	DET
iajs-3630	220	18	biochemical	biochemical	ADJ
iajs-3630	220	19	,	,	PUNCT
iajs-3630	220	20	hormones	hormone	NOUN
iajs-3630	220	21	and	and	CCONJ
iajs-3630	220	22	adipocytokines	adipocytokine	NOUN
iajs-3630	220	23	parameters	parameter	NOUN
iajs-3630	220	24	in	in	ADP
iajs-3630	220	25	iraqi	iraqi	ADJ
iajs-3630	220	26	type	type	NOUN
iajs-3630	220	27	2	2	NUM
iajs-3630	220	28	diabetes	diabetes	NOUN
iajs-3630	220	29	mellitus	mellitus	NOUN
iajs-3630	220	30	patients	patient	NOUN
iajs-3630	220	31	.	.	PUNCT
iajs-3630	221	1	int	int	NOUN
iajs-3630	221	2	res	re	NOUN
iajs-3630	221	3	j	j	PROPN
iajs-3630	221	4	pharm	pharm	PROPN
iajs-3630	221	5	.	.	PUNCT
iajs-3630	222	1	2018	2018	NUM
iajs-3630	222	2	;	;	PUNCT
iajs-3630	223	1	9(12):5158	9(12):5158	X
iajs-3630	223	2	.	.	PUNCT
iajs-3630	224	1	https://doi.org/10.7897/2230-8407.0912286	https://doi.org/10.7897/2230-8407.0912286	PROPN
iajs-3630	224	2	15	15	NUM
iajs-3630	224	3	.	.	PUNCT
iajs-3630	225	1	lai	lai	PROPN
iajs-3630	225	2	y	y	PROPN
iajs-3630	225	3	,	,	PUNCT
iajs-3630	225	4	qi	qi	PROPN
iajs-3630	225	5	j	j	PROPN
iajs-3630	225	6	,	,	PUNCT
iajs-3630	225	7	tao	tao	PROPN
iajs-3630	225	8	x	x	PROPN
iajs-3630	225	9	,	,	PUNCT
iajs-3630	225	10	huang	huang	PROPN
iajs-3630	225	11	k	k	PROPN
iajs-3630	225	12	,	,	PUNCT
iajs-3630	225	13	yan	yan	PROPN
iajs-3630	225	14	s	s	PROPN
iajs-3630	225	15	,	,	PUNCT
iajs-3630	225	16	chen	chen	PROPN
iajs-3630	225	17	m	m	PROPN
iajs-3630	225	18	,	,	PUNCT
iajs-3630	225	19	hao	hao	PROPN
iajs-3630	225	20	j	j	PROPN
iajs-3630	225	21	,	,	PUNCT
iajs-3630	225	22	tao	tao	PROPN
iajs-3630	225	23	f.	f.	PROPN
iajs-3630	225	24	associations	association	NOUN
iajs-3630	225	25	of	of	ADP
iajs-3630	225	26	grandparental	grandparental	ADJ
iajs-3630	225	27	diabetes	diabetes	NOUN
iajs-3630	225	28	mellitus	mellitus	NOUN
iajs-3630	225	29	with	with	ADP
iajs-3630	225	30	grandchild	grandchild	ADJ
iajs-3630	225	31	bmi	bmi	NOUN
iajs-3630	225	32	status	status	NOUN
iajs-3630	225	33	.	.	PUNCT
iajs-3630	226	1	bmc	bmc	VERB
iajs-3630	226	2	public	public	ADJ
iajs-3630	226	3	health	health	NOUN
iajs-3630	226	4	.	.	PUNCT
iajs-3630	227	1	2019	2019	NUM
iajs-3630	227	2	;	;	PUNCT
iajs-3630	227	3	19:1	19:1	X
iajs-3630	227	4	-	-	SYM
iajs-3630	227	5	8	8	NUM
iajs-3630	227	6	.	.	PUNCT
iajs-3630	228	1	https://doi.org/10.1186/s12889-019-6485-y	https://doi.org/10.1186/s12889-019-6485-y	NOUN
iajs-3630	228	2	16	16	NUM
iajs-3630	228	3	.	.	PUNCT
iajs-3630	229	1	nuttall	nuttall	PROPN
iajs-3630	229	2	fq	fq	PROPN
iajs-3630	229	3	.	.	PROPN
iajs-3630	229	4	body	body	PROPN
iajs-3630	229	5	mass	mass	PROPN
iajs-3630	229	6	index	index	NOUN
iajs-3630	229	7	:	:	PUNCT
iajs-3630	229	8	obesity	obesity	NOUN
iajs-3630	229	9	,	,	PUNCT
iajs-3630	229	10	bmi	bmi	NOUN
iajs-3630	229	11	,	,	PUNCT
iajs-3630	229	12	and	and	CCONJ
iajs-3630	229	13	health	health	NOUN
iajs-3630	229	14	:	:	PUNCT
iajs-3630	229	15	a	a	DET
iajs-3630	229	16	critical	critical	ADJ
iajs-3630	229	17	review	review	NOUN
iajs-3630	229	18	.	.	PUNCT
iajs-3630	230	1	nutr	nutr	PROPN
iajs-3630	230	2	today	today	NOUN
iajs-3630	230	3	.	.	PROPN
iajs-3630	231	1	2015	2015	NUM
iajs-3630	231	2	;	;	PUNCT
iajs-3630	231	3	50(3	50(3	NUM
iajs-3630	231	4	):	):	PUNCT
iajs-3630	231	5	117	117	NUM
iajs-3630	231	6	-	-	SYM
iajs-3630	231	7	128	128	NUM
iajs-3630	231	8	.	.	PUNCT
iajs-3630	232	1	https://doi.org/10.1097/nt.0000000000000092	https://doi.org/10.1097/nt.0000000000000092	PROPN
iajs-3630	232	2	17	17	NUM
iajs-3630	232	3	.	.	PUNCT
iajs-3630	233	1	evers	evers	PROPN
iajs-3630	233	2	j	j	PROPN
iajs-3630	233	3	,	,	PUNCT
iajs-3630	233	4	grotenhuis	grotenhuis	PROPN
iajs-3630	233	5	aj	aj	PROPN
iajs-3630	233	6	,	,	PUNCT
iajs-3630	233	7	aben	aben	PROPN
iajs-3630	233	8	kk	kk	PROPN
iajs-3630	233	9	,	,	PUNCT
iajs-3630	233	10	kiemeney	kiemeney	PROPN
iajs-3630	233	11	la	la	PROPN
iajs-3630	233	12	,	,	PUNCT
iajs-3630	233	13	vrieling	vriele	VERB
iajs-3630	233	14	a.	a.	NOUN
iajs-3630	233	15	no	no	DET
iajs-3630	233	16	clear	clear	ADJ
iajs-3630	233	17	associations	association	NOUN
iajs-3630	233	18	of	of	ADP
iajs-3630	233	19	adult	adult	NOUN
iajs-3630	233	20	bmi	bmi	NOUN
iajs-3630	233	21	and	and	CCONJ
iajs-3630	233	22	diabetes	diabetes	NOUN
iajs-3630	233	23	mellitus	mellitus	NOUN
iajs-3630	233	24	with	with	ADP
iajs-3630	233	25	non	non	ADJ
iajs-3630	233	26	-	-	ADJ
iajs-3630	233	27	muscle	muscle	ADJ
iajs-3630	233	28	invasive	invasive	ADJ
iajs-3630	233	29	bladder	bladder	NOUN
iajs-3630	233	30	cancer	cancer	NOUN
iajs-3630	233	31	recurrence	recurrence	NOUN
iajs-3630	233	32	and	and	CCONJ
iajs-3630	233	33	progression	progression	NOUN
iajs-3630	233	34	.	.	PUNCT
iajs-3630	234	1	plos	plos	PROPN
iajs-3630	234	2	one	one	NUM
iajs-3630	234	3	.	.	PUNCT
iajs-3630	235	1	2020	2020	NUM
iajs-3630	235	2	;	;	PUNCT
iajs-3630	235	3	15(3):e0229384	15(3):e0229384	NUM
iajs-3630	235	4	.	.	PUNCT
iajs-3630	236	1	https://doi.org/10.1371/journal.pone.0229384	https://doi.org/10.1371/journal.pone.0229384	PROPN
iajs-3630	236	2	18	18	NUM
iajs-3630	236	3	.	.	PUNCT
iajs-3630	237	1	awasthi	awasthi	ADV
iajs-3630	237	2	a	a	PRON
iajs-3630	237	3	,	,	PUNCT
iajs-3630	237	4	rao	rao	PROPN
iajs-3630	237	5	cr	cr	PROPN
iajs-3630	237	6	,	,	PUNCT
iajs-3630	237	7	hegde	hegde	PROPN
iajs-3630	237	8	ds	ds	PROPN
iajs-3630	237	9	.	.	PROPN
iajs-3630	237	10	association	association	NOUN
iajs-3630	237	11	between	between	ADP
iajs-3630	237	12	type	type	NOUN
iajs-3630	237	13	2	2	NUM
iajs-3630	237	14	diabetes	diabetes	NOUN
iajs-3630	237	15	mellitus	mellitus	NOUN
iajs-3630	237	16	and	and	CCONJ
iajs-3630	237	17	anthropometric	anthropometric	ADJ
iajs-3630	237	18	measurements	measurement	NOUN
iajs-3630	237	19	:	:	PUNCT
iajs-3630	237	20	a	a	DET
iajs-3630	237	21	case	case	NOUN
iajs-3630	237	22	-	-	PUNCT
iajs-3630	237	23	control	control	NOUN
iajs-3630	237	24	study	study	NOUN
iajs-3630	237	25	in	in	ADP
iajs-3630	237	26	south	south	PROPN
iajs-3630	237	27	india	india	PROPN
iajs-3630	237	28	.	.	PUNCT
iajs-3630	238	1	j	j	PROPN
iajs-3630	238	2	prev	prev	PROPN
iajs-3630	238	3	med	med	PROPN
iajs-3630	238	4	hyg	hyg	PROPN
iajs-3630	238	5	.	.	PROPN
iajs-3630	238	6	2017	2017	NUM
iajs-3630	238	7	;	;	PUNCT
iajs-3630	238	8	58(1):e56	58(1):e56	NUM
iajs-3630	238	9	.	.	PUNCT
iajs-3630	239	1	https://doi.org/10.15167/2421-4248/jpmh2017.58.1.648	https://doi.org/10.15167/2421-4248/jpmh2017.58.1.648	NOUN
iajs-3630	239	2	19	19	NUM
iajs-3630	239	3	.	.	PUNCT
iajs-3630	240	1	sun	sun	PROPN
iajs-3630	240	2	y	y	PROPN
iajs-3630	240	3	,	,	PUNCT
iajs-3630	240	4	liu	liu	PROPN
iajs-3630	240	5	b	b	PROPN
iajs-3630	240	6	,	,	PUNCT
iajs-3630	240	7	snetselaar	snetselaar	NOUN
iajs-3630	240	8	lg	lg	NOUN
iajs-3630	240	9	,	,	PUNCT
iajs-3630	240	10	wallace	wallace	PROPN
iajs-3630	240	11	rb	rb	PROPN
iajs-3630	240	12	,	,	PUNCT
iajs-3630	240	13	caan	caan	PROPN
iajs-3630	240	14	bj	bj	PROPN
iajs-3630	240	15	,	,	PUNCT
iajs-3630	240	16	rohan	rohan	PROPN
iajs-3630	240	17	te	te	PROPN
iajs-3630	240	18	,	,	PUNCT
iajs-3630	240	19	bao	bao	PROPN
iajs-3630	240	20	w.	w.	PROPN
iajs-3630	240	21	association	association	PROPN
iajs-3630	240	22	of	of	ADP
iajs-3630	240	23	normal	normal	ADJ
iajs-3630	240	24	-	-	PUNCT
iajs-3630	240	25	weight	weight	NOUN
iajs-3630	240	26	central	central	ADJ
iajs-3630	240	27	obesity	obesity	NOUN
iajs-3630	240	28	with	with	ADP
iajs-3630	240	29	all	all	DET
iajs-3630	240	30	-	-	PUNCT
iajs-3630	240	31	cause	cause	NOUN
iajs-3630	240	32	and	and	CCONJ
iajs-3630	240	33	cause	cause	NOUN
iajs-3630	240	34	-	-	PUNCT
iajs-3630	240	35	specific	specific	ADJ
iajs-3630	240	36	mortality	mortality	NOUN
iajs-3630	240	37	among	among	ADP
iajs-3630	240	38	postmenopausal	postmenopausal	ADJ
iajs-3630	240	39	women	woman	NOUN
iajs-3630	240	40	.	.	PUNCT
iajs-3630	241	1	jama	jama	PROPN
iajs-3630	241	2	netw	netw	PROPN
iajs-3630	241	3	open	open	ADJ
iajs-3630	241	4	.	.	PUNCT
iajs-3630	242	1	2019	2019	NUM
iajs-3630	242	2	;	;	PUNCT
iajs-3630	242	3	2(7):e197337	2(7):e197337	X
iajs-3630	242	4	-	-	PUNCT
iajs-3630	242	5	e197337	e197337	PROPN
iajs-3630	242	6	.	.	PUNCT
iajs-3630	243	1	https://doi.org/10.1001/jamanetworkopen.2019.7337	https://doi.org/10.1001/jamanetworkopen.2019.7337	PROPN
iajs-3630	243	2	https://doi.org/10.24996/ijs.2021.62.10.2	https://doi.org/10.24996/ijs.2021.62.10.2	PUNCT
iajs-3630	243	3	https://doi.org/10.29252/ijwph.14.1.105	https://doi.org/10.29252/ijwph.14.1.105	PROPN
iajs-3630	243	4	.	.	PUNCT
iajs-3630	244	1	https://doi.org/10.22034/ecc.2022.325049.1307	https://doi.org/10.22034/ecc.2022.325049.1307	X
iajs-3630	244	2	.	.	PUNCT
iajs-3630	245	1	.%20https:/doi.org/10.1016	.%20https:/doi.org/10.1016	PUNCT
iajs-3630	245	2	/	/	SYM
iajs-3630	245	3	j.cytogfr.2021.05.002	j.cytogfr.2021.05.002	NOUN
iajs-3630	245	4	.	.	PUNCT
iajs-3630	246	1	.%20https:/doi.org/10.1371	.%20https:/doi.org/10.1371	PUNCT
iajs-3630	246	2	/	/	SYM
iajs-3630	247	1	journal.pgen.1009018	journal.pgen.1009018	PROPN
iajs-3630	247	2	.	.	PUNCT
iajs-3630	248	1	https://doi.org/10.1146/annurev-publhealth-090419-102644	https://doi.org/10.1146/annurev-publhealth-090419-102644	PROPN
iajs-3630	248	2	.	.	PUNCT
iajs-3630	249	1	https://doi.org/10.1038/nrendo.2017.151	https://doi.org/10.1038/nrendo.2017.151	PROPN
iajs-3630	249	2	.	.	PUNCT
iajs-3630	250	1	https://doi.org/10.1186/s12872-021-02380-0	https://doi.org/10.1186/s12872-021-02380-0	NUM
iajs-3630	250	2	.	.	PUNCT
iajs-3630	251	1	https://doi.org/10.21608/ejchem.2022.112977.5143	https://doi.org/10.21608/ejchem.2022.112977.5143	NOUN
iajs-3630	251	2	.	.	PUNCT
iajs-3630	252	1	https://doi.org/10.7897/2230-8407.0912286	https://doi.org/10.7897/2230-8407.0912286	PROPN
iajs-3630	252	2	.	.	PUNCT
iajs-3630	253	1	https://doi.org/10.1186/s12889-019-6485-y	https://doi.org/10.1186/s12889-019-6485-y	PROPN
iajs-3630	253	2	.	.	PUNCT
iajs-3630	254	1	https://doi.org/10.1097/nt.0000000000000092	https://doi.org/10.1097/nt.0000000000000092	PROPN
iajs-3630	254	2	.	.	PUNCT
iajs-3630	254	3	https://doi.org/10.1371/journal.pone.0229384	https://doi.org/10.1371/journal.pone.0229384	PROPN
iajs-3630	254	4	.	.	PUNCT
iajs-3630	254	5	https://doi.org/10.15167/2421-4248/jpmh2017.58.1.648	https://doi.org/10.15167/2421-4248/jpmh2017.58.1.648	PROPN
iajs-3630	254	6	.	.	PUNCT
iajs-3630	254	7	.%20https:/doi.org/10.1001	.%20https:/doi.org/10.1001	PROPN
iajs-3630	254	8	/	/	SYM
iajs-3630	254	9	jamanetworkopen.2019.7337	jamanetworkopen.2019.7337	PROPN
iajs-3630	254	10	ihjpas	ihjpas	PROPN
iajs-3630	254	11	.	.	PUNCT
iajs-3630	255	1	2025	2025	NUM
iajs-3630	255	2	,	,	PUNCT
iajs-3630	255	3	38	38	NUM
iajs-3630	255	4	(	(	PUNCT
iajs-3630	255	5	1	1	NUM
iajs-3630	255	6	)	)	PUNCT
iajs-3630	255	7	312	312	NUM
iajs-3630	255	8	20	20	NUM
iajs-3630	255	9	.	.	PUNCT
iajs-3630	256	1	elimam	elimam	PROPN
iajs-3630	256	2	h	h	PROPN
iajs-3630	256	3	,	,	PUNCT
iajs-3630	256	4	abdulla	abdulla	PROPN
iajs-3630	256	5	am	am	PROPN
iajs-3630	256	6	,	,	PUNCT
iajs-3630	256	7	taha	taha	PROPN
iajs-3630	257	1	i	i	PRON
iajs-3630	257	2	m.	m.	VERB
iajs-3630	257	3	inflammatory	inflammatory	ADJ
iajs-3630	257	4	markers	marker	NOUN
iajs-3630	257	5	and	and	CCONJ
iajs-3630	257	6	control	control	NOUN
iajs-3630	257	7	of	of	ADP
iajs-3630	257	8	type	type	NOUN
iajs-3630	257	9	2	2	NUM
iajs-3630	257	10	diabetes	diabetes	NOUN
iajs-3630	257	11	mellitus	mellitus	NOUN
iajs-3630	257	12	.	.	PUNCT
iajs-3630	258	1	diabetes	diabetes	NOUN
iajs-3630	258	2	metab	metab	ADJ
iajs-3630	258	3	syndr	syndr	PROPN
iajs-3630	258	4	clin	clin	PROPN
iajs-3630	258	5	res	res	PROPN
iajs-3630	258	6	rev	rev	PROPN
iajs-3630	258	7	.	.	PROPN
iajs-3630	258	8	2019	2019	NUM
iajs-3630	258	9	;	;	PUNCT
iajs-3630	258	10	13(1):800	13(1):800	NUM
iajs-3630	258	11	-	-	NOUN
iajs-3630	258	12	804	804	NUM
iajs-3630	258	13	.	.	PUNCT
iajs-3630	259	1	https://doi.org/10.1016/j.dsx.2018.11.061	https://doi.org/10.1016/j.dsx.2018.11.061	PROPN
iajs-3630	259	2	21	21	NUM
iajs-3630	259	3	.	.	PUNCT
iajs-3630	260	1	misra	misra	PROPN
iajs-3630	260	2	a	a	PRON
iajs-3630	260	3	,	,	PUNCT
iajs-3630	260	4	bloomgarden	bloomgarden	ADJ
iajs-3630	260	5	zt	zt	PROPN
iajs-3630	260	6	.	.	PROPN
iajs-3630	260	7	discordance	discordance	NOUN
iajs-3630	260	8	between	between	ADP
iajs-3630	260	9	hba1c	hba1c	PROPN
iajs-3630	260	10	and	and	CCONJ
iajs-3630	260	11	glycemia	glycemia	PROPN
iajs-3630	260	12	.	.	PUNCT
iajs-3630	261	1	j	j	PROPN
iajs-3630	261	2	diabetes	diabetes	NOUN
iajs-3630	261	3	.	.	PUNCT
iajs-3630	262	1	2018	2018	NUM
iajs-3630	262	2	;	;	PUNCT
iajs-3630	262	3	10	10	NUM
iajs-3630	262	4	:	:	PUNCT
iajs-3630	262	5	908–910	908–910	NUM
iajs-3630	262	6	.	.	PUNCT
iajs-3630	263	1	https://doi.org/10.1111/1753-0407.12843	https://doi.org/10.1111/1753-0407.12843	NOUN
iajs-3630	263	2	22	22	NUM
iajs-3630	263	3	.	.	PUNCT
iajs-3630	264	1	mohsen	mohsen	PROPN
iajs-3630	264	2	ih	ih	PROPN
iajs-3630	264	3	,	,	PUNCT
iajs-3630	264	4	zaidan	zaidan	PROPN
iajs-3630	264	5	hk	hk	PROPN
iajs-3630	264	6	,	,	PUNCT
iajs-3630	264	7	al	al	PROPN
iajs-3630	264	8	-	-	PUNCT
iajs-3630	264	9	saadi	saadi	PROPN
iajs-3630	264	10	ah	ah	INTJ
iajs-3630	264	11	.	.	PUNCT
iajs-3630	264	12	interaction	interaction	NOUN
iajs-3630	264	13	of	of	ADP
iajs-3630	264	14	insulin	insulin	NOUN
iajs-3630	264	15	hormone	hormone	NOUN
iajs-3630	264	16	with	with	ADP
iajs-3630	264	17	microalbuminuria	microalbuminuria	PROPN
iajs-3630	264	18	and	and	CCONJ
iajs-3630	264	19	blood	blood	NOUN
iajs-3630	264	20	pressure	pressure	NOUN
iajs-3630	264	21	in	in	ADP
iajs-3630	264	22	type	type	NOUN
iajs-3630	264	23	2	2	NUM
iajs-3630	264	24	diabetic	diabetic	ADJ
iajs-3630	264	25	patients	patient	NOUN
iajs-3630	264	26	.	.	PUNCT
iajs-3630	265	1	j	j	PROPN
iajs-3630	265	2	univ	univ	PROPN
iajs-3630	265	3	babylon	babylon	PROPN
iajs-3630	265	4	.	.	PROPN
iajs-3630	265	5	2016	2016	NUM
iajs-3630	265	6	;	;	PUNCT
iajs-3630	265	7	24(5):1493	24(5):1493	NUM
iajs-3630	265	8	-	-	SYM
iajs-3630	265	9	1500	1500	NUM
iajs-3630	265	10	.	.	PUNCT
iajs-3630	266	1	23	23	NUM
iajs-3630	266	2	.	.	PUNCT
iajs-3630	267	1	wali	wali	PROPN
iajs-3630	267	2	ja	ja	PROPN
iajs-3630	267	3	,	,	PUNCT
iajs-3630	267	4	thomas	thomas	PROPN
iajs-3630	268	1	he	he	PRON
iajs-3630	268	2	,	,	PUNCT
iajs-3630	268	3	sutherland	sutherland	PROPN
iajs-3630	268	4	apr	apr	PROPN
iajs-3630	268	5	.	.	PUNCT
iajs-3630	269	1	linking	link	VERB
iajs-3630	269	2	obesity	obesity	NOUN
iajs-3630	269	3	with	with	ADP
iajs-3630	269	4	type	type	NOUN
iajs-3630	269	5	2	2	NUM
iajs-3630	269	6	diabetes	diabete	NOUN
iajs-3630	269	7	:	:	PUNCT
iajs-3630	269	8	the	the	DET
iajs-3630	269	9	role	role	NOUN
iajs-3630	269	10	of	of	ADP
iajs-3630	269	11	t	t	PROPN
iajs-3630	269	12	-	-	PUNCT
iajs-3630	269	13	bet	bet	NOUN
iajs-3630	269	14	.	.	PUNCT
iajs-3630	270	1	diabetes	diabetes	NOUN
iajs-3630	270	2	metab	metab	NOUN
iajs-3630	270	3	syndr	syndr	NOUN
iajs-3630	270	4	obes	obe	NOUN
iajs-3630	270	5	.	.	PUNCT
iajs-3630	271	1	2014;7:331	2014;7:331	NOUN
iajs-3630	271	2	-	-	PUNCT
iajs-3630	271	3	340	340	NUM
iajs-3630	271	4	.	.	PUNCT
iajs-3630	272	1	https://doi.org/10.2147/dmso.s51432	https://doi.org/10.2147/dmso.s51432	NOUN
iajs-3630	272	2	24	24	NUM
iajs-3630	272	3	.	.	PUNCT
iajs-3630	273	1	al	al	PROPN
iajs-3630	273	2	-	-	PUNCT
iajs-3630	273	3	attaby	attaby	PROPN
iajs-3630	273	4	akt	akt	PROPN
iajs-3630	273	5	,	,	PUNCT
iajs-3630	273	6	al	al	PROPN
iajs-3630	273	7	-	-	PUNCT
iajs-3630	273	8	lami	lami	PROPN
iajs-3630	273	9	mqd	mqd	NOUN
iajs-3630	273	10	.	.	PUNCT
iajs-3630	274	1	role	role	NOUN
iajs-3630	274	2	of	of	ADP
iajs-3630	274	3	calcium	calcium	NOUN
iajs-3630	274	4	-	-	PUNCT
iajs-3630	274	5	regulating	regulate	VERB
iajs-3630	274	6	hormones	hormone	NOUN
iajs-3630	274	7	,	,	PUNCT
iajs-3630	274	8	adipocytokines	adipocytokine	NOUN
iajs-3630	274	9	and	and	CCONJ
iajs-3630	274	10	renal	renal	ADJ
iajs-3630	274	11	function	function	NOUN
iajs-3630	274	12	tests	test	NOUN
iajs-3630	274	13	in	in	ADP
iajs-3630	274	14	the	the	DET
iajs-3630	274	15	progress	progress	NOUN
iajs-3630	274	16	of	of	ADP
iajs-3630	274	17	type	type	NOUN
iajs-3630	274	18	2	2	NUM
iajs-3630	274	19	diabetes	diabetes	NOUN
iajs-3630	274	20	mellitus	mellitus	NOUN
iajs-3630	274	21	in	in	ADP
iajs-3630	274	22	a	a	DET
iajs-3630	274	23	sample	sample	NOUN
iajs-3630	274	24	of	of	ADP
iajs-3630	274	25	iraqi	iraqi	ADJ
iajs-3630	274	26	patients	patient	NOUN
iajs-3630	274	27	.	.	PUNCT
iajs-3630	275	1	iraqi	iraqi	ADJ
iajs-3630	275	2	j	j	PROPN
iajs-3630	275	3	agric	agric	PROPN
iajs-3630	275	4	sci	sci	PROPN
iajs-3630	275	5	.	.	PROPN
iajs-3630	275	6	2019	2019	NUM
iajs-3630	275	7	;	;	PUNCT
iajs-3630	275	8	50(1):343	50(1):343	PROPN
iajs-3630	275	9	-	-	PUNCT
iajs-3630	275	10	351	351	NUM
iajs-3630	275	11	.	.	PUNCT
iajs-3630	276	1	https://doi.org/10.36103/ijas.v50i1.300	https://doi.org/10.36103/ijas.v50i1.300	NOUN
iajs-3630	276	2	25	25	NUM
iajs-3630	276	3	.	.	PUNCT
iajs-3630	277	1	yassin	yassin	PROPN
iajs-3630	277	2	mm	mm	PROPN
iajs-3630	277	3	,	,	PUNCT
iajs-3630	277	4	altibi	altibi	PROPN
iajs-3630	277	5	hi	hi	PROPN
iajs-3630	277	6	,	,	PUNCT
iajs-3630	277	7	el	el	PROPN
iajs-3630	277	8	shanti	shanti	PROPN
iajs-3630	277	9	ae	ae	PROPN
iajs-3630	277	10	.	.	PUNCT
iajs-3630	278	1	clinical	clinical	ADJ
iajs-3630	278	2	and	and	CCONJ
iajs-3630	278	3	biochemical	biochemical	ADJ
iajs-3630	278	4	features	feature	NOUN
iajs-3630	278	5	of	of	ADP
iajs-3630	278	6	type	type	NOUN
iajs-3630	278	7	2	2	NUM
iajs-3630	278	8	diabetic	diabetic	ADJ
iajs-3630	278	9	patients	patient	NOUN
iajs-3630	278	10	in	in	ADP
iajs-3630	278	11	gaza	gaza	PROPN
iajs-3630	278	12	governorate	governorate	PROPN
iajs-3630	278	13	,	,	PUNCT
iajs-3630	278	14	gaza	gaza	PROPN
iajs-3630	278	15	strip	strip	PROPN
iajs-3630	278	16	.	.	PUNCT
iajs-3630	279	1	west	west	PROPN
iajs-3630	279	2	afr	afr	PROPN
iajs-3630	279	3	j	j	PROPN
iajs-3630	279	4	med	med	PROPN
iajs-3630	279	5	.	.	PUNCT
iajs-3630	279	6	2011	2011	NUM
iajs-3630	279	7	;	;	PUNCT
iajs-3630	279	8	30(1):51	30(1):51	NUM
iajs-3630	279	9	-	-	SYM
iajs-3630	279	10	56	56	NUM
iajs-3630	279	11	.	.	PUNCT
iajs-3630	280	1	https://doi.org/10.4314/wajm.v30i1.69918	https://doi.org/10.4314/wajm.v30i1.69918	X
iajs-3630	280	2	26	26	NUM
iajs-3630	280	3	.	.	PUNCT
iajs-3630	280	4	ali	ali	PROPN
iajs-3630	280	5	ee	ee	PROPN
iajs-3630	280	6	,	,	PUNCT
iajs-3630	280	7	dafalla	dafalla	PROPN
iajs-3630	280	8	am	be	AUX
iajs-3630	280	9	,	,	PUNCT
iajs-3630	280	10	mohammed	mohammed	PROPN
iajs-3630	280	11	ya	ya	PROPN
iajs-3630	280	12	,	,	PUNCT
iajs-3630	280	13	nour	nour	PROPN
iajs-3630	280	14	by	by	ADP
iajs-3630	280	15	.	.	PUNCT
iajs-3630	281	1	correlation	correlation	NOUN
iajs-3630	281	2	between	between	ADP
iajs-3630	281	3	serum	serum	NOUN
iajs-3630	281	4	cd36	cd36	PROPN
iajs-3630	281	5	level	level	NOUN
iajs-3630	281	6	and	and	CCONJ
iajs-3630	281	7	lipid	lipid	NOUN
iajs-3630	281	8	profile	profile	NOUN
iajs-3630	281	9	in	in	ADP
iajs-3630	281	10	patients	patient	NOUN
iajs-3630	281	11	with	with	ADP
iajs-3630	281	12	type	type	NOUN
iajs-3630	281	13	2	2	NUM
iajs-3630	281	14	diabetes	diabetes	NOUN
iajs-3630	281	15	mellitus	mellitus	NOUN
iajs-3630	281	16	,	,	PUNCT
iajs-3630	281	17	khartoum	khartoum	PROPN
iajs-3630	281	18	state	state	PROPN
iajs-3630	281	19	,	,	PUNCT
iajs-3630	281	20	sudan	sudan	PROPN
iajs-3630	281	21	.	.	PUNCT
iajs-3630	282	1	j	j	PROPN
iajs-3630	282	2	diabetes	diabetes	PROPN
iajs-3630	282	3	mellitus	mellitus	NOUN
iajs-3630	282	4	.	.	PUNCT
iajs-3630	283	1	2023;13(1):68	2023;13(1):68	NUM
iajs-3630	283	2	-	-	SYM
iajs-3630	283	3	75	75	NUM
iajs-3630	283	4	.	.	PUNCT
iajs-3630	284	1	https://doi.org/10.4236/jdm.2023.131007	https://doi.org/10.4236/jdm.2023.131007	ADJ
iajs-3630	284	2	27	27	NUM
iajs-3630	284	3	.	.	PUNCT
iajs-3630	285	1	choi	choi	PROPN
iajs-3630	285	2	yk	yk	PROPN
iajs-3630	285	3	,	,	PUNCT
iajs-3630	285	4	kim	kim	PROPN
iajs-3630	285	5	mk	mk	PROPN
iajs-3630	285	6	,	,	PUNCT
iajs-3630	285	7	bae	bae	PROPN
iajs-3630	285	8	kh	kh	PROPN
iajs-3630	285	9	,	,	PUNCT
iajs-3630	285	10	seo	seo	PROPN
iajs-3630	285	11	ha	ha	INTJ
iajs-3630	285	12	,	,	PUNCT
iajs-3630	285	13	jeong	jeong	PROPN
iajs-3630	285	14	jy	jy	PROPN
iajs-3630	285	15	,	,	PUNCT
iajs-3630	285	16	lee	lee	PROPN
iajs-3630	285	17	wk	wk	PROPN
iajs-3630	285	18	,	,	PUNCT
iajs-3630	285	19	park	park	NOUN
iajs-3630	285	20	kg	kg	PROPN
iajs-3630	285	21	.	.	PUNCT
iajs-3630	286	1	serum	serum	PROPN
iajs-3630	286	2	irisin	irisin	PROPN
iajs-3630	286	3	levels	level	NOUN
iajs-3630	286	4	in	in	ADP
iajs-3630	286	5	new	new	ADJ
iajs-3630	286	6	-	-	PUNCT
iajs-3630	286	7	onset	onset	NOUN
iajs-3630	286	8	type	type	NOUN
iajs-3630	286	9	2	2	NUM
iajs-3630	286	10	diabetes	diabetes	NOUN
iajs-3630	286	11	.	.	PUNCT
iajs-3630	287	1	diabetes	diabetes	NOUN
iajs-3630	287	2	res	re	VERB
iajs-3630	287	3	clin	clin	PROPN
iajs-3630	287	4	pract	pract	PROPN
iajs-3630	287	5	.	.	PUNCT
iajs-3630	288	1	2013	2013	NUM
iajs-3630	288	2	;	;	PUNCT
iajs-3630	289	1	100(1):96	100(1):96	NUM
iajs-3630	289	2	-	-	SYM
iajs-3630	289	3	101	101	NUM
iajs-3630	289	4	.	.	PUNCT
iajs-3630	290	1	https://doi.org/10.1016/j.diabres.2013.01.007	https://doi.org/10.1016/j.diabres.2013.01.007	PROPN
iajs-3630	290	2	28	28	NUM
iajs-3630	290	3	.	.	PUNCT
iajs-3630	291	1	shoukry	shoukry	PROPN
iajs-3630	291	2	a	a	PRON
iajs-3630	291	3	,	,	PUNCT
iajs-3630	291	4	shalaby	shalaby	X
iajs-3630	291	5	sm	sm	PROPN
iajs-3630	291	6	,	,	PUNCT
iajs-3630	291	7	el‐arabi	el‐arabi	VERB
iajs-3630	291	8	bdeer	bdeer	NOUN
iajs-3630	291	9	s	s	PROPN
iajs-3630	291	10	,	,	PUNCT
iajs-3630	291	11	mahmoud	mahmoud	PROPN
iajs-3630	291	12	aa	aa	PROPN
iajs-3630	291	13	,	,	PUNCT
iajs-3630	291	14	mousa	mousa	PROPN
iajs-3630	291	15	mm	mm	PROPN
iajs-3630	291	16	,	,	PUNCT
iajs-3630	291	17	khalifa	khalifa	PROPN
iajs-3630	291	18	a.	a.	NOUN
iajs-3630	291	19	circulating	circulate	VERB
iajs-3630	291	20	serum	serum	NOUN
iajs-3630	291	21	irisin	irisin	PROPN
iajs-3630	291	22	levels	level	NOUN
iajs-3630	291	23	in	in	ADP
iajs-3630	291	24	obesity	obesity	NOUN
iajs-3630	291	25	and	and	CCONJ
iajs-3630	291	26	type	type	NOUN
iajs-3630	291	27	2	2	NUM
iajs-3630	291	28	diabetes	diabetes	NOUN
iajs-3630	291	29	mellitus	mellitus	NOUN
iajs-3630	291	30	.	.	PUNCT
iajs-3630	292	1	iubmb	iubmb	NOUN
iajs-3630	292	2	life	life	NOUN
iajs-3630	292	3	.	.	PUNCT
iajs-3630	293	1	2016	2016	NUM
iajs-3630	293	2	;	;	PUNCT
iajs-3630	293	3	68(7):544	68(7):544	NUM
iajs-3630	293	4	-	-	SYM
iajs-3630	293	5	556	556	NUM
iajs-3630	293	6	.	.	PUNCT
iajs-3630	294	1	https://doi.org/	https://doi.org/	PROPN
iajs-3630	294	2	10.1002	10.1002	NUM
iajs-3630	294	3	/	/	SYM
iajs-3630	294	4	iub.1511	iub.1511	PROPN
iajs-3630	294	5	29	29	NUM
iajs-3630	294	6	.	.	PUNCT
iajs-3630	295	1	moreno	moreno	PROPN
iajs-3630	295	2	-	-	PUNCT
iajs-3630	295	3	navarrete	navarrete	PROPN
iajs-3630	295	4	jm	jm	PROPN
iajs-3630	295	5	,	,	PUNCT
iajs-3630	295	6	ortega	ortega	PROPN
iajs-3630	295	7	f	f	PROPN
iajs-3630	295	8	,	,	PUNCT
iajs-3630	295	9	serrano	serrano	PROPN
iajs-3630	295	10	m	m	PROPN
iajs-3630	295	11	,	,	PUNCT
iajs-3630	295	12	guerra	guerra	PROPN
iajs-3630	295	13	e	e	PROPN
iajs-3630	295	14	,	,	PUNCT
iajs-3630	295	15	pardo	pardo	PROPN
iajs-3630	295	16	g	g	PROPN
iajs-3630	295	17	,	,	PUNCT
iajs-3630	295	18	tinahones	tinahones	PROPN
iajs-3630	295	19	f	f	PROPN
iajs-3630	295	20	,	,	PUNCT
iajs-3630	295	21	fernández	fernández	PROPN
iajs-3630	295	22	-	-	PUNCT
iajs-3630	295	23	real	real	ADJ
iajs-3630	295	24	jm	jm	PROPN
iajs-3630	295	25	.	.	PROPN
iajs-3630	295	26	irisin	irisin	PROPN
iajs-3630	295	27	is	be	AUX
iajs-3630	295	28	expressed	express	VERB
iajs-3630	295	29	and	and	CCONJ
iajs-3630	295	30	produced	produce	VERB
iajs-3630	295	31	by	by	ADP
iajs-3630	295	32	human	human	ADJ
iajs-3630	295	33	muscle	muscle	NOUN
iajs-3630	295	34	and	and	CCONJ
iajs-3630	295	35	adipose	adipose	PRON
iajs-3630	295	36	tissue	tissue	NOUN
iajs-3630	295	37	in	in	ADP
iajs-3630	295	38	association	association	NOUN
iajs-3630	295	39	with	with	ADP
iajs-3630	295	40	obesity	obesity	NOUN
iajs-3630	295	41	and	and	CCONJ
iajs-3630	295	42	insulin	insulin	NOUN
iajs-3630	295	43	resistance.j	resistance.j	NOUN
iajs-3630	295	44	clin	clin	PROPN
iajs-3630	295	45	endocrinol	endocrinol	NOUN
iajs-3630	295	46	metab	metab	NOUN
iajs-3630	295	47	.	.	PUNCT
iajs-3630	296	1	2013	2013	NUM
iajs-3630	296	2	;	;	PUNCT
iajs-3630	296	3	98(4	98(4	NUM
iajs-3630	296	4	):	):	PUNCT
iajs-3630	296	5	e769	e769	PROPN
iajs-3630	296	6	-	-	SYM
iajs-3630	296	7	e778	e778	PROPN
iajs-3630	296	8	.	.	PUNCT
iajs-3630	297	1	https://doi.org/10.1210/jc.20122749	https://doi.org/10.1210/jc.20122749	PROPN
iajs-3630	297	2	30	30	NUM
iajs-3630	297	3	.	.	PUNCT
iajs-3630	298	1	huh	huh	INTJ
iajs-3630	299	1	jh	jh	PROPN
iajs-3630	299	2	,	,	PUNCT
iajs-3630	299	3	ahn	ahn	PROPN
iajs-3630	299	4	sv	sv	PROPN
iajs-3630	299	5	,	,	PUNCT
iajs-3630	299	6	choi	choi	PROPN
iajs-3630	299	7	jh	jh	PROPN
iajs-3630	299	8	,	,	PUNCT
iajs-3630	299	9	koh	koh	PROPN
iajs-3630	299	10	sb	sb	PROPN
iajs-3630	299	11	,	,	PUNCT
iajs-3630	299	12	chung	chung	PROPN
iajs-3630	299	13	ch	ch	PROPN
iajs-3630	299	14	.	.	PROPN
iajs-3630	299	15	high	high	ADJ
iajs-3630	299	16	serum	serum	NOUN
iajs-3630	299	17	irisin	irisin	NOUN
iajs-3630	299	18	level	level	NOUN
iajs-3630	299	19	as	as	ADP
iajs-3630	299	20	an	an	DET
iajs-3630	299	21	independent	independent	ADJ
iajs-3630	299	22	predictor	predictor	NOUN
iajs-3630	299	23	of	of	ADP
iajs-3630	299	24	diabetes	diabetes	NOUN
iajs-3630	299	25	mellitus	mellitus	NOUN
iajs-3630	299	26	:	:	PUNCT
iajs-3630	299	27	a	a	DET
iajs-3630	299	28	longitudinal	longitudinal	ADJ
iajs-3630	299	29	population	population	NOUN
iajs-3630	299	30	-	-	PUNCT
iajs-3630	299	31	based	base	VERB
iajs-3630	299	32	study	study	NOUN
iajs-3630	299	33	.	.	PUNCT
iajs-3630	300	1	medicine	medicine	NOUN
iajs-3630	300	2	(	(	PUNCT
iajs-3630	300	3	baltimore	baltimore	PROPN
iajs-3630	300	4	)	)	PUNCT
iajs-3630	300	5	.	.	PUNCT
iajs-3630	301	1	2016	2016	NUM
iajs-3630	301	2	;	;	PUNCT
iajs-3630	301	3	95(23):e3742	95(23):e3742	NUM
iajs-3630	301	4	.	.	PUNCT
iajs-3630	302	1	https://doi.org/10.1097/md.0000000000003742	https://doi.org/10.1097/md.0000000000003742	X
iajs-3630	302	2	31	31	NUM
iajs-3630	302	3	.	.	PUNCT
iajs-3630	303	1	al	al	PROPN
iajs-3630	303	2	-	-	PUNCT
iajs-3630	303	3	daghri	daghri	PROPN
iajs-3630	303	4	nm	nm	PROPN
iajs-3630	303	5	,	,	PUNCT
iajs-3630	303	6	alokail	alokail	PROPN
iajs-3630	303	7	ms	ms	PROPN
iajs-3630	303	8	,	,	PUNCT
iajs-3630	303	9	rahman	rahman	PROPN
iajs-3630	303	10	s	s	PROPN
iajs-3630	303	11	,	,	PUNCT
iajs-3630	303	12	amer	amer	PROPN
iajs-3630	303	13	oe	oe	PROPN
iajs-3630	303	14	,	,	PUNCT
iajs-3630	303	15	al	al	PROPN
iajs-3630	303	16	-	-	PUNCT
iajs-3630	303	17	attas	attas	PROPN
iajs-3630	303	18	o	o	NOUN
iajs-3630	303	19	,	,	PUNCT
iajs-3630	303	20	alfawaz	alfawaz	NOUN
iajs-3630	303	21	h	h	NOUN
iajs-3630	303	22	,	,	PUNCT
iajs-3630	303	23	tripathi	tripathi	PROPN
iajs-3630	303	24	g	g	PROPN
iajs-3630	303	25	,	,	PUNCT
iajs-3630	303	26	sabico	sabico	NOUN
iajs-3630	303	27	s	s	PART
iajs-3630	303	28	,	,	PUNCT
iajs-3630	303	29	chrousos	chrousos	PROPN
iajs-3630	303	30	gp	gp	NOUN
iajs-3630	303	31	,	,	PUNCT
iajs-3630	303	32	mcternan	mcternan	NOUN
iajs-3630	303	33	pg	pg	PROPN
iajs-3630	303	34	,	,	PUNCT
iajs-3630	303	35	piya	piya	PROPN
iajs-3630	303	36	mk	mk	PROPN
iajs-3630	303	37	.	.	PUNCT
iajs-3630	304	1	habitual	habitual	ADJ
iajs-3630	304	2	physical	physical	ADJ
iajs-3630	304	3	activity	activity	NOUN
iajs-3630	304	4	is	be	AUX
iajs-3630	304	5	associated	associate	VERB
iajs-3630	304	6	with	with	ADP
iajs-3630	304	7	circulating	circulate	VERB
iajs-3630	304	8	irisin	irisin	NOUN
iajs-3630	304	9	in	in	ADP
iajs-3630	304	10	healthy	healthy	ADJ
iajs-3630	304	11	controls	control	NOUN
iajs-3630	304	12	but	but	CCONJ
iajs-3630	304	13	not	not	PART
iajs-3630	304	14	in	in	ADP
iajs-3630	304	15	subjects	subject	NOUN
iajs-3630	304	16	with	with	ADP
iajs-3630	304	17	diabetes	diabetes	NOUN
iajs-3630	304	18	mellitus	mellitus	NOUN
iajs-3630	304	19	type	type	VERB
iajs-3630	304	20	2	2	NUM
iajs-3630	304	21	.	.	PUNCT
iajs-3630	304	22	eur	eur	PROPN
iajs-3630	304	23	j	j	PROPN
iajs-3630	304	24	clin	clin	PROPN
iajs-3630	304	25	invest	invest	PROPN
iajs-3630	304	26	.	.	PUNCT
iajs-3630	305	1	2015	2015	NUM
iajs-3630	305	2	;	;	PUNCT
iajs-3630	306	1	45(8):775781	45(8):775781	NUM
iajs-3630	306	2	.	.	PUNCT
iajs-3630	307	1	https://doi.org/10.1111/eci.12468	https://doi.org/10.1111/eci.12468	NOUN
iajs-3630	307	2	.	.	PUNCT
iajs-3630	308	1	32	32	NUM
iajs-3630	308	2	.	.	PUNCT
iajs-3630	309	1	park	park	PROPN
iajs-3630	309	2	k	k	PROPN
iajs-3630	309	3	,	,	PUNCT
iajs-3630	309	4	zaichenko	zaichenko	PROPN
iajs-3630	309	5	l	l	NOUN
iajs-3630	309	6	,	,	PUNCT
iajs-3630	309	7	brinkoetter	brinkoetter	PROPN
iajs-3630	309	8	m	m	PROPN
iajs-3630	309	9	,	,	PUNCT
iajs-3630	309	10	thakkar	thakkar	PROPN
iajs-3630	309	11	b	b	PROPN
iajs-3630	309	12	,	,	PUNCT
iajs-3630	309	13	sahin	sahin	PROPN
iajs-3630	309	14	-	-	PUNCT
iajs-3630	309	15	efe	efe	PROPN
iajs-3630	309	16	a	a	NOUN
iajs-3630	309	17	,	,	PUNCT
iajs-3630	309	18	joung	joung	PROPN
iajs-3630	309	19	ke	ke	PROPN
iajs-3630	309	20	,	,	PUNCT
iajs-3630	309	21	mantzoros	mantzoros	PROPN
iajs-3630	309	22	cs	cs	PROPN
iajs-3630	309	23	.	.	PROPN
iajs-3630	309	24	circulating	circulate	VERB
iajs-3630	309	25	irisin	irisin	NOUN
iajs-3630	309	26	in	in	ADP
iajs-3630	309	27	relation	relation	NOUN
iajs-3630	309	28	to	to	ADP
iajs-3630	309	29	insulin	insulin	NOUN
iajs-3630	309	30	resistance	resistance	NOUN
iajs-3630	309	31	and	and	CCONJ
iajs-3630	309	32	the	the	DET
iajs-3630	309	33	metabolic	metabolic	NOUN
iajs-3630	309	34	syndrome	syndrome	NOUN
iajs-3630	309	35	.	.	PUNCT
iajs-3630	310	1	j	j	PROPN
iajs-3630	310	2	clin	clin	PROPN
iajs-3630	310	3	endocrinol	endocrinol	PROPN
iajs-3630	310	4	metab	metab	NOUN
iajs-3630	310	5	.	.	PUNCT
iajs-3630	311	1	2013	2013	NUM
iajs-3630	311	2	;	;	PUNCT
iajs-3630	311	3	98(12	98(12	NUM
iajs-3630	311	4	):	):	PUNCT
iajs-3630	311	5	4899	4899	NUM
iajs-3630	311	6	-	-	SYM
iajs-3630	311	7	4907	4907	NUM
iajs-3630	311	8	.	.	PUNCT
iajs-3630	312	1	https://doi.org/10.1210/jc.2013-2373	https://doi.org/10.1210/jc.2013-2373	NOUN
iajs-3630	312	2	https://doi.org/10.1016/j.dsx.2018.11.061	https://doi.org/10.1016/j.dsx.2018.11.061	PROPN
iajs-3630	312	3	.	.	PUNCT
iajs-3630	313	1	https://doi.org/10.1111/1753-0407.12843	https://doi.org/10.1111/1753-0407.12843	NOUN
iajs-3630	313	2	.	.	PUNCT
iajs-3630	314	1	https://doi.org/10.2147/dmso.s51432	https://doi.org/10.2147/dmso.s51432	VERB
iajs-3630	314	2	https://doi.org/10.36103/ijas.v50i1.300	https://doi.org/10.36103/ijas.v50i1.300	PROPN
iajs-3630	314	3	.	.	PUNCT
iajs-3630	315	1	https://doi.org/10.4314/wajm.v30i1.69918	https://doi.org/10.4314/wajm.v30i1.69918	NOUN
iajs-3630	315	2	.	.	PUNCT
iajs-3630	316	1	https://doi.org/10.4236/jdm.2023.131007	https://doi.org/10.4236/jdm.2023.131007	PROPN
iajs-3630	316	2	.	.	PUNCT
iajs-3630	317	1	https://doi.org/10.1016/j.diabres.2013.01.007	https://doi.org/10.1016/j.diabres.2013.01.007	PROPN
iajs-3630	317	2	https://doi.org/%2010.1002/iub.1511	https://doi.org/%2010.1002/iub.1511	PROPN
iajs-3630	317	3	.	.	PUNCT
iajs-3630	318	1	https://doi.org/10.1210/jc.2012-2749	https://doi.org/10.1210/jc.2012-2749	PROPN
iajs-3630	318	2	.	.	PUNCT
iajs-3630	319	1	https://doi.org/10.1210/jc.2012-2749	https://doi.org/10.1210/jc.2012-2749	NOUN
iajs-3630	319	2	.	.	PUNCT
iajs-3630	320	1	https://doi.org/10.1097/md.0000000000003742	https://doi.org/10.1097/md.0000000000003742	X
iajs-3630	320	2	.	.	PUNCT
iajs-3630	321	1	https://doi.org/10.1111/eci.12468	https://doi.org/10.1111/eci.12468	NOUN
iajs-3630	321	2	.	.	PUNCT
iajs-3630	322	1	https://doi.org/10.1210/jc.2013-2373	https://doi.org/10.1210/jc.2013-2373	NOUN